
<!DOCTYPE html>
<html>
<head>
<!-- Required meta tags -->
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<!-- Check Browser, as well as Hostname and set JS, CSS, Favicon path based on that-->

<!-- Favicon --><!-- cpcommit -->
<!-- <link rel="shortcut icon" type="image/x-icon" href="https://www.sec.gov/favicon.ico"> -->

<script>
	(function() {
		var hostName = window.location.hostname;

		var browserAccepted = function() {

			var ua = window.navigator.userAgent;
			var trident = ua.indexOf('Trident/'); //IE 11;
			var msie = ua.indexOf('MSIE '); // IE 10 or older
			if (msie > 0) {
				return false;
			}
			return true;
		}();

		var pathToLibs = 'https://www.sec.gov/js';
		var pathToError = '/';
		if (hostName === 'www-test.sec.gov' || hostName === 'www.sec.gov') {
			pathToLibs = 'https://www.sec.gov/ixviewer/js';
			pathToError = '/ixviewer/';
		}
		if (browserAccepted) {

			// css
			document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/custom-bootstrap.css>');
			document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/lib/fontawesome/css/all.min.css>');
			document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/app.css>');

			// js
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/jquery-3.3.1.slim.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/popper.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/bootstrap.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/moment.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/vanilla-picker.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/he.js"><\/script>');

			var date = new Date();
			var todaysDate = date.getDate() + '-' + (date.getMonth() + 1) + '-'
					+ date.getFullYear();
			document.write('<script type = "text/javascript" defer=true src="'
					+ pathToLibs + '/production.min.js?d=' + todaysDate
					+ '"><\/script>');
		} else {
			// user us on a browser that we do not support
			var currentUrl = window.location.href.split('?')[0];
			var browserError = currentUrl.substring(0, currentUrl
					.lastIndexOf('/'));
			browserError += pathToError + 'browser-error.html?url='
					+ encodeURIComponent(window.location.href);
			window.location.href = browserError;
		}
	})();
</script><link rel="stylesheet" href="https://www.sec.gov/ixviewer/js/css/custom-bootstrap.css"><link rel="stylesheet" href="https://www.sec.gov/ixviewer/js/lib/fontawesome/css/all.min.css"><link rel="stylesheet" href="https://www.sec.gov/ixviewer/js/css/app.css"><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/jquery-3.3.1.slim.min.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/popper.min.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/bootstrap.min.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/moment.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/vanilla-picker.min.js"></script><style>.picker_wrapper.no_alpha .picker_alpha{display:none}.picker_wrapper.no_editor .picker_editor{position:absolute;z-index:-1;opacity:0}.picker_wrapper.no_cancel .picker_cancel{display:none}.layout_default.picker_wrapper{display:-webkit-box;display:flex;-webkit-box-orient:horizontal;-webkit-box-direction:normal;flex-flow:row wrap;-webkit-box-pack:justify;justify-content:space-between;-webkit-box-align:stretch;align-items:stretch;font-size:10px;width:25em;padding:.5em}.layout_default.picker_wrapper input,.layout_default.picker_wrapper button{font-size:1rem}.layout_default.picker_wrapper>*{margin:.5em}.layout_default.picker_wrapper::before{content:'';display:block;width:100%;height:0;-webkit-box-ordinal-group:2;order:1}.layout_default .picker_slider,.layout_default .picker_selector{padding:1em}.layout_default .picker_hue{width:100%}.layout_default .picker_sl{-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_sl::before{content:'';display:block;padding-bottom:100%}.layout_default .picker_editor{-webkit-box-ordinal-group:2;order:1;width:6.5rem}.layout_default .picker_editor input{width:100%;height:100%}.layout_default .picker_sample{-webkit-box-ordinal-group:2;order:1;-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_done,.layout_default .picker_cancel{-webkit-box-ordinal-group:2;order:1}.picker_wrapper{box-sizing:border-box;background:#f2f2f2;box-shadow:0 0 0 1px silver;cursor:default;font-family:sans-serif;color:#444;pointer-events:auto}.picker_wrapper:focus{outline:none}.picker_wrapper button,.picker_wrapper input{box-sizing:border-box;border:none;box-shadow:0 0 0 1px silver;outline:none}.picker_wrapper button:focus,.picker_wrapper button:active,.picker_wrapper input:focus,.picker_wrapper input:active{box-shadow:0 0 2px 1px dodgerblue}.picker_wrapper button{padding:.4em .6em;cursor:pointer;background-color:whitesmoke;background-image:-webkit-gradient(linear, left bottom, left top, from(gainsboro), to(transparent));background-image:-webkit-linear-gradient(bottom, gainsboro, transparent);background-image:linear-gradient(0deg, gainsboro, transparent)}.picker_wrapper button:active{background-image:-webkit-gradient(linear, left bottom, left top, from(transparent), to(gainsboro));background-image:-webkit-linear-gradient(bottom, transparent, gainsboro);background-image:linear-gradient(0deg, transparent, gainsboro)}.picker_wrapper button:hover{background-color:white}.picker_selector{position:absolute;z-index:1;display:block;-webkit-transform:translate(-50%, -50%);transform:translate(-50%, -50%);border:2px solid white;border-radius:100%;box-shadow:0 0 3px 1px #67b9ff;background:currentColor;cursor:pointer}.picker_slider .picker_selector{border-radius:2px}.picker_hue{position:relative;background-image:-webkit-gradient(linear, left top, right top, from(red), color-stop(yellow), color-stop(lime), color-stop(cyan), color-stop(blue), color-stop(magenta), to(red));background-image:-webkit-linear-gradient(left, red, yellow, lime, cyan, blue, magenta, red);background-image:linear-gradient(90deg, red, yellow, lime, cyan, blue, magenta, red);box-shadow:0 0 0 1px silver}.picker_sl{position:relative;box-shadow:0 0 0 1px silver;background-image:-webkit-gradient(linear, left top, left bottom, from(white), color-stop(50%, rgba(255,255,255,0))),-webkit-gradient(linear, left bottom, left top, from(black), color-stop(50%, rgba(0,0,0,0))),-webkit-gradient(linear, left top, right top, from(gray), to(rgba(128,128,128,0)));background-image:-webkit-linear-gradient(top, white, rgba(255,255,255,0) 50%),-webkit-linear-gradient(bottom, black, rgba(0,0,0,0) 50%),-webkit-linear-gradient(left, gray, rgba(128,128,128,0));background-image:linear-gradient(180deg, white, rgba(255,255,255,0) 50%),linear-gradient(0deg, black, rgba(0,0,0,0) 50%),linear-gradient(90deg, gray, rgba(128,128,128,0))}.picker_alpha,.picker_sample{position:relative;background:url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E") left top/contain white;box-shadow:0 0 0 1px silver}.picker_alpha .picker_selector,.picker_sample .picker_selector{background:none}.picker_editor input{font-family:monospace;padding:.2em .4em}.picker_sample::before{content:'';position:absolute;display:block;width:100%;height:100%;background:currentColor}.picker_arrow{position:absolute;z-index:-1}.picker_wrapper.popup{position:absolute;z-index:2;margin:1.5em}.picker_wrapper.popup,.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{background:#f2f2f2;box-shadow:0 0 10px 1px rgba(0,0,0,0.4)}.picker_wrapper.popup .picker_arrow{width:3em;height:3em;margin:0}.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{content:"";display:block;position:absolute;top:0;left:0;z-index:-99}.picker_wrapper.popup .picker_arrow::before{width:100%;height:100%;-webkit-transform:skew(45deg);transform:skew(45deg);-webkit-transform-origin:0 100%;transform-origin:0 100%}.picker_wrapper.popup .picker_arrow::after{width:150%;height:150%;box-shadow:none}.popup.popup_top{bottom:100%;left:0}.popup.popup_top .picker_arrow{bottom:0;left:0;-webkit-transform:rotate(-90deg);transform:rotate(-90deg)}.popup.popup_bottom{top:100%;left:0}.popup.popup_bottom .picker_arrow{top:0;left:0;-webkit-transform:rotate(90deg) scale(1, -1);transform:rotate(90deg) scale(1, -1)}.popup.popup_left{top:0;right:100%}.popup.popup_left .picker_arrow{top:0;right:0;-webkit-transform:scale(-1, 1);transform:scale(-1, 1)}.popup.popup_right{top:0;left:100%}.popup.popup_right .picker_arrow{top:0;left:0}</style><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/he.js"></script><script type="text/javascript" defer="true" src="https://www.sec.gov/ixviewer/js/production.min.js?d=20-4-2022"></script>
<title>Inline XBRL Viewer</title>
<style type="text/css" id="customized-styles"> #dynamic-xbrl-form [enabled-taxonomy="true"][continued-taxonomy="false"]{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;display:inline;} #dynamic-xbrl-form [enabled-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;} #dynamic-xbrl-form [enabled-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;border-top:none;border-bottom:none;} #dynamic-xbrl-form [highlight-taxonomy="true"]{background-color:#FFD700 !important;} #dynamic-xbrl-form [highlight-taxonomy="true"] > *{background-color:#FFD700 !important;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-taxonomy="false"]{border:3px solid #003768 !important;display:inline;} #dynamic-xbrl-form [hover-taxonomy="true"]{background-color:rgba(255,0,0,0.3);} .tagged-data-example-1{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;} .search-results-example-1{background-color:#FFD700;} .tag-shading-exmple-1:hover{background-color:rgba(255,0,0,0.3);} .selected-fact-example-1{border:3px solid #003768 !important;}</style></head>
<body style="overflow:auto">

  
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html">



<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><span><ix:nonnumeric name="dei:AmendmentFlag" id="fact-identifier-0" contextref="c20210101to20211231" format="ixt:booleanfalse" inside-table="false" data-original-id="Fact_7a8b5948cbcb4a849d7e90308875f94d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="true" isstandardonly="true" iscustomonly="false">false</ix:nonnumeric></span><span><ix:nonnumeric name="dei:CurrentFiscalYearEndDate" id="fact-identifier-1" contextref="c20210101to20211231" format="ixt:datemonthday" inside-table="false" data-original-id="Fact_55e2b3cbc45742db91b9008d66efcbf7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="true" isstandardonly="true" iscustomonly="false">12-31</ix:nonnumeric></span><span><ix:nonnumeric name="dei:DocumentFiscalYearFocus" id="fact-identifier-2" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_fe5a1d14f741429bbc22e598d513d309" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="true" isstandardonly="true" iscustomonly="false">2021</ix:nonnumeric></span><span><ix:nonnumeric name="dei:DocumentFiscalPeriodFocus" id="fact-identifier-3" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_ad468d1bdf894ec2bfe65e90c83d3856" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="true" isstandardonly="true" iscustomonly="false">FY</ix:nonnumeric></span><span><ix:nonnumeric name="dei:EntityCentralIndexKey" id="fact-identifier-4" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_8a43ebc385264a97b96b02ca6ac782fe" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="true" isstandardonly="true" iscustomonly="false">0001824119</ix:nonnumeric></span><ix:nonnumeric id="Fact_347ad5ef7ca34f2393a389714c1eaab8">P10D</ix:nonnumeric><ix:nonnumeric id="Fact_4712fd7049bb4d76a00ab7336be1d6a1">688</ix:nonnumeric></ix:hidden><ix:references><link:schemaref xlink:href="jyac-20211231.xsd" xlink:type="simple"></link:schemaref></ix:references><ix:resources><xbrli:context id="c20210101to20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220415_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220415_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200826_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200826_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200826_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-08-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200826_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PrivatePlacementUnitsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201210to20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PublicSharesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-12-10</xbrli:startdate><xbrli:enddate>2020-12-10</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201123to20201123_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PrivatePlacementUnitsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-23</xbrli:startdate><xbrli:enddate>2020-11-23</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201123to20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PublicSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-23</xbrli:startdate><xbrli:enddate>2020-11-23</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201210to20201210_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PrivatePlacementUnitsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-12-10</xbrli:startdate><xbrli:enddate>2020-12-10</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201210_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PrivatePlacementUnitsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201123_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PrivatePlacementUnitsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PublicSharesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PublicSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201210to20201210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2020-12-10</xbrli:startdate><xbrli:enddate>2020-12-10</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201123to20201123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-23</xbrli:startdate><xbrli:enddate>2020-11-23</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20211231_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_SubsidiarySaleOfStockAxis_IPOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_SubsidiarySaleOfStockAxis_IPOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201122to20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PublicSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-22</xbrli:startdate><xbrli:enddate>2020-12-10</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">jyac:PublicSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201210to20201210_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-12-10</xbrli:startdate><xbrli:enddate>2020-12-10</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201123to20201123_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-23</xbrli:startdate><xbrli:enddate>2020-11-23</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201210_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201123_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200909to20200909_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-09-09</xbrli:startdate><xbrli:enddate>2020-09-09</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_SteveKelseyMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:SteveKelseyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-13</xbrli:startdate><xbrli:enddate>2020-11-13</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_SrinivasAkkarajuMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:SrinivasAkkarajuMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-13</xbrli:startdate><xbrli:enddate>2020-11-13</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_PamelaKleinMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:PamelaKleinMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-13</xbrli:startdate><xbrli:enddate>2020-11-13</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210924to20210924_RelatedPartyTransactionsByRelatedPartyAxis_DrLoriFriedmanMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:DrLoriFriedmanMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-09-24</xbrli:startdate><xbrli:enddate>2021-09-24</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_PerryKarsenMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:PerryKarsenMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-13</xbrli:startdate><xbrli:enddate>2020-11-13</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_CoryFreedlandMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:CoryFreedlandMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-13</xbrli:startdate><xbrli:enddate>2020-11-13</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_DanielSpiegelmanMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:DanielSpiegelmanMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-13</xbrli:startdate><xbrli:enddate>2020-11-13</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_RichardVanDorenMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:RichardVanDorenMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-13</xbrli:startdate><xbrli:enddate>2020-11-13</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201030to20201030_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-10-30</xbrli:startdate><xbrli:enddate>2020-10-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201210to20201210_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-12-10</xbrli:startdate><xbrli:enddate>2020-12-10</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201210_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201030_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201030_RangeAxis_MaximumMember_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20211231_RangeAxis_MinimumMember_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_RangeAxis_MinimumMember_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201104to20201104_GranteeStatusAxis_VicePresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-04</xbrli:startdate><xbrli:enddate>2020-11-04</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201116to20201116_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-16</xbrli:startdate><xbrli:enddate>2020-11-16</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201116to20201116_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionAxis_FounderSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-16</xbrli:startdate><xbrli:enddate>2020-11-16</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201104to20201104_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-04</xbrli:startdate><xbrli:enddate>2020-11-04</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionAxis_FounderSharesMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionAxis_FounderSharesMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionAxis_FounderSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:FounderSharesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20211231_GranteeStatusAxis_VicePresidentMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BalanceSheetLocationAxis_AccountsPayableAndAccruedLiabilitiesMember_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BalanceSheetLocationAxis_AccountsPayableAndAccruedLiabilitiesMember_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201118to20201118_RelatedPartyTransactionAxis_AdministrativeSupportAgreementMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:AdministrativeSupportAgreementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-18</xbrli:startdate><xbrli:enddate>2020-11-18</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_RelatedPartyTransactionAxis_AdministrativeSupportAgreementMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:AdministrativeSupportAgreementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_RelatedPartyTransactionAxis_AdministrativeSupportAgreementMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:AdministrativeSupportAgreementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200909_RangeAxis_MaximumMember_RelatedPartyTransactionAxis_PromissoryNoteMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:PromissoryNoteMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_RelatedPartyTransactionAxis_PromissoryNoteMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:PromissoryNoteMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_RelatedPartyTransactionAxis_PromissoryNoteMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:PromissoryNoteMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_RelatedPartyTransactionAxis_WorkingCapitalLoansMember_RelatedPartyTransactionsByRelatedPartyAxis_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:WorkingCapitalLoansMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20211231_RelatedPartyTransactionAxis_WorkingCapitalLoansMember_RelatedPartyTransactionsByRelatedPartyAxis_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:WorkingCapitalLoansMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_RelatedPartyTransactionAxis_WorkingCapitalLoansMember_RelatedPartyTransactionsByRelatedPartyAxis_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">jyac:WorkingCapitalLoansMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jyac:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20211231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_SubsidiarySaleOfStockAxis_ForwardPurchaseArrangementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">jyac:ForwardPurchaseArrangementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201116to20201116_GranteeStatusAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-16</xbrli:startdate><xbrli:enddate>2020-11-16</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201116to20201116_GranteeStatusAxis_VicePresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-11-16</xbrli:startdate><xbrli:enddate>2020-11-16</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20201116_GranteeStatusAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201116_GranteeStatusAxis_VicePresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_GranteeStatusAxis_VicePresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_GranteeStatusAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_GranteeStatusAxis_VicePresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_GranteeStatusAxis_VicePresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:GranteeStatusAxis">srt:VicePresidentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200826_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200827to20211231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20200827to20201231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-08-27</xbrli:startdate><xbrli:enddate>2020-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001824119</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U001"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U002"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U003"><xbrli:divide><xbrli:unitnumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitnumerator><xbrli:unitdenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitdenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U004"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U005"><xbrli:measure>jyac:Demand</xbrli:measure></xbrli:unit><xbrli:unit id="U006"><xbrli:measure>jyac:Vote</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt;">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt;">Washington, D.C. 20549</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <span><ix:nonnumeric name="dei:DocumentType" id="fact-identifier-5" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_f8038396ed1648bf97e14aea0057af1f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10-K</ix:nonnumeric></span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">(Mark One)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span><ix:nonnumeric name="dei:DocumentAnnualReport" id="fact-identifier-6" contextref="c20210101to20211231" format="ixt-sec:boolballotbox" inside-table="false" data-original-id="Fact_6ff4c766dee64e31bb7b7cad87d944d6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☒</ix:nonnumeric></span> <span style="font-weight: bold;">ANNUAL REPORT PURSUANT TO SECTION 13 OR
          15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><br>
        For the fiscal year ended <span><ix:nonnumeric name="dei:DocumentPeriodEndDate" id="fact-identifier-7" contextref="c20210101to20211231" format="ixt:datemonthdayyearen" inside-table="false" data-original-id="Fact_165126eefd46428cbd5149d432cf880b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">December 31, 2021</ix:nonnumeric></span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">OR</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span><ix:nonnumeric name="dei:DocumentTransitionReport" id="fact-identifier-8" contextref="c20210101to20211231" format="ixt-sec:boolballotbox" inside-table="false" data-original-id="Fact_b9cee9ce1c65441f9fb69cc8cd85ed0c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☐</ix:nonnumeric></span> <span style="font-weight: bold;">TRANSITION REPORT PURSUANT TO SECTION 13
          OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><br>
        &nbsp;For the transition period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;<a id="BKMK_5"></a></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">Commission File Number <span><ix:nonnumeric name="dei:EntityFileNumber" id="fact-identifier-9" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_d824130a5f074bb5baa387faad253887" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">001-39719</ix:nonnumeric></span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><span><ix:nonnumeric name="dei:EntityRegistrantName" id="fact-identifier-10" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_ce40ae79958a4088a74c0bd20cfc3473" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">JIYA ACQUISITION CORP.</ix:nonnumeric></span><br>
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Exact Name of Registrant as Specified in Its Charter)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tbody><tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonnumeric name="dei:EntityIncorporationStateCountryCode" id="fact-identifier-11" contextref="c20210101to20211231" format="ixt-sec:stateprovnameen" inside-table="true" data-original-id="Fact_e94d82009cef48f89fd9b2ea62a584dd" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Delaware</ix:nonnumeric></span><br>
              </div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman';">&nbsp;</div>
            </td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonnumeric name="dei:EntityTaxIdentificationNumber" id="fact-identifier-12" contextref="c20210101to20211231" inside-table="true" data-original-id="Fact_a455ab2dd8934c71b243dbc986325e4e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">85-2789517</ix:nonnumeric></span><br>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman';">(State or Other Jurisdiction of Incorporation or Organization)</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman';">&nbsp;</div>
            </td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman';">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonnumeric name="dei:EntityAddressAddressLine1" id="fact-identifier-13" contextref="c20210101to20211231" inside-table="true" data-original-id="Fact_198c5778ea824a23aa9d0ac43c48a133" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">628 Middlefield Road</ix:nonnumeric></span><br>
              </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonnumeric name="dei:EntityAddressCityOrTown" id="fact-identifier-14" contextref="c20210101to20211231" inside-table="true" data-original-id="Fact_b459aa160e0b4474bf275297d1bf9851" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Palo Alto</ix:nonnumeric></span>, <span><ix:nonnumeric name="dei:EntityAddressStateOrProvince" id="fact-identifier-15" contextref="c20210101to20211231" inside-table="true" data-original-id="Fact_c8ba5fa1dace4da59e912d989a7d24d7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">CA</ix:nonnumeric></span></div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman';">&nbsp;</div>
            </td>

    <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><br>
                <span><ix:nonnumeric name="dei:EntityAddressPostalZipCode" id="fact-identifier-16" contextref="c20210101to20211231" inside-table="true" data-original-id="Fact_b522fc6d64634caa9a3101e4be3e3152" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">94301</ix:nonnumeric></span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman';">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman';">&nbsp;</div>
            </td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman';">Zip Code</div>
            </td>

  </tr>


</tbody></table>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant’s telephone number, including area code: +1 <span><ix:nonnumeric name="dei:CityAreaCode" id="fact-identifier-17" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_713fcfe93348412c8d4866e846b52f72" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">650</ix:nonnumeric></span>-<span><ix:nonnumeric name="dei:LocalPhoneNumber" id="fact-identifier-18" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_c718c5beaff444e597ff82f35f0b7777" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">285-4270</ix:nonnumeric></span></div>

      </div>

      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tbody><tr>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-weight: bold;">
                <div style="text-align: center; font-family: 'Times New Roman';">Title of Each Class</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 32.01%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-weight: bold;">
                <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman';">Trading Symbol(s)</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 32.01%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-weight: bold;">
                <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman';">Name of Each Exchange on Which Registered</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman';"><span><ix:nonnumeric name="dei:Security12bTitle" id="fact-identifier-19" contextref="c20210101to20211231" inside-table="true" data-original-id="Fact_a832007d023d4abab666e124b1992073" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Shares of Class A common stock, par value $0.0001</ix:nonnumeric></span><br>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 32.01%; vertical-align: top;">
              <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman';"><span><ix:nonnumeric name="dei:TradingSymbol" id="fact-identifier-20" contextref="c20210101to20211231" inside-table="true" data-original-id="Fact_acb80c4793a1413cad5bb6c11645b86f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">JYAC</ix:nonnumeric></span><br>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 32.01%; vertical-align: top;">
              <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman';"><span><ix:nonnumeric name="dei:SecurityExchangeName" id="fact-identifier-21" contextref="c20210101to20211231" format="ixt-sec:exchnameen" inside-table="true" data-original-id="Fact_4f777de84e8f462f8d3db464a7ef725f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">The Nasdaq Stock Market LLC</ix:nonnumeric></span><br>
              </div>
            </td>

  </tr>


</tbody></table>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(g) of the Act:</div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <span style="font-family: 'Times New Roman';">☐</span> <span><ix:nonnumeric name="dei:EntityWellKnownSeasonedIssuer" id="fact-identifier-22" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_67dd87f69838448498b27e28d1a9a6a1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">No</ix:nonnumeric></span> <span style="font-family: 'Times New Roman';">☒</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting
        under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <span><ix:nonnumeric name="dei:IcfrAuditorAttestationFlag" id="fact-identifier-23" contextref="c20210101to20211231" format="ixt-sec:boolballotbox" inside-table="false" data-original-id="Fact_26288a2e64ec4b05aa94cc9ceafe2ab9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☐</ix:nonnumeric></span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes <span style="font-family: 'Times New Roman';">☐</span> <span><ix:nonnumeric name="dei:EntityVoluntaryFilers" id="fact-identifier-24" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_a040045fe01b4bc696377fb32891d0f1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">No</ix:nonnumeric></span> <span style="font-family: 'Times New Roman';">☒</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
        (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days <span><ix:nonnumeric name="dei:EntityCurrentReportingStatus" id="fact-identifier-25" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_d8d70e752be8423fb550a23610d25f3f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Yes</ix:nonnumeric></span> <span style="font-family: 'Times New Roman';">☒</span> No <span style="font-family: 'Times New Roman';">☐</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this
        chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). <span><ix:nonnumeric name="dei:EntityInteractiveDataCurrent" id="fact-identifier-26" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_fa67e8c7a74a4147b2c23a28fbcf7edb" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Yes</ix:nonnumeric></span> <span style="font-family: 'Times New Roman';">☒</span> No <span style="font-family: 'Times New Roman';">☐</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See
        the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: auto; margin-right: auto;">


  <tbody><tr>

    <td style="width: 25%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">Large accelerated filer</div>
            </td>

    <td style="width: 5.71%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">☐</div>
            </td>

    <td style="width: 30%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">&nbsp;</div>
            </td>

    <td style="width: 26%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">Accelerated filer</div>
            </td>

    <td style="width: 3%; vertical-align: top;">
              <div style="margin-left: 1.2pt; font-family: 'Times New Roman';">☐</div>
            </td>

  </tr>

  <tr>

    <td style="width: 25%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';"><span><ix:nonnumeric name="dei:EntityFilerCategory" id="fact-identifier-27" contextref="c20210101to20211231" format="ixt-sec:entityfilercategoryen" inside-table="true" data-original-id="Fact_66f4a6b440e1476e9864ea5679b4ebd1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Non-accelerated filer</ix:nonnumeric></span><br>
              </div>
            </td>

    <td style="width: 5.71%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">☒</div>
            </td>

    <td style="width: 30%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">&nbsp;</div>
            </td>

    <td style="width: 26%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">Smaller reporting company</div>
            </td>

    <td style="width: 3%; vertical-align: top;">
              <div style="margin-left: 1.2pt; font-family: 'Times New Roman';"><span><ix:nonnumeric name="dei:EntitySmallBusiness" id="fact-identifier-28" contextref="c20210101to20211231" format="ixt-sec:boolballotbox" inside-table="true" data-original-id="Fact_a92773fbe0824223a638d49dc709c173" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☒</ix:nonnumeric></span><br>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 25%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">&nbsp;</div>
            </td>

    <td style="width: 5.71%; vertical-align: top;">&nbsp;</td>

    <td style="width: 30%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">&nbsp;</div>
            </td>

    <td style="width: 26%; vertical-align: top;">
              <div style="font-family: 'Times New Roman';">Emerging growth company</div>
            </td>

    <td style="width: 3%; vertical-align: top;">
              <div style="margin-left: 1.2pt; font-family: 'Times New Roman';"><span><ix:nonnumeric name="dei:EntityEmergingGrowthCompany" id="fact-identifier-29" contextref="c20210101to20211231" format="ixt-sec:boolballotbox" inside-table="true" data-original-id="Fact_fde3d651ca664f19bd53588cfd4d6d81" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☒</ix:nonnumeric></span><br>
              </div>
            </td>

  </tr>


</tbody></table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
        standards provided pursuant to Section 13(a) of the Exchange Act. <span><ix:nonnumeric name="dei:EntityExTransitionPeriod" id="fact-identifier-30" contextref="c20210101to20211231" format="ixt-sec:boolballotbox" inside-table="false" data-original-id="Fact_4c12fdf7567947abb90b7e4f0779a603" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☐</ix:nonnumeric></span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes <span><ix:nonnumeric name="dei:EntityShellCompany" id="fact-identifier-31" contextref="c20210101to20211231" format="ixt-sec:boolballotbox" inside-table="false" data-original-id="Fact_d7f5b2c34db24bccbbc0ad8a47bccd57" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">☒</ix:nonnumeric></span> No <span style="font-family: 'Times New Roman';">☐</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">As of June 30, 2021 (the last business day of the registrant’s second fiscal quarter), the aggregate market value of its voting and non-voting common equity held by non-affiliates was $<span><ix:nonfraction name="dei:EntityPublicFloat" id="fact-identifier-32" contextref="c20210630" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_8659dc4509a74bfaa9f512e6dfd8bedc" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">102,899,278</ix:nonfraction></span>&nbsp; based upon the closing sales price of the registrant’s Class A common stock as reported on The Nasdaq Stock Market. For purposes of this
        computation, all officers, directors and 10% beneficial owners of the registrant of which the registrant is aware are deemed to be affiliates. Such determination should not be deemed to be an admission that such officers, directors or 10%
        beneficial owners are, in fact, affiliates of the registrant.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">As of April 15, 2022, <span><ix:nonfraction name="dei:EntityCommonStockSharesOutstanding" id="fact-identifier-33" contextref="c20220415_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="INF" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_b011d96ccedb4a39b3337e252dbc65b0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,859,081</ix:nonfraction></span> shares of Class A common stock, par value
        $0.0001 per share, and <span><ix:nonfraction name="dei:EntityCommonStockSharesOutstanding" id="fact-identifier-34" contextref="c20220415_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="INF" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_ab71543fff7d457a9466e5a5d5fdfcc8" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,588,010</ix:nonfraction></span> shares of Class B ordinary shares, par value $0.0001 per share, were issued and outstanding,
        respectively.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DOCUMENTS INCORPORATED BY REFERENCE</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">None</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>

      <div>
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <!--PROfilePageNumberReset%LCR%1%%%-->
    <div>
      <div style="text-align: center; font-weight: bold;">JIYACQUISITION CORP.</div>

      <div style="text-align: center; font-weight: bold;">ANNUAL REPORT ON FORM 10-K</div>

      <div>&nbsp;</div>

      <div style="text-align: center; font-weight: bold;"><a id="TABLEOF"><!--Anchor--></a>TABLE OF CONTENTS</div>

      <div style="font-weight: 400;">
<div><br></div>

        <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 20%; color: rgb(0, 0, 0); margin-left: auto; margin-right: auto;"></div>

      <div> <br>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td colspan="2" style="vertical-align: top;">&nbsp;</td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;"><span style="text-decoration: underline;">Page</span></div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" colspan="2" style="vertical-align: top;">&nbsp;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#CAUTIONARYNOTEREGARDINGFO" tabindex="18">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND RISK FACTOR SUMMARY</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">iii</div>
            </td>

  </tr>

  <tr>

    <td colspan="2" style="vertical-align: top;">
              <div><a href="#PARTI" tabindex="18">PART I</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">1</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item1." tabindex="18">Item 1. Business</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">1</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item1A." tabindex="18">Item 1A. Risk Factors</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">17</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item1B." tabindex="18">Item 1B. Unresolved Staff Comments</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">45</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item2." tabindex="18">Item 2. Property</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">45</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item3." tabindex="18">Item 3. Legal Proceedings</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">45</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item4." tabindex="18">Item 4. Mine Safety Disclosure</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">45</div>
            </td>

  </tr>

  <tr>

    <td colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#PARTII" tabindex="18">PART II</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">46</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item5." tabindex="18">Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">46</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item6." tabindex="18">Item 6. [Reserved]</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">47</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item7." tabindex="18">Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">48</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item7A." tabindex="18">Item 7A. Quantitative and Qualitative Disclosures about Market Risk</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">51</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item8." tabindex="18">Item 8. Financial Statements and Supplementary Data</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">51</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item9." tabindex="18">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">51</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item9A." tabindex="18">Item 9A. Controls and Procedures.</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">51</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item9B." tabindex="18">Item 9B. Other Information.</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">52</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item9C." tabindex="18">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">52</div>
            </td>

  </tr>

  <tr>

    <td colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#PARTIII" tabindex="18">PART III</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">53</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item10." tabindex="18">Item 10. Directors, Executive Officers and Corporate Governance</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">53</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item11." tabindex="18">Item 11. Executive Officer and Director Compensation.</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">62</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item12." tabindex="18">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">64</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item13." tabindex="18">Item 13. Certain Relationships and Related Transactions, and Director Independence</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">66</div>
            </td>

  </tr>

  <tr>

    <td colspan="2" style="vertical-align: top;">
              <div><a href="#PARTIV" tabindex="18">PART IV</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">69</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#Item15." tabindex="18">Item 15<span style="font-style: italic;">.</span> Exhibits, Financial Statement Schedules</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">69</div>
            </td>

  </tr>

  <tr>

    <td style="width: 3%; vertical-align: top;">&nbsp;</td>

    <td style="width: 92%; vertical-align: top;">
              <div><a href="#Item16." tabindex="18">Item 16. Form 10-K Summary</a></div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">70</div>
            </td>

  </tr>

  <tr>

    <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="#INDEXTOFINANCIALSTATEMENT" tabindex="18">INDEX TO FINANCIAL STATEMENTS</a></div>
            </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">F-1</div>
            </td>

  </tr>


</tbody></table>
      <div><br></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">i</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-align: center; font-weight: bold;">CERTAIN TERMS</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Unless otherwise stated in this Annual Report on Form 10-K (this “Annual Report”) or the context otherwise requires, references to:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“we,” “us,” “our,” “company” or “our company” are to Jiya Acquisition Corp., a Delaware corporation;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“common stock” are to our Class A common stock and our Class B common stock;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“DGCL” refers to the Delaware General Corporation Law as the same may be amended from time to time;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“directors” are to our directors and director nominees;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“forward purchase agreement” are to an agreement that provides for the sale of the forward purchase shares to Samsara BioCapital and its permitted transferees in a private placement that may close simultaneously with the closing of our
                initial business combination;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“forward purchase shares” are to the shares of our Class A common stock to be issued pursuant to the forward purchase agreement;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“forward transferees” are to any entity to which Samsara BioCapital transfers any portion of its obligation to purchase the forward purchase shares under the forward purchase agreement;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“founder shares” are to shares of Class B common stock initially purchased by our sponsor in a private placement prior to our initial public offering and the shares of Class A common stock that will be issued upon the automatic
                conversion of the shares of Class B common stock at the time of our initial business combination as described herein;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“initial stockholders” are to holders of our founder shares prior to our initial public offering;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“management” or our “management team” are to our executive officers and directors;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“public shares” are to shares of Class A common stock sold as part of the shares in our initial public offering (whether they were purchased in our initial public offering or thereafter in the open market);</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“public stockholders” are to the holders of our public shares, including our initial stockholders and management team to the extent our initial stockholders and/or members of our management team purchase public shares, provided that each
                initial stockholder’s and member of our management team’s status as a “public stockholder” will only exist with respect to such public shares;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“private placement shares” are to the shares issued to our sponsor in a private placement simultaneously with the closing of our initial public offering;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“Samsara BioCapital” or “Samsara” are to Samsara BioCapital, L.P., a Delaware limited partnership and its affiliates;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“Samsara Fund” are to a domestic private pooled investment vehicle managed by Samsara BioCapital; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>“sponsor” are to Jiya Holding Company LLC, a Delaware limited liability company.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">ii</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-align: center; font-weight: bold;"><a id="CAUTIONARYNOTEREGARDINGFO"><!--Anchor--></a>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND RISK FACTOR SUMMARY</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Some of the statements contained in this Annual Report may constitute “forward-looking statements” for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements
        regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances,
        including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would”
        and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These risks and uncertainties include, but are not limited to, the following risks, uncertainties
        and other factors:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our ability to select an appropriate target business or businesses;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our ability to complete our initial business combination;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our expectations around the performance of the prospective target business or businesses;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our potential ability to obtain additional financing to complete our initial business combination;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our pool of prospective target businesses;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>the ability of our officers and directors to generate a number of potential business combination opportunities;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our public securities’ liquidity and trading;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>the use of proceeds not held in the trust account or available to us from interest income on the trust account balance;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>the trust account not being subject to claims of third parties;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our financial performance following our initial public offering; or</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>the other risks and uncertainties discussed in “Risk Factors” and elsewhere in this Annual Report.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div>The forward-looking statements contained in this Annual Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us
        will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different
        from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors.” Should one or more of these risks or uncertainties
        materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements,
        whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.</div>

      <div> <br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">iii</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%1%%%-->
      <div style="text-align: center; font-weight: bold;"><a id="PARTI"><!--Anchor--></a>PART I</div>

      <div>&nbsp;</div>

      <a id="Item1."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 1.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Business</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>
<div>
      &nbsp; &nbsp; &nbsp; &nbsp; We are a blank check company incorporated on August 27, 2020 as a Delaware corporation formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
      with one or more businesses, which we refer to throughout this Annual Report as our initial business combination.
      </div>
<div style="text-indent: 18pt;"> <br>
      </div>
<div>
      &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; While we may pursue an initial business combination opportunity in any industry or geographical location, we intend to capitalize on our management team’s background and experience to identify promising opportunities in the biopharmaceutical
      sector.
      </div>
<div>&nbsp;</div>
<div>
      &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In addition, we believe our ability to complete our initial business combination is enhanced by our having entered into the forward purchase agreement pursuant to which Samsara BioCapital agreed to purchase an aggregate of 2,500,000 forward
      purchase shares, at a purchase price of $25,000,000 in the aggregate, in a private placement to close substantially concurrently with the closing of our initial business combination.
      </div>
<div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); font-weight: bold;">Samsara BioCapital and its Competitive Advantages</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">Samsara BioCapital, which commenced operations on March 22, 2017, was organized for the purpose of providing a limited number of select investors with the opportunity to realize long-term capital
        appreciation from investments in assets and securities of all kinds, including debt securities, in public and private companies in life science-related industries.&nbsp; As of September 1, 2020, the partnership had $671 million in regulatory assets
        under management.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">Samsara BioCapital is ultimately controlled by Dr. Srinivas Akkaraju, M.D., Ph.D., and is registered with the Securities and Exchange Commission as an investment advisor under the U.S. Investment
        Advisors Act of 1940.&nbsp; Samsara BioCapital’s general partner is responsible for the investment decisions on behalf of Samsara BioCapital, including naming such agents of Samsara BioCapital as it deems advisable, including, but not limited to, the
        investment manager, and for development and implementation of Samsara BioCapital’s investment policy and strategy.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">Samsara’s investment strategy is focused on long-term value creation. Samsara believes that innovation and meaningful patient impact will drive attractive risk-adjusted returns, and that the time
        scale for this value accretion parallels the development and commercialization of innovative therapeutics. It invests in both public and private biopharmaceutical companies across all financing rounds from seed to crossover to initial public
        offering, private investments in public equity (PIPEs) and follow-on offerings. It is agnostic with respect to development stage and therapeutic area with current investments ranging from an early-stage incubator, focused on facilitating the
        advancement of academic research, to public companies with marketed products.&nbsp; Samsara invests in companies in the U.S. as well as other global markets.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; text-indent: 18pt;">Since 2017, Samsara has met with and evaluated over 1,000 private and public biopharmaceutical companies, investing in
          80 private and public companies in various financing rounds. As of March 3, 2022, 22 portfolio companies have completed initial public offerings and one company has announced its acquisition. Representative investments by Samsara include Allakos
          (Nasdaq:&nbsp; ALLK), Chinook Therapeutics (Nasdaq: KDNY), Dewpoint Therapeutics, Forma Therapeutics (Nasdaq:&nbsp; FMTX), Graphite Bio (Nasdaq: GRPH), Principia Biopharma (Nasdaq:&nbsp; PRNB), and Nkarta Therapeutics (Nasdaq:&nbsp; NKTX). Samsara has also been
          instrumental in the creation of an early-stage incubator called Autobahn Labs. Autobahn Labs collaborates with scientists at leading academic institutions to accelerate the translation of scientific ideas to novel therapeutics.</div>

      </div>
<div><br>

      <br></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">1</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">Samsara has deep knowledge of the biopharmaceutical sector and an extensive network of relationships across the biopharmaceutical ecosystem including leading academic researchers, discovery scientists, clinicians,
        entrepreneurs, pharmaceutical and biotechnology executives, investment bankers and venture capitalists as well as other members of the healthcare industry ecosystem. Samsara’s opportunity evaluation centers on understanding of the underlying
        pathophysiology of a particular disease state, the rationale of a proposed therapeutic target, detailed understanding of the proposed therapeutic modality and clinical development program, regulatory requirements for product approval and the
        end-market clinical and commercial opportunity, including market access and reimbursement. These factors are integrated to develop an investment thesis focused on intrinsic value and a capital formation plan to achieve significant milestones.
        Critical to the investment process is the identification of specific management talent that can successfully develop and commercialize the company’s products. Samsara is an active investor with significant operating and board experience in guiding
        companies through the drug discovery and development process, and ultimately to successful commercialization. Samsara’s expertise and broad network of industry relationships combined with our management team and independent Board members will
        facilitate the identification and evaluation of investment targets with high probabilities of technical success and attractive investment risk profiles.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">We are led by Rekha Hemrajani who serves as our Chief Executive Officer (CEO) and serves on our Board of Directors. Ms. Hemrajani is an experienced biopharma executive with extensive senior
        management experience in both large and small publicly traded biopharmaceutical companies, including serving as President &amp; Chief Executive Officer of Aravive, Inc (Nasdaq: ARAV), Chief Financial Officer &amp; Chief Operating Officer of Arcus
        Biosciences (Nasdaq: RCUS), Chief Operating Officer of RAPT Therapeutics (Nasdaq: RAPT), Vice President - Head of Licensing and M&amp;A at Onyx Pharmaceuticals (Nasdaq: ONXX, acquired by Amgen for $10.4 billion), Vice President of Business
        Development at Exelixis (Nasdaq: EXEL), as well as prior investment banking experience with Credit Suisse First Boston and Lehman Brothers.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">Ms. Hemrajani is supported by a dedicated research team, as well as the Samsara investment team and an experienced Board of Directors with significant investing, operating, and clinical development
        experience. All of our independent directors have had significant experience in the leadership of both large and small biopharmaceutical companies.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&nbsp;</sup>We believe that the
        depth of experience and industry relationships that our directors possess will help ensure our Management’s ability to identify and diligence potential business combination targets and successfully complete our business combination. In addition,
        having a dedicated management team puts us in a unique position to potentially create new companies as business combination targets with promising assets we may in-license from pharmaceutical or biotechnology companies, or combine target companies
        with additional assets to create critical mass in a therapeutic area.&nbsp; We further believe that the experience of our highly experienced Board will help position the merged company for success following the business combination by helping guide the
        company in areas such as clinical development, portfolio strategy, business development, financing and building key leadership talent. We believe this unique structure makes us highly differentiated and creates the optimal leverage for the company
        to pursue a broader set of investment opportunities and create shareholder value.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); font-weight: bold;">Industry Opportunity</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">The last decade has seen unprecedented innovation in the biopharmaceutical industry, including the introduction of a multitude of new therapies for serious diseases and the establishment of new
        therapeutic modalities. These innovations have resulted in significant advances for clinicians and patients, and markedly improved the outcomes for patients suffering from a wide range of diseases. Among the most significant advances during this
        period was the introduction of new immuno-oncology agents that leverage a patient’s immune system to fight their disease. These medications have become the backbone treatment for many cancers and were led by the approvals by the U.S. FDA of Yervoy
        (2011) and Keytruda (2014). In the years since the first approvals, a number of additional agents have been approved and a large number are currently in clinical trials. In 2013, a functional cure for patients suffering from specific types of the
        hepatitis C virus was approved by the U.S. FDA. The industry also saw the first cell and gene therapy products approved by the U.S. FDA this decade, with the approval and launches of chimeric antigen receptor (CAR) T cell therapy for cancer and
        gene therapies for a genetic form of blindness and spinal muscular atrophy (“SMA”), an orphan disease characterized by neuromuscular issues and early death.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; text-indent: 18pt;">These new medicines and modalities represent the culmination of decades of basic science research and significant
          advances in our understanding of disease pathophysiology as well as the advancement in manufacturing techniques for these new therapeutic approaches. The advances in our understanding of the underlying causes of disease have been facilitated by
          significant improvements in the cost, speed, and accuracy of tools that allow researchers to identify the specific genetic, genomic, and cellular aberrations associated with disease. This has enabled better identification of biological targets as
          well as facilitated broader use of biomarkers as surrogate biological indicators of efficacy in clinical development, allowing researchers to refine and enhance clinical trial designs, and direct treatments to the patients that will benefit most.</div>

      </div>

      <div style="text-indent: 24pt; color: rgb(0, 0, 0);"> <br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">2</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; text-indent: 18pt;">This innovation has been supported, and indeed accelerated, by regulatory bodies such as the U.S. FDA which have
          utilized a number of tools to catalyze the introduction of new medicines to physicians and patients. The U.S. FDA, and similar agencies in other territories, has established a number of regulatory tools that allow biopharmaceutical companies to
          accelerate the drug development process and the advancement of new therapies to patients. These regulatory tools include orphan drug designation which provides defined regulatory exclusivity for products targeting under 200,000 patients in the
          U.S., fast track designation which decreases the FDA review time from 10 months to 6 months, accelerated approval which allows for the approval of new medicines based on surrogate markers of efficacy, priority review and breakthrough designation
          which provides additional access and interaction to the FDA for diseases with high unmet medical needs. From 2014 to 2021, the U.S. FDA approved 364 NMEs, with 49% of approvals receiving orphan drug designation, 66% receiving priority review, 18%
          receiving accelerated approval, and 29% designated as breakthrough therapies.</div>

      </div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Largely based on the confluence of scientific innovation, regulatory alignment and patient need, the pace of private company formation as
          well as IPOs has been very strong. From 2019 to 2021, there were over 600 private biopharmaceutical financing rounds in the US and EU raising over $63 billion in proceeds. During the same period, there were 192 biopharmaceutical IPOs in the US
          and EU, raising over $39 billion in proceeds. Despite the recent volume of IPOs, the process of “going public” is replete with myriad challenges that are specific to the biopharmaceutical industry and results in significant inefficiencies in the
          biopharmaceutical equity markets. This includes the need for a private biotech company management team to assemble their own syndicate of sophisticated investors who are able to understand the complex scientific, clinical and regulatory factors
          needed for creating successful medicines.&nbsp; We believe that key to the successful growth and maturation of a biopharmaceutical company is to reduce its cost of capital, diversify its shareholder base, and increase its visibility in the broader
          healthcare ecosystem through access to the public markets. The additional capital available in the public markets allows companies to advance products through more advanced stages of the drug development and regulatory process, and potentially to
          eventual commercialization, leading to significant value inflections in their market capitalization and shareholder returns.</div>

      </div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">We believe that this universe of private companies is fertile ground for accessing the public markets via a business combination with our company. In addition to existing private companies, large
        biotechnology and pharmaceutical companies continue to evolve their therapeutic focus and strategies leading to rationalization of their product portfolios. We believe that this pool of rationalized assets also represents an attractive pool of
        acquisition candidates. We believe we are uniquely positioned to leverage these market inefficiencies to identify high value assets that are under appreciated by the broader investment community.&nbsp; Our management team and Board, combined with
        Samsara’s expertise, network and premier deal flow, provide us with unparalleled visibility across all stages of biopharmaceutical companies.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; text-indent: 18pt;">The biopharmaceutical industry has also benefited significantly from a continued need for larger pharmaceutical and
          biotechnology companies to build their pipelines of drugs via mergers and acquisitions (M&amp;A). There are many drivers of M&amp;A activity in the biopharmaceutical industry, including significant loss of revenues due to patent expirations and
          the need to access next generation technologies to drive future growth. Since the beginning of 2018, in North America and Europe there have been over 100 M&amp;A transactions in the biopharmaceutical industry with transaction value greater than
          $500 million each, resulting in a cumulative M&amp;A volume of over $590 billion. Industry analysts predict that M&amp;A activity is expected to continue as biopharmaceutical companies continue to face patent expirations and depend on
          acquisitions to drive innovation and growth. Since 2019, there have been a number of M&amp;A transactions in the biopharmaceutical industry with transaction value greater than $1 billion. A few recent examples include Bristol-Myers Squibb’s
          acquisition of Celgene for $74 billion, Abbvie’s acquisition of Allergan for $63 billion, and AstraZeneca’s acquisition of Alexion for $39 billion. In addition, recently announced M&amp;A transactions with transaction value greater than $1
          billion that recently closed or may soon close include&nbsp;&nbsp; Merck’s acquisition of Acceleron for $11.5 billion, Novo Nordisk’s acquisition of Dicerna for $3.3 billion, and Pfizer’s acquisition of Arena for $6.7 billion.</div>

        <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"></sup></div>
</div>

      <div><br></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">3</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="font-weight: bold;">Acquisition Strategy</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; color: rgb(0, 0, 0);">Our acquisition strategy includes identifying and acquiring an innovative biopharmaceutical company, in-licensing promising assets from pharmaceutical and biotechnology companies, or combining
        target companies with additional assets to create critical mass in a therapeutic area. We believe our management team working alongside Samsara is uniquely positioned to identify potential acquisition targets, and our collective reach and
        reputation in the industry will make us a preferred partner. Our dedicated management team puts us in a unique position, if needed, to take operating or board roles and help position the merged company for success following the business
        combination. We believe that our focus on patient impact and long-term value creation is a meaningful differentiator in the industry. Our selection process leverages the relationships of our Management and Board and relies on our industry leading
        approach to diligence and building companies that create significant shareholder value.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); font-weight: bold;">Investment Criteria</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;">We have identified the following criteria to evaluate prospective target businesses based on our investment strategy and process. These criteria are not meant to be exhaustive, and we may decide to
        enter into our initial business combination with a target business that does not meet all of these criteria. We intend to seek to acquire one or more businesses that we believe:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><span style="font-weight: bold;">Target significant unmet medical needs.</span> We seek to identify businesses targeting significant unmet medical needs. We believe that filling material gaps in treatment
                paradigms aligns all relevant stakeholders including patients, payors, and regulators and offers the best opportunity for differentiated risk-adjusted returns</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><span style="font-weight: bold;">Have a high probability of clinical and regulatory success.</span> The core of our investment approach is to target clinical stage assets that we believe will have a high
                probability of technical and regulatory success. We believe that probability of technical success is directly correlated with deep understanding of the underlying pathobiology of a specific disease, the natural history of the disease,
                current standard of care, and the regulatory landscape</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><span style="font-weight: bold;">Leverage innovative science and approaches to drug development.</span> We intend to identify businesses that leverage innovative approaches to drug discovery and development
                including genetics, genomics, and biomarkers which we believe allow for early evidence of clinical benefit and more capital-efficient drug development with higher probabilities of success</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><span style="font-weight: bold;">Possess scarcity value via a unique approach to disease targeting. </span>We intend to identify businesses with unique therapeutic strategies to disease targeting resulting
                in asset scarcity value and the creation of a differentiated profile for a publicly traded company</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><span style="font-weight: bold;">Have a clear plan for capital formation. </span>We believe that capital adequacy is key to success in drug development, and we will focus on businesses that can be
                capitalized through key value inflection points</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><span style="font-weight: bold;">Have strong existing Management or key expertise that can benefit from the managerial experience of our team and Board.</span> We intend to focus on companies with strong and
                experienced management teams who could benefit from the guidance of our management team and Board. In addition, if needed, members of our team or Board may be willing to take operating or board roles following a business combination</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt; color: rgb(0, 0, 0);">The evaluation of a particular business combination target may be based, to the extent relevant, on these general criteria as well as other considerations that our management may deem relevant.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Samsara BioCapital has entered into an agreement to make an aggregate investment of up to $25,000,000 in us at the time of our initial business combination through the purchase of up to 2,500,000 forward purchase
        shares in a private placement that may close simultaneously with the closing of our initial business combination. Samsara BioCapital’s commitment under the forward purchase agreement is subject to, among other conditions, the business combination
        (including the target assets or business, and the terms of the business combination) being reasonably acceptable to Samsara BioCapital. This purchase will be eligible to be made regardless of whether any shares of Class A common stock are redeemed
        by our public stockholders. The forward purchase shares will be issued only in connection with the closing of the initial business combination. The proceeds from the sale of forward purchase shares, if any, may be used as part of the consideration
        to the sellers in our initial business combination, expenses in connection with our initial business combination or for working capital in the post-transaction company.</div>

      <div style="text-indent: 18pt;"> <br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">4</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="font-weight: bold;">Initial Business Combination</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Nasdaq rules require that we must complete one or more business combinations having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the deferred
        underwriting commissions and taxes payable on the interest earned on the trust account) at the time of our signing a definitive agreement in connection with our initial business combination. Our Board of Directors will make the determination as to
        the fair market value of our initial business combination. If our Board of Directors is not able to independently determine the fair market value of our initial business combination, we will obtain an opinion from an independent investment banking
        firm which is a member of FINRA or a valuation or appraisal firm with respect to the satisfaction of such criteria. While we consider it unlikely that our Board of Directors will not be able to make an independent determination of the fair market
        value of our initial business combination, it may be unable to do so if it is less familiar or experienced with the business of a particular target or if there is a significant amount of uncertainty as to the value of the target’s assets or
        prospects.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We anticipate structuring our initial business combination so that the post-transaction company in which our public stockholders own shares will own or acquire 100% of the equity interests or assets of the target
        business or businesses. We may, however, structure our initial business combination such that the post-transaction company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the
        target management team or stockholders or for other reasons, but we will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a
        controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act. Even if the post-transaction company owns or acquires
        50% or more of the voting securities of the target, our stockholders prior to the business combination may collectively own a minority interest in the post-transaction company, depending on valuations ascribed to the target and us in the business
        combination transaction. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% controlling interest in
        the target. However, as a result of the issuance of a substantial number of new shares, our stockholders immediately prior to our initial business combination could own less than a majority of our outstanding shares subsequent to our initial
        business combination. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be
        taken into account for purposes of the 80% of net assets test described above. If the business combination involves more than one target business, the 80% of net assets test will be based on the aggregate value of all of the target businesses.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We are not presently engaged in, and we will not engage in, any operations for an indefinite period of time. We intend to effectuate our initial business combination using cash from the proceeds of our initial public
        offering, the private placement of the private placement shares and the forward purchase shares, if any, the proceeds of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop
        agreements we may enter into following our initial public offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing. We may seek to
        complete our initial business combination with a company or business that may be financially unstable or in its early stages of development or growth, which would subject us to the numerous risks inherent in such companies and businesses.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If our initial business combination is paid for using equity or debt securities, or not all of the funds released from the trust account are used for payment of the consideration in connection with our initial business
        combination or used for redemptions of our Class A common stock, we may apply the balance of the cash released to us from the trust account for general corporate purposes, including for maintenance or expansion of operations of the post-transaction
        company, the payment of principal or interest due on indebtedness incurred in completing our initial business combination, to fund the purchase of other companies or for working capital.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">5</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">We may need to obtain additional financing to complete our initial business combination, either because the transaction requires more cash than is available from the proceeds held in our trust account or because we
        become obligated to redeem a significant number of our public shares upon completion of the business combination, in which case we may issue additional securities or incur debt in connection with such business combination. There are no prohibitions
        on our ability to issue securities or incur debt in connection with our initial business combination. We are not currently a party to any arrangement or understanding with any third party with respect to raising any additional funds through the
        sale of securities, the incurrence of debt or otherwise.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Sourcing of Potential Initial Business Combination Targets</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Certain members of our management team have spent significant portions of their careers working with businesses in the healthcare industry, and have developed a wide network of professional services contacts and
        business relationships in that industry. The members of our Board of Directors also have significant executive management and public company experience with healthcare and healthcare-related companies.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">This network has provided our management team with a flow of referrals that have resulted in numerous transactions. We believe that the network of contacts and relationships of our management team provides us with an
        important source of acquisition opportunities. In addition, we anticipate that target business candidates will be brought to our attention from various unaffiliated sources, including investment market participants, private equity groups,
        investment banks, consultants, accounting firms and large business enterprises.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, executive officers or directors, or making the acquisition through a joint venture or other form
        of shared ownership with our sponsor, executive officers or directors. In the event we seek to complete an initial business combination with a target that is affiliated with our sponsor, executive officers or directors, we, or a committee of
        independent directors, would obtain an opinion from an independent investment banking which is a member of FINRA or a qualified independent accounting firm that such an initial business combination is fair to our company from a financial point of
        view. We are not required to obtain such an opinion in any other context.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If any of our executive officers becomes aware of a business combination opportunity that falls within the line of business of any entity to which he or she has pre-existing fiduciary or contractual obligations, he or
        she may be required to present such business combination opportunity to such entity prior to presenting such business combination opportunity to us. All of our executive officers currently have certain relevant fiduciary duties or contractual
        obligations that may take priority over their duties to us. Our amended and restated certificate of incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is
        expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Target business candidates may also be brought to our attention from various unaffiliated sources, including investment bankers, private investment funds and other intermediaries. Target businesses may be brought to
        our attention by such unaffiliated sources as a result of being solicited by us through calls or mailings. These sources may also introduce us to target businesses in which they think we may be interested on an unsolicited basis, since many of
        these sources will have read this Annual Report and know what types of businesses we are targeting. Our officers and directors, as well as their affiliates, may also bring to our attention target business candidates that they become aware of
        through their business contacts as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In addition, we expect to receive a number of proprietary opportunities that would not
        otherwise necessarily be available to us as a result of the track record and business relationships of our officers and directors.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Financial Position</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">With funds available at December 31, 2021 for a business combination initially in the amount of $99,919,760 (assuming no redemptions and assuming no funding under the forward purchase agreement), after payment of
        $3,623,214 of deferred underwriting fees, we offer a target business a variety of options such as creating a liquidity event for its owners, providing capital for the potential growth and expansion of its operations or strengthening its balance
        sheet by reducing its debt ratio. Because we are able to complete our initial business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that will
        allow us to tailor the consideration to be paid to the target business to fit its needs and desires. However, we have not taken any steps to secure third party financing and there can be no assurance it will be available to us.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">6</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Lack of Business Diversification</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">For an indefinite period of time after the completion of our initial business combination, the prospects for our success may depend entirely on the future performance of a single business. Unlike other entities that
        have the resources to complete business combinations with multiple entities in one or several industries, it is probable that we will not have the resources to diversify our operations and mitigate the risks of being in a single line of business.
        By completing our initial business combination with only a single entity, our lack of diversification may:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination, and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>cause us to depend on the marketing and sale of a single product or limited number of products or services.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Limited Ability to Evaluate the Target’s Management Team</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Although we intend to closely scrutinize the management of a prospective target business when evaluating the desirability of effecting our initial business combination with that business, our assessment of the target
        business’s management may not prove to be correct. In addition, the future management may not have the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of members of our management team, if any,
        in the target business cannot presently be stated with any certainty. The determination as to whether any of the members of our management team will remain with the combined company will be made at the time of our initial business combination.
        While it is possible that one or more of our directors will remain associated in some capacity with us following our initial business combination, it is unlikely that any of them will devote their full efforts to our affairs subsequent to our
        initial business combination. Moreover, we cannot assure you that members of our management team will have significant experience or knowledge relating to the operations of the particular target business.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We cannot assure you that any of our key personnel will remain in senior management or advisory positions with the combined company. The determination as to whether any of our key personnel will remain with the
        combined company will be made at the time of our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Following a business combination, we may seek to recruit additional managers to supplement the incumbent management of the target business. We cannot assure you that we will have the ability to recruit additional
        managers, or that additional managers will have the requisite skills, knowledge or experience necessary to enhance the incumbent management.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Stockholders May Not Have the Ability to Approve Our Initial Business Combination</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We may conduct redemptions without a stockholder vote pursuant to the tender offer rules of the SEC subject to the provisions of our amended and restated certificate of incorporation. However, we will seek stockholder
        approval if it is required by law or applicable stock exchange rule, or we may decide to seek stockholder approval for business or other legal reasons.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Presented in the table below is a graphic explanation of the types of initial business combinations we may consider and whether stockholder approval is currently required under Delaware law for each such transaction.</div>

      <div style="text-indent: 18pt;"> <br>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div>&nbsp;</div>
                <div style="text-align: center; font-weight: bold;">Type of Transaction</div>
              </div>
            </td>

    <td style="width: 1%; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td style="width: 14%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Whether</div>
                <div style="text-align: center; font-weight: bold;">Stockholder</div>
                <div style="text-align: center; font-weight: bold;">Approval is</div>
                <div style="text-align: center; font-weight: bold;">Required</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Purchase of assets</div>
            </td>

    <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1">&nbsp;</td>

    <td style="width: 14%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">No</div>
            </td>

  </tr>

  <tr>

    <td style="width: 85%; vertical-align: bottom;">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Purchase of stock of target not involving a merger with the company</div>
            </td>

    <td style="width: 1%; vertical-align: bottom;" colspan="1">&nbsp;</td>

    <td style="width: 14%; vertical-align: bottom;">
              <div style="text-align: center;">No</div>
            </td>

  </tr>

  <tr>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Merger of target into a subsidiary of the company</div>
            </td>

    <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1">&nbsp;</td>

    <td style="width: 14%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">No</div>
            </td>

  </tr>

  <tr>

    <td style="width: 85%; vertical-align: bottom;">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Merger of the company with a target</div>
            </td>

    <td style="width: 1%; vertical-align: bottom;" colspan="1">&nbsp;</td>

    <td style="width: 14%; vertical-align: bottom;">
              <div style="text-align: center;">Yes</div>
            </td>

  </tr>


</tbody></table>
      <div><br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">7</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">Under Nasdaq’s listing rules, stockholder approval would be required for our initial business combination if, for example:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>We issue shares of common stock that will be equal to or in excess of 20% of the number of our shares of common stock then outstanding (other than in a public offering);</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>Any of our directors, officers or substantial stockholders (as defined by Nasdaq rules) has a 5% or greater interest earned on the trust account (or such persons collectively have a 10% or greater interest), directly or indirectly, in
                the target business or assets to be acquired or otherwise and the present or potential issuance of common stock could result in an increase in outstanding common stock or voting power of 5% or more; or</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>The issuance or potential issuance of common stock will result in our undergoing a change of control.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Permitted Purchases of Our Securities</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, initial
        stockholders, directors, executive officers, advisors or their affiliates may purchase shares in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. There is no
        limit on the number of shares our initial stockholders, directors, officers, advisors or their affiliates may purchase in such transactions, subject to compliance with applicable law and Nasdaq rules. None of the funds in the trust account will be
        used to purchase shares in such transactions. If they engage in such transactions, they will be restricted from making any such purchases when they are in possession of any material non-public information not disclosed to the seller or if such
        purchases are prohibited by Regulation M under the Exchange Act.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In the event that our sponsor, initial stockholders, directors, officers, advisors or their affiliates purchase shares in privately negotiated transactions from public stockholders who have already elected to exercise
        their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their shares. We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer
        rules under the Exchange Act or a going-private transaction subject to the going-private rules under the Exchange Act; however, if the purchasers determine at the time of any such purchases that the purchases are subject to such rules, the
        purchasers will comply with such rules.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The purpose of any such purchases of shares could be to (i) vote such shares in favor of the business combination and thereby increase the likelihood of obtaining stockholder approval of the business combination or
        (ii) to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our initial business combination, where it appears that such requirement would otherwise
        not be met. Any such purchases of our securities may result in the completion of our initial business combination that may not otherwise have been possible.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In addition, if such purchases are made, the public “float” of our Class A common stock may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain or
        obtain the quotation, listing or trading of our securities on a national securities exchange.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our sponsor, initial stockholders, officers, directors and/or their affiliates anticipate that they may identify the stockholders with whom our initial stockholders, officers, directors or their affiliates may pursue
        privately negotiated purchases by either the stockholders contacting us directly or by our receipt of redemption requests submitted by stockholders (in the case of Class A common stock) following our mailing of proxy materials in connection with
        our initial business combination. To the extent that our sponsor, officers, directors, advisors or their affiliates enter into a private purchase, they would identify and contact only potential selling stockholders who have expressed their election
        to redeem their shares for a pro rata share of the trust account or vote against our initial business combination, whether or not such stockholder has already submitted a proxy with respect to our initial business combination but only if such
        shares have not already been voted at the stockholder meeting related to our initial business combination. Our sponsor, executive officers, directors, advisors or any of their affiliates will select which stockholders to purchase shares from based
        on a negotiated price and number of shares and any other factors that they may deem relevant, and will only purchase shares if such purchases comply with Regulation M under the Exchange Act and the other federal securities laws. Our sponsor,
        officers, directors and/or their affiliates will be restricted from making purchases of shares if the purchases would violate Section 9(a)(2) or Rule 10b-5 of the Exchange Act. We expect any such purchases will be reported pursuant to Section 13
        and Section 16 of the Exchange Act to the extent such purchases are subject to such reporting requirements.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">8</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Redemption Rights for Public Stockholders upon Completion of Our Initial Business Combination</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We will provide our public stockholders with the opportunity to redeem all or a portion of their shares of Class A common stock upon the completion of our initial business combination at a per-share price, payable in
        cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account and not
        previously released to us to pay our taxes, divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is at least $10.00 per public share. The per
        share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters. Our initial stockholders, sponsor, officers and directors have entered into
        a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares they may hold in connection with the completion of our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Limitations on Redemptions</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our amended and restated certificate of incorporation provides that in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001. In addition, our
        proposed initial business combination may impose a minimum cash requirement for: (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general corporate purposes or (iii) the retention of cash to
        satisfy other conditions. In the event the aggregate cash consideration we would be required to pay for all shares of Class A common stock that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the
        terms of the proposed initial business combination exceed the aggregate amount of cash available to us, we will not complete the initial business combination or redeem any shares in connection with such initial business combination, and all shares
        of Class A common stock submitted for redemption will be returned to the holders thereof. We may, however, raise funds through the issuance of equity-linked securities or through loans, advances or other indebtedness in connection with our initial
        business combination, including pursuant to forward purchase agreements or backstop arrangements we may enter into following consummation of our initial public offering, in order to, among other reasons, satisfy such net tangible assets or minimum
        cash requirements.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Manner of Conducting Redemptions</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We will provide our public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination either (i) in connection with a stockholder meeting
        called to approve the initial business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether we will seek stockholder approval of a proposed initial business combination or conduct a tender offer will
        be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require us to seek stockholder approval under applicable law or stock exchange
        listing requirements. Asset acquisitions and stock purchases would not typically require stockholder approval while direct mergers with our company where we do not survive and any transactions where we issue more than 20% of our outstanding common
        stock or seek to amend our amended and restated certificate of incorporation would require stockholder approval. So long as we obtain and maintain a listing for our securities on Nasdaq, we will be required to comply with Nasdaq’s stockholder
        approval rules.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The requirement that we provide our public stockholders with the opportunity to redeem their public shares by one of the two methods listed above are contained in provisions of our amended and restated certificate of
        incorporation and apply whether or not we maintain our registration under the Exchange Act or our listing on Nasdaq. Such provisions may be amended if approved by holders of 65% of our common stock entitled to vote thereon.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">9</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">If we provide our public stockholders with the opportunity to redeem their public shares in connection with a stockholder meeting, we will:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules, and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>file proxy materials with the SEC.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we seek stockholder approval, we will complete our initial business combination only if a majority of the outstanding shares of common stock voted are voted in favor of the initial business combination. A quorum for
        such meeting will consist of the holders present in person or by proxy of shares of outstanding capital stock of the Company representing a majority of the voting power of all outstanding shares of capital stock of the Company entitled to vote at
        such meeting. Our initial stockholders will count towards this quorum and, pursuant to the letter agreement, our sponsor, officers and directors have agreed to vote any founder shares and private placement shares they hold and any public shares
        purchased during or after our initial public offering (including in open market and privately-negotiated transactions) in favor of our initial business combination. For purposes of seeking approval of the majority of our outstanding shares of
        common stock voted, non-votes will have no effect on the approval of our initial business combination once a quorum is obtained. As a result, in addition to our initial stockholders’ founder shares and shares of Class A common stock issued as part
        of the private placement shares, we would need only 3,628,496, or approximately 35%, of the 10,352,040 public shares sold in our initial public offering to be voted in favor of an initial business combination in order to have our initial business
        combination approved (assuming all outstanding shares are voted). These quorum and voting thresholds, and the voting agreements of our initial stockholders, may make it more likely that we will complete our initial business combination. Each public
        stockholder may elect to redeem its public shares irrespective of whether they vote for or against the proposed transaction or whether they were a stockholder on the record date for the stockholder meeting held to approve the proposed transaction.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If a stockholder vote is not required and we do not decide to hold a stockholder vote for business or other legal reasons, we will:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>file tender offer documents with the SEC prior to completing our initial business combination, which contain substantially the same financial and other information about the initial business combination and the redemption rights as is
                required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In the event we conduct redemptions pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule 14e-1(a) under the Exchange Act, and we will not be
        permitted to complete our initial business combination until the expiration of the tender offer period. In addition, the tender offer will be conditioned on public stockholders not tendering more than a specified number of public shares, which
        number will be based on the requirement that we may not redeem public shares in an amount that would cause our net tangible assets to be less than $5,000,001. If public stockholders tender more shares than we have offered to purchase, we will
        withdraw the tender offer and not complete the initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Upon the public announcement of our initial business combination, if we elect to conduct redemptions pursuant to the tender offer rules, we or our sponsor will terminate any plan established in accordance with Rule
        10b5-1 to purchase shares of our Class A common stock in the open market, in order to comply with Rule 14e-5 under the Exchange Act.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">10</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">We intend to require our public stockholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” to, at the holder’s option, either deliver their stock
        certificates to our transfer agent or deliver their shares to our transfer agent electronically using The Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) system, prior to the date set forth in the proxy materials or tender offer
        documents, as applicable. In the case of proxy materials, this date may be up to two business days prior to the vote on the proposal to approve the initial business combination. In addition, if we conduct redemptions in connection with a
        stockholder vote, we intend to require a public stockholder seeking redemption of its public shares to also submit a written request for redemption to our transfer agent two business days prior to the vote in which the name of the beneficial owner
        of such shares is included. The proxy materials or tender offer documents, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will indicate whether we are requiring public
        stockholders to satisfy such delivery requirements. We believe that this will allow our transfer agent to efficiently process any redemptions without the need for further communication or action from the redeeming public stockholders, which could
        delay redemptions and result in additional administrative cost. If the proposed initial business combination is not approved and we continue to search for a target company, we will promptly return any certificates or shares delivered by public
        stockholders who elected to redeem their shares.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our amended and restated certificate of incorporation provides that in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001. In addition, our
        proposed initial business combination may impose a minimum cash requirement for: (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general corporate purposes or (iii) the retention of cash to
        satisfy other conditions. In the event the aggregate cash consideration we would be required to pay for all shares of Class A common stock that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the
        terms of the proposed initial business combination exceed the aggregate amount of cash available to us, we will not complete the initial business combination or redeem any shares in connection with such initial business combination, and all shares
        of Class A common stock submitted for redemption will be returned to the holders thereof. We may, however, raise funds through the issuance of equity-linked securities or through loans, advances or other indebtedness in connection with our initial
        business combination, including pursuant to forward purchase agreements or backstop arrangements we may enter into following consummation of our initial public offering, in order to, among other reasons, satisfy such net tangible assets or minimum
        cash requirements.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Limitation on Redemption Upon Completion of Our Initial Business Combination If We Seek Stockholder Approval</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated
        certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act),
        will be restricted from seeking redemption rights with respect to Excess Shares, without our prior consent. We believe this restriction will discourage stockholders from accumulating large blocks of shares, and subsequent attempts by such holders
        to use their ability to exercise their redemption rights against a proposed business combination as a means to force us or our management to purchase their shares at a significant premium to the then-current market price or on other undesirable
        terms. Absent this provision, a public stockholder holding more than an aggregate of 15% of the shares sold in our initial public offering could threaten to exercise its redemption rights if such holder’s shares are not purchased by us, our sponsor
        or our management at a premium to the then-current market price or on other undesirable terms. By limiting our stockholders’ ability to redeem no more than 15% of the shares sold in our initial public offering without our prior consent, we believe
        we will limit the ability of a small group of stockholders to unreasonably attempt to block our ability to complete our initial business combination, particularly in connection with a business combination with a target that requires as a closing
        condition that we have a minimum net worth or a certain amount of cash.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">However, we would not be restricting our stockholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Delivering Stock Certificates in Connection with the Exercise of Redemption Rights</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">As described above, we intend to require our public stockholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” to, at the holder’s option, either
        deliver their stock certificates to our transfer agent or deliver their shares to our transfer agent electronically using The Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) system, prior to the date set forth in the proxy
        materials or tender offer documents, as applicable. In the case of proxy materials, this date may be up to two business days prior to the vote on the proposal to approve the initial business combination. In addition, if we conduct redemptions in
        connection with a stockholder vote, we intend to require a public stockholder seeking redemption of its public shares to also submit a written request for redemption to our transfer agent two business days prior to the vote in which the name of the
        beneficial owner of such shares is included. The proxy materials or tender offer documents, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will indicate whether we are
        requiring public stockholders to satisfy such delivery requirements. Accordingly, a public stockholder would have up to two business days prior to the vote on the initial business combination if we distribute proxy materials, or from the time we
        send out our tender offer materials until the close of the tender offer period, as applicable, to submit or tender its shares if it wishes to seek to exercise its redemption rights. In the event that a stockholder fails to comply with these or any
        other procedures disclosed in the proxy or tender offer materials, as applicable, its shares may not be redeemed. Given the relatively short exercise period, it is advisable for stockholders to use electronic delivery of their public shares.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">11</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">There is a nominal cost associated with the above-referenced process and the act of certificating the shares or delivering them through the DWAC system. The transfer agent will typically charge the broker submitting or
        tendering shares a fee of approximately $80.00 and it would be up to the broker whether or not to pass this cost on to the redeeming holder. However, this fee would be incurred regardless of whether or not we require holders seeking to exercise
        redemption rights to submit or tender their shares. The need to deliver shares is a requirement of exercising redemption rights regardless of the timing of when such delivery must be effectuated.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Any request to redeem such shares, once made, may be withdrawn at any time up to the date set forth in the proxy materials or tender offer documents, as applicable. Furthermore, if a holder of a public share delivered
        its certificate in connection with an election of redemption rights and subsequently decides prior to the applicable date not to elect to exercise such rights, such holder may simply request that the transfer agent return the certificate
        (physically or electronically). It is anticipated that the funds to be distributed to holders of our public shares electing to redeem their shares will be distributed promptly after the completion of our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If our initial business combination is not approved or completed for any reason, then our public stockholders who elected to exercise their redemption rights would not be entitled to redeem their shares for the
        applicable pro rata share of the trust account. In such case, we will promptly return any certificates delivered by public holders who elected to redeem their shares.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If our initial proposed initial business combination is not completed, we may continue to try to complete an initial business combination with a different target until 24 months from the closing of our initial public
        offering.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-weight: bold;">Redemption of Public Shares and Liquidation if No Initial Business Combination</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our amended and restated certificate of incorporation provides that we will have only 24 months from the closing of our initial public offering to complete our initial business combination. If we do not complete our
        initial business combination within such 24-month period, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a
        per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (less taxes payable and up to $100,000 of interest to pay dissolution expenses),
        divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as
        reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board of Directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors
        and the requirements of other applicable law.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our initial stockholders, sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have waived their rights to liquidating distributions from the trust account with respect
        to any founder shares they hold if we fail to complete our initial business combination within 24 months from the closing of our initial public offering. However, if our initial stockholders, sponsor or management team acquire public shares in or
        after our initial public offering, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our initial business combination within the allotted 24-month time period.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">12</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">Our initial stockholders, sponsor, officers and directors have agreed, pursuant to a letter agreement with us, that they will not propose any amendment to our amended and restated certificate of incorporation to modify
        the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering or with respect to any other material provisions
        relating to stockholders’ rights or pre-initial business combination activity, unless we provide our public stockholders with the opportunity to redeem their public shares upon approval of any such amendment at a per-share price, payable in cash,
        equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, divided by the number of then outstanding public shares.
        However, we may not redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001. If this optional redemption right is exercised with respect to an excessive number of public shares such that we cannot
        satisfy the net tangible asset requirement, we would not proceed with the amendment or the related redemption of our public shares at such time.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be funded from amounts remaining out of the approximately $2,000,000 of proceeds
        held outside the trust account, although we cannot assure you that there will be sufficient funds for such purpose. However, if those funds are not sufficient to cover the costs and expenses associated with implementing our plan of dissolution, to
        the extent that there is any interest accrued in the trust account not required to pay taxes, we may request the trustee to release to us an additional amount of up to $100,000 of such accrued interest to pay those costs and expenses.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we were to expend all of the net proceeds of our initial public offering and the sale of the private placement shares, other than the proceeds deposited in the trust account, and without taking into account
        interest, if any, earned on the trust account and any tax payments or expenses for the dissolution of the trust, the per-share redemption amount received by stockholders upon our dissolution would be approximately $10.00.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The proceeds deposited in the trust account could, however, become subject to the claims of our creditors which would have higher priority than the claims of our public stockholders. We cannot assure you that the
        actual per-share redemption amount received by stockholders will not be substantially less than $10.00. Under Section 281(b) of the DGCL, our plan of dissolution must provide for all claims against us to be paid in full or make provision for
        payments to be made in full, as applicable, if there are sufficient assets. These claims must be paid or provided for before we make any distribution of our remaining assets to our stockholders. While we intend to pay such amounts, if any, we
        cannot assure you that we will have funds sufficient to pay or provide for all creditors’ claims.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Although we will seek to have all vendors, service providers, prospective target businesses and other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any
        kind in or to any monies held in the trust account for the benefit of our public stockholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing claims
        against the trust account including but not limited to fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage
        with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will consider whether
        competitive alternatives are reasonably available to us and will only enter into an agreement with such third party if management believes that such third party’s engagement would be in the best interests of the company under the circumstances.
        Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular expertise or skills are believed by management to be significantly superior to
        those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. The underwriters of our initial public offering did not execute agreements with us
        waiving such claims to the monies held in the trust account. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or
        agreements with us and will not seek recourse against the trust account for any reason. In order to protect the amounts held in the trust account, our sponsor has agreed that it will be liable to us if and to the extent any claims by a third party
        for services rendered or products sold to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in
        the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per public share due to
        reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust
        account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters of our initial public offering against certain liabilities, including liabilities under the Securities Act. However, we have
        not asked our sponsor to reserve for such indemnification obligations, nor have we independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our sponsor’s only assets are securities of
        our company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the trust account, the funds available for our initial business combination and
        redemptions could be reduced to less than $10.00 per public share. In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount per share in connection with any redemption of your public
        shares. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">13</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">In the event that the proceeds in the trust account are reduced below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of
        the trust account if less than $10.00 per share due to reductions in the value of the trust assets, in each case less taxes payable, and our sponsor asserts that it is unable to satisfy its indemnification obligations or that it has no
        indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently expect that our independent
        directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any particular
        instance. Accordingly, we cannot assure you that due to claims of creditors the actual value of the per-share redemption price will not be less than $10.00 per share.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We will seek to reduce the possibility that our sponsor will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other
        entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account. Our sponsor will also not be liable as to any claims under our indemnity of the
        underwriters of our initial public offering against certain liabilities, including liabilities under the Securities Act. We will have access to up to approximately $2,000,000 from the proceeds of our initial public offering with which to pay any
        such potential claims (including costs and expenses incurred in connection with our liquidation, currently estimated to be no more than approximately $100,000). In the event that we liquidate and it is subsequently determined that the reserve for
        claims and liabilities is insufficient, stockholders who received funds from our trust account could be liable for claims made by creditors. In the event that our offering expenses exceed our estimate of $1,000,000, we may fund such excess with
        funds from the funds not to be held in the trust account. In such case, the amount of funds we intend to be held outside the trust account would decrease by a corresponding amount. Conversely, in the event that the offering expenses are less than
        our estimate of $1,000,000, the amount of funds we intend to be held outside the trust account would increase by a corresponding amount.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Under the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by them in a dissolution. The pro rata portion of our trust account distributed
        to our public stockholders upon the redemption of our public shares in the event we do not complete our initial business combination within 24 months from the closing of our initial public offering may be considered a liquidating distribution under
        Delaware law. If the corporation complies with certain procedures set forth in Section 280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during which any third-party
        claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders, any liability of
        stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third
        anniversary of the dissolution.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Furthermore, if the pro rata portion of our trust account distributed to our public stockholders upon the redemption of our public shares in the event we do not complete our initial business combination within 24
        months from the closing of our initial public offering, is not considered a liquidating distribution under Delaware law and such redemption distribution is deemed to be unlawful (potentially due to the imposition of legal proceedings that a party
        may bring or due to other circumstances that are currently unknown), then pursuant to Section 174 of the DGCL, the statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three
        years, as in the case of a liquidating distribution. If we do not complete our initial business combination within 24 months from the closing of our initial public offering, we will: (i) cease all operations except for the purpose of winding up,
        (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on
        the funds held in the trust account (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as
        stockholders (including the right to receive further liquidating distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board of Directors,
        dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Accordingly, it is our intention to redeem our public shares as soon as reasonably
        possible following our 24th month and, therefore, we do not intend to comply with those procedures. As such, our stockholders could potentially be liable for any claims to the extent of distributions received by them (but no more) and any liability
        of our stockholders may extend well beyond the third anniversary of such date.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">14</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">Because we will not be complying with Section 280, Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to us at such time that will provide for our payment of all existing and pending claims or
        claims that may be potentially brought against us within the subsequent 10 years. However, because we are a blank check company, rather than an operating company, and our operations are limited to searching for prospective target businesses to
        acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. As described above, pursuant to the obligation contained in our underwriting agreement, we will seek to
        have all vendors, service providers, prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account. As a
        result of this obligation, the claims that could be made against us are significantly limited and the likelihood that any claim that would result in any liability extending to the trust account is remote. Further, our sponsor may be liable only to
        the extent necessary to ensure that the amounts in the trust account are not reduced below (i) $10.00 per public share or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the trust account, due
        to reductions in value of the trust assets, in each case net of the amount of interest withdrawn to pay taxes and will not be liable as to any claims under our indemnity of the underwriters of our initial public offering against certain
        liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy law, and may be
        included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the trust account, we cannot assure you we will be able to return $10.00 per
        share to our public stockholders. Additionally, if we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, any distributions received by stockholders could be viewed under applicable
        debtor/creditor and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy court could seek to recover some or all amounts received by our stockholders. Furthermore, our Board of Directors may
        be viewed as having breached its fiduciary duty to our creditors and/or may have acted in bad faith, and thereby exposing itself and our company to claims of punitive damages, by paying public stockholders from the trust account prior to addressing
        the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our public stockholders will be entitled to receive funds from the trust account only (i) in the event of the redemption of our public shares if we do not complete our initial business combination within 24 months from
        the closing of our initial public offering, (ii) in connection with a stockholder vote to amend our amended and restated certificate of incorporation to modify the substance or timing of our obligation to redeem 100% of our public shares if we do
        not complete our initial business combination within 24 months from the closing of our initial public offering or with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity or (iii)
        if they redeem their respective shares for cash upon the completion of our initial business combination. In no other circumstances will a stockholder have any right or interest of any kind to or in the trust account. In the event we seek
        stockholder approval in connection with our initial business combination, a stockholder’s voting in connection with the business combination alone will not result in a stockholder’s redeeming its shares to us for an applicable pro rata share of the
        trust account. Such stockholder must have also exercised its redemption rights described above. These provisions of our amended and restated certificate of incorporation, like all provisions of our amended and restated certificate of incorporation,
        may be amended with a stockholder vote.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">15</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="font-weight: bold;">Competition</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In identifying, evaluating and selecting a target business for our initial business combination, we may encounter competition from other entities having a business objective similar to ours, including other special
        purpose acquisition companies, private equity groups and leveraged buyout funds, public companies and operating businesses seeking strategic acquisitions. Many of these entities are well established and have extensive experience identifying and
        effecting business combinations directly or through affiliates. Moreover, many of these competitors possess greater financial, technical, human and other resources than us. Our ability to acquire larger target businesses will be limited by our
        available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a target business. Furthermore, our obligation to pay cash in connection with our public stockholders who exercise their redemption
        rights may reduce the resources available to us for our initial business combination and the future dilution they potentially represent, may not be viewed favorably by certain target businesses. Either of these factors may place us at a competitive
        disadvantage in successfully negotiating an initial business combination.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Facilities</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We currently utilize office space at 628 Middlefield Road, Palo Alto, CA 94301 from our sponsor and the members of our management team. We consider our current office space adequate for our current operations.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Employees</div>

      <div style="font-weight: bold;"> <br>
      </div>

      <div style="text-indent: 36pt;">&nbsp;We currently have four executive officers, including our Chief Executive Officer, Rekha Hemrajani and our VP of Corporate Development, Dr. Mayank Gandhi. Aside from Ms. Hemrajani and Dr. Gandhi, members of our
        management team are not obligated to devote any specific number of hours to our matters but they intend to devote as much of their time as they deem necessary to our affairs until we have completed our initial business combination. The amount of
        time that any such person will devote in any time period will vary based on whether a target business has been selected for our initial business combination and the current stage of the business combination process.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">16</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <a id="Item1A."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold; white-space: nowrap;">Item 1A.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Risk Factors</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt; font-style: italic;">An investment in our securities involves a high degree of risk. You should consider carefully all of the risks described below, together with the other information contained in this Annual Report,
        before making a decision to invest in our shares. If any of the following events occur, our business, financial condition and operating results may be materially adversely affected. In that event, the trading price of our securities could decline,
        and you could lose all or part of your investment.</div>

      <div>&nbsp;</div>

      <div style="font-style: italic; font-weight: bold;">General Risk Factors</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We are a blank check company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We are a blank check company incorporated under the laws of the State of Delaware and all of our activities to date have been related to our formation, our initial public offering and our search for a business
        combination target. Because we lack a significant operating history, you have no basis upon which to evaluate our ability to achieve our business objective of completing our initial business combination. If we fail to complete our initial business
        combination, we will never generate any operating revenues.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and we take advantage of certain exemptions from disclosure
        requirements available to emerging growth companies or smaller reporting companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We are an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to
        other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor internal controls attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
        obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute
        payments not previously approved. As a result, our stockholders may not have access to certain information they may deem important. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that
        status earlier, including if the market value of our Class A common stock held by non-affiliates exceeds $700 million as of any June 30 before that time, in which case we would no longer be an emerging growth company as of the following December
        31. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of
        our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a
        Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can
        elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period
        which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or
        revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or
        impossible because of the potential differences in accounting standards used.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Additionally, we are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things,
        providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates exceeds $250 million as of the prior
        June 30th, or (2) our annual revenues exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior June 30th. To the extent we take advantage of such
        reduced disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.</div>

      <div style="text-indent: 18pt;"> <br>
      </div>

      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Our independent registered public accounting firm’s report contains an explanatory paragraph that
          expresses substantial doubt about our ability to continue as a “going concern.”</div>

        <div style="text-align: left; text-indent: 36pt;"><br>
        </div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 18pt;">In connection with our assessment of going concern considerations in accordance with ASC Topic 205-40 Presentation
          of Financial Statements – Going Concern, management has determined that mandatory liquidation and subsequent dissolution raises substantial doubt about our company’s ability to continue as a going concern. No adjustments have been made to the
          carrying amounts of assets or liabilities should our company be required to liquidate after November 23, 2022. Although we intend to consummate a business combination on or before November 23, 2022, and may seek an extension, it is uncertain that
          we will be able to consummate a business combination, or obtain an extension, by this time. This, as well as our liquidity condition, raise substantial doubt about our ability to continue as a going concern. See “Item 7 – Management’s Discussion
          and Analysis of Financial Condition and Results of Operations – Going Concern.” The financial statements do not include any adjustment that might be necessary if our company is unable to continue as a going concern.</div>

      </div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">17</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="font-style: italic; font-weight: bold;">Risks Relating to Our Search for, and Consummation of or Inability to Consummate, a Business Combination</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our stockholders may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold a vote, holders of our founder shares will
        participate in such vote, which means we may complete our initial business combination even though a majority of our public stockholders do not support such a combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We may choose not to hold a stockholder vote to approve our initial business combination if the business combination would not require stockholder approval under applicable law or stock exchange listing requirement.
        Except for as required by applicable law or stock exchange requirement, the decision as to whether we will seek stockholder approval of a proposed business combination or will allow stockholders to sell their shares to us in a tender offer will be
        made by us, solely in our discretion, and will be based on a variety of factors, such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek stockholder approval. Even if we seek stockholder
        approval, the holders of our founder shares will participate in the vote on such approval. Accordingly, we may complete our initial business combination even if a majority of our public stockholders do not approve of the business combination we
        complete.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">In evaluating a prospective target business for our initial business combination, our management may consider the availability of funds from the sale of the forward purchase
        shares, which may be used as part of the consideration to the sellers in the initial business combination. If Samsara BioCapital decides not to exercise its right to purchase all or some of the forward purchase shares, we may lack sufficient funds
        to consummate our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have entered into a forward purchase agreement pursuant to which Samsara BioCapital agreed to purchase an aggregate of up to 2,500,000 forward purchase shares for $10.00 per share, or an aggregate maximum amount of
        $25,000,000, in a private placement that may close simultaneously with the closing of our initial business combination. The funds from the sale of the forward purchase shares, if any, are expected to be used as part of the consideration to the
        sellers in our initial business combination, and to pay expenses in connection with our initial business combination and may be used for working capital in the post-transaction company. If Samsara BioCapital does not agree to fund some or all of
        the forward purchase shares, the post-transaction company may not have enough cash available for working capital. The obligations under the forward purchase agreement do not depend on whether any public stockholders elect to redeem their shares in
        connection with our initial business combination. However, if the sale of the forward purchase shares does not close, for example, by reason of the failure of Samsara BioCapital or any forward transferee to fund the purchase price for their forward
        purchase shares, we may lack sufficient funds to consummate our initial business combination. Samsara BioCapital’s obligation to purchase forward purchase shares will, among other things, be conditioned on the business combination (including the
        target assets or business, and the terms of the business combination) being reasonably acceptable to Samsara BioCapital and on a requirement that such initial business combination is approved by a unanimous vote of our Board of Directors. In
        determining whether a target is reasonably acceptable to Samsara BioCapital, we expect that Samsara BioCapital would consider many of the same criteria as we will consider, but will also consider whether the investment is an appropriate investment
        for Samsara BioCapital. Accordingly, if we pursue an acquisition target that is not reasonably acceptable to Samsara BioCapital, or if the initial business combination is not approved by a unanimous vote of our Board of Directors, Samsara
        BioCapital would not be obligated to purchase any forward purchase shares, and we may need to seek alternative financing.&nbsp; Additionally,&nbsp; Samsara BioCapital’s and any forward transferee’s obligations to purchase the forward purchase shares will be
        subject to termination prior to the closing of the sale of such securities by mutual written consent of the Company and such party, or automatically: (i) if our initial public offering was not consummated on or prior to December 31, 2020; (ii) if
        our initial business combination is not consummated within 24 months from the closing of this offering, unless extended up to a maximum of sixty (60) days in accordance with our amended and restated certificate of incorporation; or (iii) if we
        become subject to any voluntary or involuntary petition under the United States federal bankruptcy laws or any state insolvency law, in each case which is not withdrawn within sixty (60) days after being filed, or a receiver, fiscal agent or
        similar officer is appointed by a court for business or property of us, in each case which is not removed, withdrawn or terminated within sixty (60) days after such appointment. In addition, Samsara BioCapital’s obligations to purchase the forward
        purchase shares will be subject to fulfilment of customary closing conditions, including that our initial business combination must be consummated substantially concurrently with the purchase of the forward purchase shares. In the event of any such
        failure to fund by Samsara BioCapital or any forward transferees, any obligation is so terminated or any such condition is not satisfied and not waived by such party, we may not be able to obtain additional funds to account for such shortfall on
        terms favorable to us or at all. Any such shortfall would also reduce the amount of funds that we have available for working capital of the post-business combination company.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">18</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for
        cash.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">At the time of your investment in us, you will not be provided with an opportunity to evaluate the specific merits or risks of our initial business combination. Since our Board of Directors may complete a business
        combination without seeking stockholder approval, public stockholders may not have the right or opportunity to vote on the business combination, unless we seek such stockholder vote. Accordingly, your only opportunity to affect the investment
        decision regarding our initial business combination may be limited to exercising your redemption rights within the period of time (which will be at least 20 business days) set forth in our tender offer documents mailed to our public stockholders in
        which we describe our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; font-style: italic; font-weight: bold;">The recent coronavirus (COVID-19) pandemic and the impact on business and debt and equity markets could have a material adverse effect on our search for a business combination,
        and any target business with which we ultimately complete a business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In December 2019, a novel strain of coronavirus (COVID-19) surfaced and is continuing to spread throughout the world, including the United States and Europe. On January 30, 2020, the World Health Organization declared
        the outbreak of the coronavirus a “Public Health Emergency of International Concern.” On January 31, 2020, U.S. Health and Human Services Secretary Alex M. Azar II declared a public health emergency for the United States to aid the U.S. healthcare
        community in responding to the coronavirus, and on March 11, 2020 the World Health Organization characterized the outbreak as a “pandemic”. A significant outbreak of the coronavirus and other infectious diseases could result in a widespread health
        crisis that could adversely affect the economies and financial markets worldwide, business operations and the conduct of commerce generally and could have a material adverse effect on the business of any potential target business with which we
        complete a business combination. Furthermore, we may be unable to complete a business combination if continued concerns relating to the coronavirus restrict travel, limit the ability to have meetings with potential investors or the target company’s
        personnel, vendors and services providers are unavailable to negotiate and complete a transaction in a timely manner. The extent to which the coronavirus impacts our search for a business combination will depend on future developments, which are
        highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus pandemic and the actions to contain the coronavirus or treat its impact, among others. If the disruptions posed by the
        coronavirus or other matters of global concern continue for an extensive period of time, it could have a material adverse effect on our ability to complete a business combination, or the operations of a target business with which we ultimately
        complete a business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In addition, our ability to complete a transaction may be dependent on the ability to raise equity and debt financing and the coronavirus pandemic and other related events could have a material adverse effect on our
        ability to raise adequate financing.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If we seek stockholder approval of our initial business combination, our initial stockholders and management team have agreed to vote in favor of such initial business
        combination, regardless of how our public stockholders vote.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our initial stockholders own 20% of our outstanding common stock following the completion of our initial public offering, excluding the shares of our Class A common stock issued as part of the private placement shares.
        Our initial stockholders and management team also may from time to time purchase Class A common stock prior to our initial business combination. Our amended and restated certificate of incorporation provides that, if we seek stockholder approval of
        an initial business combination, such initial business combination will be approved if we receive the affirmative vote of a majority of the shares voted at such meeting, including the founder shares. As a result, in addition to our initial
        stockholders’ founder shares and shares of Class A common stock issued as part of the private placement shares, we would need only 3,628,496, or approximately 35%, of the 10,352,040 public shares sold in our initial public offering to be voted in
        favor of an initial business combination in order to have our initial business combination approved (assuming all outstanding shares are voted). Accordingly, if we seek stockholder approval of our initial business combination, the agreement by our
        initial stockholders and management team to vote in favor of our initial business combination will increase the likelihood that we will receive the requisite stockholder approval for such initial business combination.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">19</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">The ability of our public stockholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it
        difficult for us to enter into a business combination with a target.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We may seek to enter into a business combination transaction agreement with minimum cash requirement for (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general
        corporate purposes or (iii) the retention of cash to satisfy other conditions. If too many public stockholders exercise their redemption rights, we would not be able to meet such closing condition and, as a result, would not be able to proceed with
        the business combination. Furthermore, in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001. Consequently, if accepting all properly submitted redemption requests would cause
        our net tangible assets to be less than $5,000,001 or make us unable to satisfy a minimum cash condition as described above, we would not proceed with such redemption and the related business combination and may instead search for an alternate
        business combination. Prospective targets will be aware of these risks and, thus, may be reluctant to enter into a business combination transaction with us.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business
        combination or optimize our capital structure.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">At the time we enter into an agreement for our initial business combination, we will not know how many stockholders may exercise their redemption rights, and therefore will need to structure the transaction based on
        our expectations as to the number of shares that will be submitted for redemption. If our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a
        minimum amount of cash at closing, we will need to reserve a portion of the cash in the trust account to meet such requirements, or arrange for third party financing. In addition, if a larger number of shares is submitted for redemption than we
        initially expected, we may need to restructure the transaction to reserve a greater portion of the cash in the trust account or arrange for third party financing. Raising additional third-party financing may involve dilutive equity issuances or the
        incurrence of indebtedness at higher than desirable levels. Furthermore, this dilution would increase to the extent that the anti-dilution provision of the Class B common stock results in the issues of shares of Class A common stock on a greater
        than one-to-one basis upon conversion of the shares of Class B common stock at the time of our initial business combination. In addition, the amount of the deferred underwriting commissions payable to the underwriters will not be adjusted for any
        shares that are redeemed in connection with an initial business combination. The per share amount we will distribute to stockholders who properly exercise their redemption rights will not be reduced by the deferred underwriting commission and after
        such redemptions, the amount held in trust will continue to reflect our obligation to pay the entire deferred underwriting commissions. The above considerations may limit our ability to complete the most desirable business combination available to
        us or optimize our capital structure.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business
        combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing, the probability that
        our initial business combination would be unsuccessful is increased. If our initial business combination is unsuccessful, you would not receive your pro rata portion of the trust account until we liquidate the trust account. If you are in need of
        immediate liquidity, you could attempt to sell your shares in the open market; however, at such time our shares may trade at a discount to the pro rata amount per share in the trust account. In either situation, you may suffer a material loss on
        your investment or lose the benefit of funds expected in connection with your exercise of redemption rights until we liquidate or you are able to sell your shares in the open market.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">20</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">The requirement that we complete our initial business combination within 24 months after the closing of our initial public offering may give potential target businesses leverage
        over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to
        complete our initial business combination on terms that would produce value for our stockholders.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Any potential target business with which we enter into negotiations concerning a business combination will be aware that we must complete our initial business combination within 24 months from the closing of our
        initial public offering. Consequently, such target business may obtain leverage over us in negotiating a business combination, knowing that if we do not complete our initial business combination with that particular target business, we may be
        unable to complete our initial business combination with any target business. This risk will increase as we get closer to the timeframe described above. In addition, we may have limited time to conduct due diligence and may enter into our initial
        business combination on terms that we would have rejected upon a more comprehensive investigation.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may not be able to complete our initial business combination within 24 months after the closing of our initial public offering, in which case we would cease all operations
        except for the purpose of winding up and we would redeem our public shares and liquidate.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We may not be able to find a suitable target business and complete our initial business combination within 24 months after the closing of our initial public offering. Our ability to complete our initial business
        combination may be negatively impacted by general market conditions, volatility in the capital and debt markets and the other risks described herein. If we have not completed our initial business combination within such time period, we will: (i)
        cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then
        on deposit in the trust account, including interest earned on the funds held in the trust account (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which
        redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the
        approval of our remaining stockholders and our Board of Directors, liquidate and dissolve, subject in each case, to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If we seek stockholder approval of our initial business combination, our sponsor, initial stockholders, directors, executive officers, advisors and their affiliates may elect to
        purchase shares from public stockholders, which may influence a vote on a proposed business combination and reduce the public “float” of our Class A common stock.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, initial
        stockholders, directors, executive officers, advisors or their affiliates may purchase shares in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination, although they
        are under no obligation to do so. There is no limit on the number of shares our initial stockholders, directors, officers, advisors or their affiliates may purchase in such transactions, subject to compliance with applicable law and Nasdaq rules.
        None of the funds in the trust account will be used to purchase shares in such transactions. Such purchases may include a contractual acknowledgment that such stockholder, although still the record holder of our shares, is no longer the beneficial
        owner thereof and therefore agrees not to exercise its redemption rights.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In the event that our sponsor, initial stockholders, directors, executive officers, advisors or their affiliates purchase shares in privately negotiated transactions from public stockholders who have already elected to
        exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their shares. The purpose of any such purchases of shares could be to vote such shares in favor of the business combination and
        thereby increase the likelihood of obtaining stockholder approval of the business combination or to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of
        our initial business combination, where it appears that such requirement would otherwise not be met. Any such purchases of our shares of Class A common stock may result in the completion of our initial business combination that may not otherwise
        have been possible. We expect any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">21</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">In addition, if such purchases are made, the public “float” of our shares of Class A common stock and the number of beneficial holders of our securities may be reduced, possibly making it difficult to obtain or
        maintain the quotation, listing or trading of our securities on a national securities exchange.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business
        combination. If we do not complete our initial business combination, our public stockholders may receive only their pro rata portion of the funds in the trust account that are available for distribution to public stockholders.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We expect to encounter competition from other entities having a business objective similar to ours, including private investors (which may be individuals or investment partnerships), other blank check companies and
        other entities, domestic and international, competing for the types of businesses we intend to acquire. Many of these individuals and entities are well-established and have extensive experience in identifying and effecting, directly or indirectly,
        acquisitions of companies operating in or providing services to various industries. Many of these competitors possess similar or greater technical, human and other resources to ours or more local industry knowledge than we do and our financial
        resources will be relatively limited when contrasted with those of many of these competitors. While we believe there are numerous target businesses we could potentially acquire with the net proceeds of our initial public offering and the sale of
        the private placement shares, our ability to compete with respect to the acquisition of certain target businesses that are sizable will be limited by our available financial resources. This inherent competitive limitation gives others an advantage
        in pursuing the acquisition of certain target businesses. Furthermore, we are obligated to offer holders of our public shares the right to redeem their shares for cash at the time of our initial business combination in conjunction with a
        stockholder vote or via a tender offer. Target companies will be aware that this may reduce the resources available to us for our initial business combination. Any of these obligations may place us at a competitive disadvantage in successfully
        negotiating a business combination. If we do not complete our initial business combination, our public stockholders may receive only their pro rata portion of the funds in the trust account that are available for distribution to public
        stockholders.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be
        restricted, which may make it difficult for us to complete our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>restrictions on the nature of our investments; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>restrictions on the issuance of securities,</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div>each of which may make it difficult for us to complete our initial business combination. In addition, we may have imposed upon us burdensome requirements, including:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>registration as an investment company with the SEC;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>adoption of a specific form of corporate structure; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are not subject to.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing,
        reinvesting or trading of securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our assets (exclusive of U.S. government securities and cash items)
        on an unconsolidated basis. Our business will be to identify and complete a business combination and thereafter to operate the post-transaction business or assets for the long term. We do not plan to buy businesses or assets with a view to resale
        or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">22</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">We do not believe that our principal activities will subject us to the Investment Company Act. To this end, the proceeds held in the trust account may only be invested in United States “government securities” within
        the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S.
        government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at
        acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we intend to avoid being deemed an “investment company” within the meaning of the Investment
        Company Act. This offering is not intended for persons who are seeking a return on investments in government securities or investment securities. The trust account is intended as a holding place for funds pending the earliest to occur of either:
        (i) the completion of our initial business combination; (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend our amended and restated certificate of incorporation to modify the substance or
        timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering; and (iii) absent an initial business combination within 24 months from the
        closing of this offering or with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity, our return of the funds held in the trust account to our public stockholders as part of our
        redemption of the public shares. If we do not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional
        regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to complete a business combination. If we do not complete our initial business combination, our public stockholders may only
        receive their pro rata portion of the funds in the trust account that are available for distribution to public stockholders.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our
        initial business combination, and results of operations. Because we intend to seek a business combination with a target business in the healthcare industry, we expect our future operations will be subject to laws and regulations of the U.S. FDA.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We are subject to laws and regulations enacted by national, regional and local governments. In particular, we are required to comply with certain SEC and other legal requirements and, because we intend to seek a
        business combination with a target business in the healthcare industry, we expect our future operations will be subject to laws and regulations of the U.S. FDA. Compliance with, and monitoring of, applicable laws and regulations may be difficult,
        time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In
        addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business combination, and results of
        operations.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">23</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may seek business combination opportunities in industries outside of the healthcare industry (which industries may, or may not be outside of our management’s area of
        expertise).</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Although we intend to focus on identifying business combination candidates in the healthcare industry in the United States (including candidates based in the United States which may have operations or opportunities
        outside the United States) or other developed countries, and we will not initially actively seek to identify business combination candidates in other industries (which industries may be outside our management’s area of expertise), we will consider
        a business combination outside of the healthcare industry if a business combination candidate is presented to us and we determine that such candidate offers an attractive acquisition opportunity for our company or we are unable to identify a
        suitable candidate in the healthcare industry after having expended a reasonable amount of time and effort in an attempt to do so. Although our management will endeavor to evaluate the risks inherent in any particular business combination
        candidate, we may not adequately ascertain or assess all of the risks. An investment in our shares may ultimately prove to be less favorable to investors in this offering than a direct investment, if an opportunity were available, in a business
        combination candidate.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In the event we elect to pursue a business combination outside of the healthcare industry, our management’s expertise may not be directly applicable to its evaluation or operation, and the information contained in this
        Annual Report regarding the healthcare industry would not be relevant to an understanding of the business that we elect to acquire.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Because we intend to seek a business combination with a target business in the healthcare industry, we expect our future operations to be subject to risks associated with this
        industry.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Healthcare-related companies are generally subject to greater governmental regulation than most other industries at the U.S. state and federal levels, and internationally. In recent years, both local and national
        governmental budgets have come under pressure to reduce spending and control healthcare costs, which could both adversely affect regulatory processes and public funding available for healthcare products, services and facilities. In March 2010,
        comprehensive healthcare reform legislation was enacted in the United States through the Health Care Reform Act. These laws are intended to increase health insurance coverage through individual and employer mandates, subsidies offered to lower
        income individuals, tax credits available to smaller employers and broadening of Medicaid eligibility.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">While one intent of healthcare reform is to expand health insurance coverage to more individuals, it may also involve additional regulatory mandates and other measures designed to constrain medical costs, including
        coverage and reimbursement for healthcare services. The Health Care Reform Act has had a significant impact on the healthcare sector in the U.S. and consequently has the ability to affect the companies within the healthcare industry. The ultimate
        effects of federal healthcare reform or any future legislation or regulation, or healthcare initiatives, if any, on the healthcare sector, whether implemented at the federal or state level, or internationally, cannot be predicted with certainty and
        such reform, legislation, regulation or initiatives, including the Health Care Reform Act or any successor legislation, may adversely affect the performance of a potential business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Changes in governmental policies may have a material effect on the demand for or costs of certain products and services. A healthcare-related company must receive government approval before introducing new drugs and
        medical devices or procedures. This process may delay the introduction of these products and services to the marketplace, resulting in increased development costs, delayed cost recovery and loss of competitive advantage to the extent that rival
        companies have developed competing products or procedures, adversely affecting the company’s revenues and profitability. Failure to obtain governmental approval of a key drug or device or other regulatory action could have a material adverse effect
        on the business of a portfolio company. Additionally, expansion of facilities by healthcare-related providers is subject to “determinations of need” by the appropriate government authorities. This process not only increases the time and cost
        involved in these expansions, but also makes expansion plans uncertain, limiting the revenue and profitability growth potential of healthcare-related facilities operators.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">24</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">Certain healthcare-related companies depend on the exclusive rights or patents for the products they develop and distribute. Patents have a limited duration and, upon expiration, other companies may market
        substantially similar “generic” products that are typically sold at a lower price than the patented product, causing the original developer of the product to lose market share and/or reduce the price charged for the product, resulting in lower
        profits for the original developer. As a result, the expiration of patents may adversely affect the profitability of these companies. The profitability of healthcare-related companies may also be affected, among other factors, by restrictions on
        government reimbursement for medical expenses, rising or falling costs of medical products and services, pricing pressure, an increased emphasis on outpatient services, a limited product offering, industry innovation, changes in technologies and
        other market developments. Finally, because the products and services of healthcare-related companies affect the health and well-being of many individuals, these companies are especially susceptible to product liability lawsuits.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The healthcare industry spends heavily on research and development. Research findings (e.g., regarding side effects or comparative benefits of one or more particular treatments, services or products) and technological
        innovation (together with patent expirations) may make any particular treatment, service or product less attractive if previously unknown or underappreciated risks are revealed, or if a more effective, less costly or less risky solution is or
        becomes available. Any such development could have a material adverse effect on the companies that are target businesses for investment.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Although we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business
        combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria and
        guidelines.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Although we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business with which we enter into our initial business combination will not have
        all of these positive attributes. If we complete our initial business combination with a target that does not meet some or all of these guidelines, such combination may not be as successful as a combination with a business that does meet all of our
        general criteria and guidelines. In addition, if we announce a prospective business combination with a target that does not meet our general criteria and guidelines, a greater number of stockholders may exercise their redemption rights, which may
        make it difficult for us to meet any closing condition with a target business that requires us to have a minimum net worth or a certain amount of cash. In addition, if stockholder approval of the transaction is required by law, or we decide to
        obtain stockholder approval for business or other legal reasons, it may be more difficult for us to attain stockholder approval of our initial business combination if the target business does not meet our general criteria and guidelines. If we do
        not complete our initial business combination, our public stockholders may only receive their pro rata portion of the funds in the trust account that are available for distribution to public stockholders.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We are not required to obtain an opinion from an independent investment banking firm or from a valuation or appraisal firm, and consequently, you may have no assurance from an
        independent source that the price we are paying for the business is fair to our stockholders from a financial point of view.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Unless we complete our initial business combination with an affiliated entity or our Board of Directors cannot independently determine the fair market value of the target business or businesses (including with the
        assistance of financial advisors), we are not required to obtain an opinion from an independent investment banking firm which is a member of FINRA or from a valuation or appraisal firm that the price we are paying is fair to our stockholders from a
        financial point of view. If no opinion is obtained, our stockholders will be relying on the judgment of our Board of Directors, who will determine fair market value based on standards generally accepted by the financial community. Such standards
        used will be disclosed in our proxy materials or tender offer documents, as applicable, related to our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 20.15pt; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Since only holders of our founder shares will have the right to vote on the election of directors, Nasdaq may consider us to be a ‘controlled company’
        within the meaning of Nasdaq rules and, as a result, we may qualify for exemptions from certain corporate governance requirements.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 20.15pt; color: rgb(0, 0, 0);">Only holders of our founder shares have the right to vote on the election of directors. As a result, Nasdaq may consider us to be a ‘controlled company’ within the meaning of the Nasdaq
        corporate governance standards. Under Nasdaq corporate governance standards, a company of which more than 50% of the voting power is held by an individual, group or another company is a ‘controlled company’ and may elect not to comply with certain
        corporate governance requirements, including the requirements that:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">we have a board that includes a majority of ‘independent directors,’ as defined under the rules of Nasdaq;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">25</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">we have a nominating committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt; color: rgb(0, 0, 0);">We do not intend to utilize these exemptions and intend to comply with the corporate governance requirements of Nasdaq, subject to applicable phase-in rules. However, if we determine in the future
        to utilize some or all of these exemptions, you will not have the same protections afforded to stockholders of companies that are subject to all of Nasdaq corporate governance requirements.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may issue additional shares of Class A common stock or shares of preferred stock to complete our initial business combination or under an employee incentive plan after
        completion of our initial business combination. We may also issue shares of Class A common stock upon the conversion of the founder shares at a ratio greater than one-to-one at the time of our initial business combination as a result of the
        anti-dilution provisions contained in our amended and restated certificate of incorporation. Any such issuances would dilute the interest of our stockholders and likely present other risks.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">
        <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Our amended and restated certificate of incorporation authorizes the issuance of up to 100,000,000 shares of Class A
          common stock, par value $0.0001 per share, 10,000,000 shares of Class B common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. There are 89,140,919 and 7,411,990 authorized but unissued
          shares of Class A common stock and Class B common stock, respectively, available for issuance which amount does not take into account the forward purchase shares or shares issuable upon conversion of the Class B common stock. The Class B common
          stock is automatically convertible into Class A common stock concurrently with or immediately following the consummation of our initial business combination, initially at a one-for-one ratio but subject to adjustment as set forth in our amended
          and restated certificate of incorporation. There are no shares of preferred stock issued and outstanding.</div>

        <div>&nbsp;</div>

      </div>

      <div style="text-indent: 18pt;">We may issue a substantial number of additional shares of Class A common stock or shares of preferred stock to complete our initial business combination or under an employee incentive plan after completion of our
        initial business combination. We may also issue shares of Class A common stock upon conversion of the Class B common stock at a ratio greater than one-to-one at the time of our initial business combination as a result of the anti-dilution
        provisions as set forth therein. However, our amended and restated certificate of incorporation provides, among other things, that prior to our initial business combination, we may not issue additional shares that would entitle the holders thereof
        to (i) receive funds from the trust account or (ii) vote as a class with our public shares (a) on any initial business combination or (b) to approve an amendment to our amended and restated certificate of incorporation to (x) extend the time we
        have to consummate a business combination beyond 24 months from the closing of our initial public offering or (y) amend the foregoing provisions. These provisions of our amended and restated certificate of incorporation, like all provisions of our
        amended and restated certificate of incorporation, may be amended with a stockholder vote. The issuance of additional shares of common stock or shares of preferred stock:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>may significantly dilute the equity interest of investors in this offering;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>may subordinate the rights of holders of Class A common stock if shares of preferred stock are issued with rights senior to those afforded our Class A common stock;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>could cause a change in control if a substantial number of shares of Class A common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the
                resignation or removal of our present officers and directors; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>may adversely affect prevailing market prices for our shares, Class A common stock.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">26</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Unlike some other similarly structured special purpose acquisition companies, our initial stockholders will receive additional shares of Class A common stock if we issue certain
        shares to consummate an initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The founder shares will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of our initial business combination on a one-for-one basis, subject to
        adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued
        or deemed issued in connection with our initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of
        shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed
        issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of
        Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, or forward purchase shares, to any seller in the initial business combination. This is different
        than some other similarly structured special purpose acquisition companies in which the initial stockholders will only be issued an aggregate of 20% of the total number of shares to be outstanding prior to our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Resources could be wasted in researching business combinations that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge
        with another business. If we have not completed our initial business combination within the required time period, our public stockholders may only receive their pro rata portion of the funds in the trust account that are available for distribution
        to public stockholders.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We anticipate that the investigation of each specific target business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial management
        time and attention and substantial costs for accountants, attorneys and others. If we decide not to complete a specific initial business combination, the costs incurred up to that point for the proposed transaction likely would not be recoverable.
        Furthermore, if we reach an agreement relating to a specific target business, we may fail to complete our initial business combination for any number of reasons including those beyond our control. Any such event will result in a loss to us of the
        related costs incurred which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not completed our initial business combination within the required time period, our public
        stockholders may only receive their pro rata portion of the funds in the trust account that are available for distribution to public stockholders.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Since our sponsor, executive officers and directors will lose their entire investment in us if our initial business combination is not completed (other than with respect to
        public shares they may acquire during or after this offering), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
        <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On September 9, 2020, our sponsor purchased an aggregate of 4,312,500 founder shares in exchange for a capital
          contribution of $25,000, or approximately $0.006 per share. On October 30, 2020, our sponsor forfeited 1,437,500 founder shares for no consideration. Prior to the initial investment in the company of $25,000 by the sponsor, the company had no
          assets, tangible or intangible.&nbsp; In connection with the partial exercise of the underwriters’ over-allotment option, our sponsor forfeited an additional 286,990 founder shares, such that at December 31, 2021 and 2020 there were an aggregate of
          2,588,010 founder shares outstanding. The purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares outstanding was
          determined based on the expectation that the total size of the initial public offering would be a maximum of 11,500,000 shares if the underwriters’ over-allotment option is exercised in full, and therefore that such founder shares would represent
          20% of the outstanding shares after the initial public offering. In addition, concurrently with our initial public offering, our sponsor purchased an aggregate of 507,041 private placement shares, at a price of $10.00 per share, for an aggregate
          purchase price of $5,070,410. The personal and financial interests of our executive officers and directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination and
          influencing the operation of the business following the initial business combination. This risk may become more acute as the 24-month anniversary of the closing of our initial public offering nears, which is the deadline for our completion of an
          initial business combination.</div>

        <div><br></div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">27</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may only be able to complete one business combination with the proceeds of our initial public offering and the sale of the private placement shares and the forward purchase
        shares, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We may effectuate our initial business combination with a single target business or multiple target businesses simultaneously or within a short period of time. However, we may not be able to effectuate our initial
        business combination with more than one target business because of various factors, including the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that present operating
        results and the financial condition of several target businesses as if they had been operated on a combined basis. By completing our initial business combination with only a single entity, our lack of diversification may subject us to numerous
        economic, competitive and regulatory developments. Further, we would not be able to diversify our operations or benefit from the possible spreading of risks or offsetting of losses, unlike other entities which may have the resources to complete
        several business combinations in different industries or different areas of a single industry. Accordingly, the prospects for our success may be:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>solely dependent upon the performance of a single business, property or asset, or</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>dependent upon the development or market acceptance of a single or limited number of products, processes or services.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">This lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial adverse impact upon the particular industry in which we may operate
        subsequent to our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination and
        give rise to increased costs and risks that could negatively impact our operations and profitability.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent on the simultaneous
        closings of the other business combinations, which may make it more difficult for us, and delay our ability, to complete our initial business combination. With multiple business combinations, we could also face additional risks, including
        additional burdens and costs with respect to possible multiple negotiations and due diligence investigations (if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations and services or
        products of the acquired companies in a single operating business. If we are unable to adequately address these risks, it could negatively impact our profitability and results of operations.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may attempt to complete our initial business combination with a private company about which little information is available, which may result in a business combination with a
        company that is not as profitable as we suspected, if at all.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In pursuing our business combination strategy, we may seek to effectuate our initial business combination with a privately held company. Very little public information generally exists about private companies, and we
        could be required to make our decision on whether to pursue a potential initial business combination on the basis of limited information, which may result in a business combination with a company that is not as profitable as we suspected, if at
        all.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">28</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our management may not be able to maintain our control of a target business after our initial business combination. We cannot provide assurance that, upon loss of control of a
        target business, new management will possess the skills, qualifications or abilities necessary to profitably operate such business.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We may structure our initial business combination so that the post-transaction company in which our public stockholders own shares will own less than 100% of the equity interests or assets of a target business, but we
        will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for us not to be
        required to register as an investment company under the Investment Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-transaction company owns 50% or more of the voting securities of the target
        business, our stockholders prior to the business combination may collectively own a minority interest in the post business combination company, depending on valuations ascribed to the target and us in the business combination. For example, we could
        pursue a transaction in which we issue a substantial number of new shares of Class A common stock in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% interest in the target. However, as a result
        of the issuance of a substantial number of new shares of Class A common stock, our stockholders immediately prior to such transaction could own less than a majority of our outstanding Class A common stock subsequent to such transaction. In
        addition, other minority stockholders may subsequently combine their holdings resulting in a single person or group obtaining a larger share of the company’s shares than we initially acquired. Accordingly, this may make it more likely that our
        management will not be able to maintain our control of the target business.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete our initial business combination with
        which a substantial majority of our stockholders do not agree.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our amended and restated certificate of incorporation does not provide a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that would cause our net tangible
        assets to be less than $5,000,001. In addition, our proposed initial business combination may impose a minimum cash requirement for: (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general
        corporate purposes or (iii) the retention of cash to satisfy other conditions. As a result, we may be able to complete our initial business combination even though a substantial majority of our public stockholders do not agree with the transaction
        and have redeemed their shares or, if we seek stockholder approval of our initial business combination and do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, have entered into
        privately negotiated agreements to sell their shares to our sponsor, officers, directors, advisors or any of their affiliates. In the event the aggregate cash consideration we would be required to pay for all shares of Class A common stock that are
        validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business combination or
        redeem any shares in connection with such initial business combination, all shares of Class A common stock submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business combination.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">In order to effectuate an initial business combination, special purpose acquisition companies have, in the recent past, amended various provisions of their charters and other
        governing instruments. We cannot assure you that we will not seek to amend our amended and restated certificate of incorporation or governing instruments in a manner that will make it easier for us to complete our initial business combination that
        our stockholders may not support.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In order to effectuate a business combination, special purpose acquisition companies have, in the recent past, amended various provisions of their charters and governing instruments. For example, special purpose
        acquisition companies have amended the definition of business combination, increased redemption thresholds and extended the time to consummate an initial business combination. Amending our amended and restated certificate of incorporation will
        require the approval of holders of 65% of our common stock . In addition, our amended and restated certificate of incorporation requires us to provide our public stockholders with the opportunity to redeem their public shares for cash if we propose
        an amendment to our amended and restated certificate of incorporation to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete an initial business combination within 24 months of the closing of
        our initial public offering or with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity. To the extent any of such amendments would be deemed to fundamentally change the nature of
        the securities offered through this registration statement, we would register, or seek an exemption from registration for, the affected securities. We cannot assure you that we will not seek to amend our charter or governing instruments or extend
        the time to consummate an initial business combination in order to effectuate our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">29</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">The provisions of our amended and restated certificate of incorporation that relate to our pre-business combination activity (and corresponding provisions of the agreement
        governing the release of funds from our trust account) may be amended with the approval of holders of 65% of our common stock, which is a lower amendment threshold than that of some other special purpose acquisition companies. It may be easier for
        us, therefore, to amend our amended and restated certificate of incorporation to facilitate the completion of an initial business combination that some of our stockholders may not support.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our amended and restated certificate of incorporation provides that any of its provisions related to pre-business combination activity may be amended if approved by holders of 65% of our common stock entitled to vote
        thereon and corresponding provisions of the trust agreement governing the release of funds from our trust account may be amended if approved by holders of 65% of our common stock entitled to vote thereon. In all other instances, our amended and
        restated certificate of incorporation may be amended by holders of a majority of our outstanding common stock entitled to vote thereon, subject to applicable provisions of the DGCL or applicable stock exchange rules. Our initial stockholders, who
        collectively beneficially own 20% of our common stock (including the private placement shares but assuming they did not purchase any shares in our initial public offering), may participate in any vote to amend our amended and restated certificate
        of incorporation and/or trust agreement and will have the discretion to vote in any manner they choose. As a result, we may be able to amend the provisions of our amended and restated certificate of incorporation which govern our pre-business
        combination behavior more easily than some other special purpose acquisition companies, and this may increase our ability to complete a business combination with which you do not agree. Our stockholders may pursue remedies against us for any breach
        of our amended and restated certificate of incorporation.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our sponsor, executive officers, directors and director nominees have agreed, pursuant to written agreements with us, that they will not propose any amendment to our amended and restated certificate of incorporation to
        modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering or with respect to any other material
        provisions relating to stockholders’ rights or pre-initial business combination activity, unless we provide our public stockholders with the opportunity to redeem their Class A common stock upon approval of any such amendment at a per-share price,
        payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to pay our taxes, divided by the number of then outstanding public
        shares. Our stockholders are not parties to, or third-party beneficiaries of, these agreements and, as a result, will not have the ability to pursue remedies against our sponsor, executive officers, directors or director nominees for any breach of
        these agreements. As a result, in the event of a breach, our stockholders would need to pursue a stockholder derivative action, subject to applicable law.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Certain agreements related to our initial public offering may be amended without stockholder approval.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Each of the agreements related to our initial public offering to which we are a party, other than the investment management trust agreement, may be amended without stockholder approval. Such agreements are: the
        underwriting agreement; the letter agreement among us and our initial stockholders, sponsor, officers and directors; the registration rights agreement among us and our initial stockholders; the private placement purchase agreement between us and
        our sponsor; and the administrative services agreement among us, our sponsor and an affiliate of our sponsor. These agreements contain various provisions that our public stockholders might deem to be material. For example, our letter agreement and
        the underwriting agreement contain certain lock-up provisions with respect to the founder shares, private placement shares and other securities held by our initial stockholders, sponsor, officers and directors. Amendments to such agreements would
        require the consent of the applicable parties thereto and would need to be approved by our Board of Directors, which may do so for a variety of reasons, including to facilitate our initial business combination. While we do not expect our Board of
        Directors to approve any amendment to any of these agreements prior to our initial business combination, it may be possible that our Board of Directors, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one
        or more amendments to any such agreement. Any amendment entered into in connection with the consummation of our initial business combination will be disclosed in our proxy materials or tender offer documents, as applicable, related to such initial
        business combination, and any other material amendment to any of our material agreements will be disclosed in a filing with the SEC. Any such amendments would not require approval from our stockholders, may result in the completion of our initial
        business combination that may not otherwise have been possible, and may have an adverse effect on the value of an investment in our securities. For example, amendments to the lock-up provision discussed above may result in our initial stockholders
        selling their securities earlier than they would otherwise be permitted, which may have an adverse effect on the price of our securities.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">30</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target business, which could compel us to
        restructure or abandon a particular business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have not selected any specific business combination target but intend to target businesses with enterprise values that are greater than we could acquire with the net proceeds of our initial public offering and the
        sale of the private placement shares. As a result, if the cash portion of the purchase price exceeds the amount available from the trust account, net of amounts needed to satisfy any redemption by public stockholders, we may be required to seek
        additional financing to complete such proposed initial business combination. Such financing may not be available on acceptable terms, if at all. To the extent that additional financing proves to be unavailable when needed to complete our initial
        business combination, we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative target business candidate. Further, we may be required to obtain additional financing in
        connection with the closing of our initial business combination for general corporate purposes, including for maintenance or expansion of operations of the post-transaction businesses, the payment of principal or interest due on indebtedness
        incurred in completing our initial business combination, or to fund the purchase of other companies. If we do not complete our initial business combination, our public stockholders may only receive their pro rata portion of the funds in the trust
        account that are available for distribution to public stockholders. In addition, even if we do not need additional financing to complete our initial business combination, we may require such financing to fund the operations or growth of the target
        business. The failure to secure additional financing could have a material adverse effect on the continued development or growth of the target business. None of our officers, directors or stockholders is required to provide any financing to us in
        connection with or after our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Risks Relating to our Securities</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If the net proceeds of our initial public offering not being held in the trust account are insufficient to allow us to operate for at least the 24 months following the closing
        of the offering, it could limit the amount available to fund our search for a target business or businesses and complete our initial business combination, and we will depend on loans from our sponsor or management team to fund our search and to
        complete our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Of the net proceeds of our initial public offering, only $2,000,000 is available to us initially outside the trust account to fund our working capital requirements. We believe that, upon closing of our initial public
        offering, the funds available to us outside of the trust account will be sufficient to allow us to operate for at least the 24 months following such closing; however, we cannot assure you that our estimate is accurate. Of the funds available to us,
        we could use a portion of the funds available to us to pay fees to consultants to assist us with our search for a target business. We could also use a portion of the funds as a down payment or to fund a “no-shop” provision (a provision in letters
        of intent or merger agreements designed to keep target businesses from “shopping” around for transactions with other companies or investors on terms more favorable to such target businesses) with respect to a particular proposed business
        combination, although we do not have any current intention to do so. If we entered into a letter of intent or merger agreement where we paid for the right to receive exclusivity from a target business and were subsequently required to forfeit such
        funds (whether as a result of our breach or otherwise), we might not have sufficient funds to continue searching for, or conduct due diligence with respect to, a target business.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In the event that our offering expenses exceed our estimate of $1,000,000, we may fund such excess with funds not to be held in the trust account. In such case, the amount of funds we intend to be held outside the
        trust account would decrease by a corresponding amount. Conversely, in the event that the offering expenses are less than our estimate of $1,000,000, the amount of funds we intend to be held outside the trust account would increase by a
        corresponding amount. The amount held in the trust account will not be impacted as a result of such increase or decrease. If we are required to seek additional capital, we would need to borrow funds from our sponsor, management team or other third
        parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor any of their affiliates is under any obligation to advance funds to us in such circumstances. Any such advances would be repaid only from
        funds held outside the trust account or from funds released to us upon completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into shares of the post-business combination entity at a price of $10.00 per
        share at the option of the lender. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to
        loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we do not complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease
        operations and liquidate the trust account. Consequently, our public stockholders may only receive an estimated $10.00 per share, or possibly less, on our redemption of our public shares.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">31</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition,
        results of operations and the price of our securities, which could cause you to lose some or all of your investment.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Even if we conduct extensive due diligence on a target business with which we combine, we cannot assure you that this diligence will identify all material issues that may be present with a particular target business,
        that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of the target business and outside of our control will not later arise. As a result of these factors, we may be forced to
        later write-down or write-off assets, restructure our operations, or incur impairment or other charges that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and
        previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature
        could contribute to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to violate net worth or other covenants to which we may be subject as a result of assuming pre-existing debt held by a
        target business or by virtue of our obtaining debt financing to partially finance the initial business combination or thereafter. Accordingly, any stockholders who choose to remain stockholders following the business combination could suffer a
        reduction in the value of their securities. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of
        care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that the proxy materials or tender offer documents, as applicable, relating to the business combination contained an
        actionable material misstatement or material omission.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by stockholders may be less than
        $10.00 per share.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our placing of funds in the trust account may not protect those funds from third party claims against us. Although we will seek to have all vendors, service providers, prospective target businesses and other entities
        with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public stockholders, such parties may not execute such agreements, or
        even if they execute such agreements they may not be prevented from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims
        challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims
        to the monies held in the trust account, our management will consider whether competitive alternatives are reasonably available to us and will only enter into an agreement with such third party if management believes that such third party’s
        engagement would be in the best interests of the company under the circumstances. The underwriters of our initial public offering will not execute agreements with us waiving such claims to the monies held in the trust account.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">32</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular expertise or skills are believed by management to be
        significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. For example, Marcum LLP, our independent registered public
        accounting firm and the underwriters of our initial public offering will not execute agreements with us waiving such claims to the monies held in the trust account. In addition, there is no guarantee that such entities will agree to waive any
        claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we do not complete
        our initial business combination within the prescribed timeframe, or upon the exercise of a redemption right in connection with our initial business combination, we will be required to provide for payment of claims of creditors that were not waived
        that may be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount received by public stockholders could be less than the $10.00 per public share initially held in the trust account, due to claims
        of such creditors. Pursuant to the letter agreement entered into in connection with our initial public offering, our sponsor has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or products
        sold to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the
        lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per public share due to reductions in the value of the trust
        assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is
        enforceable). However, we have not asked our sponsor to reserve for such indemnification obligations, nor have we independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our sponsor’s
        only assets are securities of our company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the trust account, the funds available for our
        initial business combination and redemptions could be reduced to less than $10.00 per public share. In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount per share in connection
        with any redemption of your public shares. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">The securities in which we invest the proceeds held in the trust account could bear a negative rate of interest, which could reduce the interest income available for payment of
        taxes or reduce the value of the assets held in trust such that the per share redemption amount received by shareholders may be less than $10.00 per share.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The proceeds held in the trust account may only be invested in direct U.S. Treasury obligations having a maturity of 185 days or less, or in certain money market funds which invest only in direct U.S. Treasury
        obligations. While short-term U.S. Treasury obligations currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent
        years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event of very low or negative yields, the amount of interest income (which
        we may withdraw to pay income taxes, if any) would be reduced. In the event that we are unable to complete our initial business combination, our public shareholders are entitled to receive their pro-rata share of the proceeds held in the trust
        account, plus any interest income. If the balance of the trust account is reduced below $103,520,400 as a result of negative interest rates, the amount of funds in the trust account available for distribution to our public shareholders may be
        reduced below $10.00 per share.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in the trust account available for
        distribution to our public stockholders.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In the event that the proceeds in the trust account are reduced below the lesser of (i) $10.00 per share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the
        trust account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case less taxes payable, and our sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification
        obligations related to a particular claim, our independent directors would determine whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take
        legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment and subject to their fiduciary duties may choose not to do so in
        any particular instance. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution to our public stockholders may be reduced below $10.00 per share.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">33</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If, after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us
        that is not dismissed, a bankruptcy court may seek to recover such proceeds, and the members of our Board of Directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our Board of Directors
        and us to claims of punitive damages.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If, after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, any distributions
        received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy court could seek to recover some or all amounts received by
        our stockholders. In addition, our Board of Directors may be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith, by paying public stockholders from the trust account prior to addressing the claims of
        creditors, thereby exposing itself and us to claims of punitive damages.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If, before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us
        that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our stockholders and the per-share amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If, before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in
        the trust account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete
        the trust account, the per-share amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our stockholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Under the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by them in a dissolution. The pro rata portion of our trust account distributed
        to our public stockholders upon the redemption of our public shares in the event we do not complete our initial business combination within 24 months from the closing of our initial public offering may be considered a liquidating distribution under
        Delaware law. If a corporation complies with certain procedures set forth in Section 280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during which any third-party
        claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders, any liability of
        stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third
        anniversary of the dissolution. However, it is our intention to redeem our public shares as soon as reasonably possible following the 24th month from the closing of our initial public offering in the event we do not complete our initial business
        combination and, therefore, we do not intend to comply with the foregoing procedures.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Because we will not be complying with Section 280, Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to us at such time that will provide for our payment of all existing and pending claims or
        claims that may be potentially brought against us within the 10 years following our dissolution. However, because we are a blank check company, rather than an operating company, and our operations will be limited to searching for prospective target
        businesses to acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. If our plan of distribution complies with Section 281(b) of the DGCL, any liability of
        stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would likely be barred after the
        third anniversary of the dissolution. We cannot assure you that we will properly assess all claims that may be potentially brought against us. As such, our stockholders could potentially be liable for any claims to the extent of distributions
        received by them (but no more) and any liability of our stockholders may extend beyond the third anniversary of such date. Furthermore, if the pro rata portion of our trust account distributed to our public stockholders upon the redemption of our
        public shares in the event we do not complete our initial business combination within 24 months from the closing of our initial public offering is not considered a liquidating distribution under Delaware law and such redemption distribution is
        deemed to be unlawful (potentially due to the imposition of legal proceedings that a party may bring or due to other circumstances that are currently unknown), then pursuant to Section 174 of the DGCL, the statute of limitations for claims of
        creditors could then be six years after the unlawful redemption distribution, instead of three years, as in the case of a liquidating distribution.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">34</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may not hold an annual meeting of stockholders until after the consummation of our initial business combination, which could delay the opportunity for our stockholders to
        elect directors.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In accordance with Nasdaq corporate governance requirements, we are not required to hold an annual meeting until no later than one year after our first fiscal year end following our listing on Nasdaq. Under Section
        211(b) of the DGCL, we are, however, required to hold an annual meeting of stockholders for the purposes of electing directors in accordance with our bylaws unless such election is made by written consent in lieu of such a meeting. We may not hold
        an annual meeting of stockholders to elect new directors prior to the consummation of our initial business combination, and thus we may not be in compliance with Section 211(b) of the DGCL, which requires an annual meeting. Therefore, if our
        stockholders want us to hold an annual meeting prior to the consummation of our initial business combination, they may attempt to force us to hold one by submitting an application to the Delaware Court of Chancery in accordance with Section 211(c)
        of the DGCL.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">The grant of registration rights to our initial stockholders may make it more difficult to complete our initial business combination, and the future exercise of such rights may
        adversely affect the market price of our Class A common stock.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Pursuant to an agreement entered into concurrently with the issuance and sale of the securities in our initial public offering, our initial stockholders and their permitted transferees can demand that we register their
        founder shares, after those shares convert to our Class A common stock at the time of our initial business combination. Pursuant to the forward purchase agreement, we agreed that we will use our commercially reasonable efforts to file within 30
        days after the closing of the initial business combination a registration statement with the SEC for a secondary offering of the forward purchase shares and to cause such registration statement to be declared effective as soon as practicable after
        it is filed. We will bear the cost of registering these securities. The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect on the market price of our Class A common
        stock. In addition, the existence of the registration rights may make our initial business combination more costly or difficult to conclude. This is because the shareholders of the target business may increase the equity stake they seek in the
        combined entity or ask for more cash consideration to offset the negative impact on the market price of our Class A common stock that is expected when the common stock owned by our initial stockholders, holders of our forward purchase shares or
        holders of our working capital loans or their respective permitted transferees are registered.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Because we are neither limited to evaluating a target business in a particular industry sector nor have we selected any specific target businesses with which to pursue our
        initial business combination, you will be unable to ascertain the merits or risks of any particular target business’s operations.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our efforts to identify a prospective initial business combination target are not be limited to a particular industry, sector or geographic region. While we may pursue an initial business combination opportunity in any
        industry or sector, we intend to capitalize on the ability of our management team to identify, acquire and operate a business or businesses that can benefit from our management team’s established global relationships and operating experience. Our
        management team has extensive experience in identifying and executing strategic investments globally and has done so successfully in a number of sectors. Our amended and restated certificate of incorporation prohibits us from effectuating a
        business combination with another blank check company or similar company with nominal operations. Because we have not yet selected any specific target business with respect to a business combination, there is no basis to evaluate the possible
        merits or risks of any particular target business’s operations, results of operations, cash flows, liquidity, financial condition or prospects. To the extent we complete our initial business combination, we may be affected by numerous risks
        inherent in the business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by the risks inherent in the business and
        operations of a financially unstable or a development stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all
        of the significant risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will
        adversely impact a target business. We also cannot assure you that an investment in our shares will ultimately prove to be more favorable to investors than a direct investment, if such opportunity were available, in a business combination target.
        Accordingly, any stockholders who choose to remain stockholders following the business combination could suffer a reduction in the value of their securities. Such stockholders are unlikely to have a remedy for such reduction in value unless they
        are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that the
        proxy materials or tender offer documents, as applicable, relating to the business combination contained an actionable material misstatement or material omission.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">35</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Past performance by our management team, the Samsara BioCapital and its affiliates may not be indicative of future performance of an investment in us.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Information regarding performance by, or businesses associated with, our management team, the Samsara BioCapital and its affiliates, or businesses associated with them, is presented for informational purposes only.
        Past performance by such individuals and entities is not a guarantee either (i) of success with respect to any business combination we may consummate or (ii) that we will be able to locate a suitable candidate for our initial business combination.
        You should not rely on the historical record of the performance of our management team, the Samsara BioCapital and its affiliates or businesses associated with them as indicative of our future performance of an investment in us or the returns we
        will, or is likely to, generate going forward.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If a stockholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for
        tendering its shares, such shares may not be redeemed.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We will comply with the proxy rules or tender offer rules, as applicable, when conducting redemptions in connection with our initial business combination. Despite our compliance with these rules, if a stockholder fails
        to receive our proxy materials or tender offer documents, as applicable, such stockholder may not become aware of the opportunity to redeem its shares. In addition, proxy materials or tender offer documents, as applicable, that we will furnish to
        holders of our public shares in connection with our initial business combination will describe the various procedures that must be complied with in order to validly tender or submit public shares for redemption. For example, we intend to require
        our public stockholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” to, at the holder’s option, either deliver their stock certificates to our transfer agent, or to deliver
        their shares to our transfer agent electronically prior to the date set forth in the proxy materials or tender offer documents, as applicable. In the case of proxy materials, this date may be up to two business days prior to the vote on the
        proposal to approve the initial business combination. In addition, if we conduct redemptions in connection with a stockholder vote, we intend to require a public stockholder seeking redemption of its public shares to also submit a written request
        for redemption to our transfer agent two business days prior to the vote in which the name of the beneficial owner of such shares is included. In the event that a stockholder fails to comply with these or any other procedures disclosed in the proxy
        or tender offer materials, as applicable, its shares may not be redeemed.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced
        to sell your public shares, potentially at a loss.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our public stockholders will be entitled to receive funds from the trust account only upon the earlier to occur of: (i) our completion of an initial business combination, and then only in connection with those shares
        of Class A common stock that such stockholder properly elected to redeem, subject to the limitations described herein, (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend our amended and
        restated certificate of incorporation to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering or
        with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity, and (iii) the redemption of our public shares if we do not complete an initial business combination within 24 months from
        the closing of our initial public offering, subject to applicable law and as further described herein. In addition, if our plan to redeem our public shares if we do not complete an initial business combination within 24 months from the closing of
        our initial public offering is not completed for any reason, compliance with Delaware law may require that we submit a plan of dissolution to our then-existing stockholders for approval prior to the distribution of the proceeds held in our trust
        account. In that case, public stockholders may be forced to wait beyond 24 months from the closing of our initial public offering before they receive funds from our trust account. In no other circumstances will a public stockholder have any right
        or interest of any kind in the trust account.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">36</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading
        restrictions.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our shares of Class A common stock are listed on Nasdaq. Although we expect to meet, on a pro forma basis, the minimum initial listing standards set forth in the Nasdaq listing standards, we cannot assure you that our
        securities will continue to be listed on Nasdaq in the future or prior to our initial business combination. In order to continue listing our securities on Nasdaq prior to our initial business combination, we must maintain certain financial,
        distribution and share price levels. Generally, we must maintain a minimum amount in stockholders’ equity (generally $2,500,000) and a minimum number of holders of our securities (generally 300 public holders). Additionally, in connection with our
        initial business combination, we will be required to demonstrate compliance with Nasdaq’s initial listing requirements, which are more rigorous than Nasdaq’s continued listing requirements, in order to continue to maintain the listing of our
        securities on Nasdaq. For instance, our share price would generally be required to be at least $4.00 per share and our stockholder’s equity would generally be required to be at least $5.0 million. We cannot assure you that we will be able to meet
        those initial listing requirements at that time.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If Nasdaq delists our securities from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an over-the-counter market.
        If this were to occur, we could face significant material adverse consequences, including:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>a limited availability of market quotations for our securities;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>reduced liquidity for our securities;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary
                trading market for our securities;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>a limited amount of news and analyst coverage; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>a decreased ability to issue additional securities or obtain additional financing in the future.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.”
        Because our Class A common stock are listed on Nasdaq, our shares of Class A common stock qualify as covered securities under the statute. Although the states are preempted from regulating the sale of our securities, the federal statute does allow
        the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While we are not aware of a state
        having used these powers to prohibit or restrict the sale of securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers, or
        threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed on Nasdaq, our securities would not qualify as covered securities under the statute and we would be
        subject to regulation in each state in which we offer our securities.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">37</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">You are not entitled to protections normally afforded to investors of many other blank check companies.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Since the net proceeds of our initial public offering and the sale of the private placement shares are intended to be used to complete an initial business combination with a target business that has not been selected,
        we may be deemed to be a “blank check” company under the United States securities laws. However, because we will have net tangible assets in excess of $5,000,000 as of the completion of our initial public offering and the sale of the private
        placement shares and we filed a Current Report on Form 8-K, including an audited balance sheet demonstrating this fact, we are exempt from rules promulgated by the SEC to protect investors in blank check companies, such as Rule 419. Accordingly,
        investors are not be afforded the benefits or protections of those rules. Among other things, this means our shares were immediately tradable and we have a longer period of time to complete our initial business combination than do companies subject
        to Rule 419. Moreover, if our initial public offering were subject to Rule 419, that rule would have prohibited the release of any interest earned on funds held in the trust account to us unless and until the funds in the trust account were
        released to us in connection with our completion of an initial business combination.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If we seek stockholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of stockholders
        are deemed to hold in excess of 15% of our shares of Class A common stock, you will lose the ability to redeem all such shares in excess of 15% of our shares of Class A common stock.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated
        certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act),
        is restricted from seeking redemption rights with respect to more than an aggregate of 15% of the shares sold in our initial public offering without our prior consent, which we refer to as the “Excess Shares.” However, we would not be restricting
        our stockholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Your inability to redeem the Excess Shares reduces your influence over our ability to complete our initial business
        combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete our
        initial business combination. And as a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would be required to sell your shares in open market transactions, potentially at a loss.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial
        condition and thus negatively impact the value of our stockholders’ investment in us.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Although we have no commitments to incur outstanding debt following our initial public offering, we may choose to incur substantial debt to complete our initial business combination. We and our officers have agreed
        that we will not incur any indebtedness unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust account. As such, no issuance of debt will affect the per share amount
        available for redemption from the trust account. Nevertheless, the incurrence of debt could have a variety of negative effects, including:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver
                or renegotiation of that covenant;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>our inability to pay dividends on our Class A common stock;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A common stock if declared, expenses, capital expenditures, acquisitions and other
                general corporate purposes;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">38</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who
                have less debt.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our initial stockholders control a substantial interest in us and thus may exert a substantial influence on actions requiring a stockholder vote, potentially in a manner that
        you do not support.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our initial stockholders own approximately 20% of our issued and outstanding common stock. Accordingly, they may exert a substantial influence on actions requiring a stockholder vote, potentially in a manner that you
        do not support, including amendments to our amended and restated certificate of incorporation. If our initial stockholders purchase any shares in this offering or if our initial stockholders purchase any additional Class A common stock in the
        aftermarket or in privately negotiated transactions, this would increase their control. Factors that would be considered in making such additional purchases would include consideration of the current trading price of our Class A common stock. In
        addition, our Board of Directors, whose members were elected by our sponsor, is and will be divided into three classes, each of which will generally serve for a terms for three years with only one class of directors being elected in each year. We
        may not hold an annual meeting of stockholders to elect new directors prior to the completion of our initial business combination, in which case all of the current directors will continue in office until at least the completion of the business
        combination. If there is an annual meeting, as a consequence of our “staggered” Board of Directors, only a minority of the Board of Directors will be considered for election and our initial stockholders, because of their ownership position, will
        have considerable influence regarding the outcome. Accordingly, our initial stockholders will continue to exert control at least until the completion of our initial business combination. The forward purchase shares will not be issued until
        completion of our initial business combination and, accordingly, will not be included in any stockholder vote until such time.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Because we must furnish our stockholders with target business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination
        with some prospective target businesses.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The federal proxy rules require that the proxy statement with respect to the vote on an initial business combination include historical and pro forma financial statement disclosure. We will include the same financial
        statement disclosure in connection with our tender offer documents, whether or not they are required under the tender offer rules. These financial statements may be required to be prepared in accordance with, or be reconciled to, accounting
        principles generally accepted in the United States of America (“GAAP”), or international financial reporting standards as issued by the International Accounting Standards Board (“IFRS”), depending on the circumstances and the historical financial
        statements may be required to be audited in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”). These financial statement requirements may limit the pool of potential target businesses we may
        acquire because some targets may be unable to provide such financial statements in time for us to disclose such statements in accordance with federal proxy rules and complete our initial business combination within the prescribed time frame.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Compliance obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate our initial business combination, require substantial financial and
        management resources, and increase the time and costs of completing an initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Section 404 of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls beginning with our Annual Report on Form 10-K for the year ending December 31, 2021. Only in the event we
        are deemed to be a large accelerated filer or an accelerated filer, and no longer qualify as an emerging growth company, will we be required to comply with the independent registered public accounting firm attestation requirement on our internal
        control over financial reporting. Further, for as long as we remain an emerging growth company, we will not be required to comply with the independent registered public accounting firm attestation requirement on our internal control over financial
        reporting. The fact that we are a blank check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us as compared to other public companies because a target business with which we seek to complete our
        initial business combination may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the internal control of any such entity to achieve compliance with the
        Sarbanes-Oxley Act may increase the time and costs necessary to complete any such business combination.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">39</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Provisions in our amended and restated certificate of incorporation and Delaware law may inhibit a takeover of us, which could limit the price investors might be willing to pay
        in the future for our shares of Class A common stock and could entrench management.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our amended and restated certificate of incorporation contains provisions that may discourage unsolicited takeover proposals that stockholders may consider to be in their best interests. These provisions include a
        staggered Board of Directors and the ability of the Board of Directors to designate the terms of and issue new series of preferred stock, which may make more difficult the removal of management and may discourage transactions that otherwise could
        involve payment of a premium over prevailing market prices for our securities.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We are also subject to anti-takeover provisions under Delaware law, which could delay or prevent a change of control. Together these provisions may make the removal of management more difficult and may discourage
        transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Provisions in our amended and restated certificate of incorporation and Delaware law may have the effect of discouraging lawsuits against our directors and officers.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our amended and restated certificate of incorporation requires, unless we consent in writing to the selection of an alternative forum, that (i) any derivative action or proceeding brought on our behalf, (ii) any action
        asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee to us or our stockholders, (iii) any action asserting a claim against us, our directors, officers or employees arising pursuant to any provision of the
        DGCL or our amended and restated certificate of incorporation or bylaws, or (iv) any action asserting a claim against us, our directors, officers or employees governed by the internal affairs doctrine may be brought only in the Court of Chancery in
        the State of Delaware, except any claim (A) as to which the Court of Chancery of the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not
        consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, (C) for which the Court of Chancery
        does not have subject matter jurisdiction, or (D) any action arising under the Securities Act, as to which the Court of Chancery and the federal district court for the District of Delaware shall have concurrent jurisdiction. If an action is brought
        outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder’s counsel. Although we believe this provision benefits us by providing increased consistency in the application of
        Delaware law in the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits against our directors and
        officers, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Notwithstanding the foregoing, our amended and restated certificate of incorporation provides that the exclusive forum provision will not apply to suits brought to enforce a duty or liability created by the Exchange
        Act or any other claim for which the federal courts have exclusive jurisdiction. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules
        and regulations thereunder. Although we believe this provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, the provision may have the effect of discouraging
        lawsuits against our directors and officers.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Cyber incidents or attacks directed at us could result in information theft, data corruption, operational disruption and/or financial loss.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We depend on digital technologies, including information systems, infrastructure and cloud applications and services, including those of third parties with which we may deal. Sophisticated and deliberate attacks on, or
        security breaches in, our systems or infrastructure, or the systems or infrastructure of third parties or the cloud, could lead to corruption or misappropriation of our assets, proprietary information and sensitive or confidential data. As an early
        stage company without significant investments in data security protection, we may not be sufficiently protected against such occurrences. We may not have sufficient resources to adequately protect against, or to investigate and remediate any
        vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have adverse consequences on our business and lead to financial loss.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">40</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">If we effect our initial business combination with a company located outside of the United States, we would be subject to a variety of additional risks that may adversely affect
        us.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we pursue a target company with operations or opportunities outside of the United States for our initial business combination, we may face additional burdens in connection with investigating, agreeing to and
        completing such initial business combination, and if we effect such initial business combination, we would be subject to a variety of additional risks that may negatively impact our operations.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we pursue a target a company with operations or opportunities outside of the United States for our initial business combination, we would be subject to risks associated with cross-border business combinations,
        including in connection with investigating, agreeing to and completing our initial business combination, conducting due diligence in a foreign jurisdiction, having such transaction approved by any local governments, regulators or agencies and
        changes in the purchase price based on fluctuations in foreign exchange rates.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">If we effect our initial business combination with such a company, we would be subject to any special considerations or risks associated with companies operating in an international setting, including any of the
        following:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>costs and difficulties inherent in managing cross-border business operations;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>rules and regulations regarding currency redemption;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>complex corporate withholding taxes on individuals;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>laws governing the manner in which future business combinations may be effected;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>exchange listing and/or delisting requirements;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>tariffs and trade barriers;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>regulations related to customs and import/export matters;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>local or regional economic policies and market conditions;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>unexpected changes in regulatory requirements;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>challenges in managing and staffing international operations;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>longer payment cycles;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>tax issues, such as tax law changes and variations in tax laws as compared to the United States;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>currency fluctuations and exchange controls;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>rates of inflation;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>challenges in collecting accounts receivable;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>cultural and language differences;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>employment regulations;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>underdeveloped or unpredictable legal or regulatory systems;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">41</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>corruption;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>protection of intellectual property;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>social unrest, crime, strikes, riots and civil disturbances;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>regime changes and political upheaval;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>terrorist attacks and wars; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>deterioration of political relations with the United States.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We may not be able to adequately address these additional risks. If we were unable to do so, we may be unable to complete such initial business combination, or, if we complete such initial business combination, our
        operations might suffer, either of which may adversely impact our business, financial condition and results of operations.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 9pt; font-style: italic; font-weight: bold;">Risks Relating to our Management Team</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We are dependent upon our executive officers and directors and their loss could adversely affect our ability to operate.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our operations are dependent upon a relatively small group of individuals and, in particular, our executive officers and directors. We believe that our success depends on the continued service of our officers and
        directors, at least until we have completed our initial business combination. In addition, our executive officers and directors are not required to commit any specified amount of time to our affairs and, accordingly, will have conflicts of interest
        in allocating their time among various business activities, including identifying potential business combinations and monitoring the related due diligence. We do not have key-man insurance on the life of any of our directors or executive officers.
        The unexpected loss of the services of one or more of our directors or executive officers could have a detrimental effect on us.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our ability to successfully effect our initial business combination and to be successful thereafter will be dependent upon the efforts of our key personnel, some of whom may
        join us following our initial business combination. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our ability to successfully effect our initial business combination is dependent upon the efforts of our key personnel. The role of our key personnel in the target business, however, cannot presently be ascertained.
        Although some of our key personnel may remain with the target business in senior management or advisory positions following our initial business combination, it is likely that some or all of the management of the target business will remain in
        place. While we closely scrutinize any individuals we engage after our initial business combination, we cannot assure you that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with the requirements
        of operating a company regulated by the SEC, which could cause us to have to expend time and resources helping them become familiar with such requirements.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination, and a particular business
        combination may be conditioned on the retention or resignation of such key personnel. These agreements may provide for them to receive compensation following our initial business combination and as a result, may cause them to have conflicts of
        interest in determining whether a particular business combination is the most advantageous.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our key personnel may be able to remain with our company after the completion of our initial business combination only if they are able to negotiate employment or consulting agreements in connection with the business
        combination. Such negotiations would take place simultaneously with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they
        would render to us after the completion of the business combination. Such negotiations also could make such key personnel’s retention or resignation a condition to any such agreement. The personal and financial interests of such individuals may
        influence their motivation in identifying and selecting a target business, subject to their fiduciary duties under Delaware law.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">42</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may have a limited ability to assess the management of a prospective target business and, as a result, may effect our initial business combination with a target business
        whose management may not have the skills, qualifications or abilities to manage a public company.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">When evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess the target business’s management may be limited due to a lack of time, resources
        or information. Our assessment of the capabilities of the target business’s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications or abilities we suspected. Should the target business’s management
        not possess the skills, qualifications or abilities necessary to manage a public company, the operations and profitability of the post-combination business may be negatively impacted. Accordingly, any stockholders who choose to remain stockholders
        following the business combination could suffer a reduction in the value of their securities. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the
        breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that the proxy solicitation or tender offer materials, as applicable,
        relating to the business combination contained an actionable material misstatement or material omission.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">The officers and directors of an acquisition candidate may resign upon completion of our initial business combination. The loss of a business combination target’s key personnel
        could negatively impact the operations and profitability of our post-combination business.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The role of an acquisition candidate’s key personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that certain members of an acquisition
        candidate’s management team will remain associated with the acquisition candidate following our initial business combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our executive officers and directors allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our
        affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our executive officers and directors are not required to commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business
        combination and their other businesses. Our executive officers may be engaged in several other business endeavors for which he or she may be entitled to substantial compensation. Our independent directors also serve as officers and board members
        for other entities. If our executive officers’ and directors’ other business affairs require them to devote substantial amounts of time to such affairs in excess of their current commitment levels, it could limit their ability to devote time to our
        affairs which may have a negative impact on our ability to complete our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our officers and directors presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities and, accordingly, may have
        conflicts of interest in determining to which entity a particular business opportunity should be presented.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We are engage in the business of identifying and combining with one or more businesses. Each of our officers and directors presently has, and any of them in the future may have, additional fiduciary or contractual
        obligations to other entities, pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, they may have conflicts of interest in determining to which entity a
        particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us. Our amended and restated certificate of
        incorporation provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company
        and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another
        legal obligation. In addition, our sponsor and our officers and directors may sponsor or form other special purpose acquisition companies similar to ours or may pursue other business or investment ventures during the period in which we are seeking
        an initial business combination. Any such companies, businesses or ventures may present additional conflicts of interest in pursuing an initial business combination. However, we do not believe that any such potential conflicts would materially
        affect our ability to complete our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">43</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Our executive officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have not adopted a policy that expressly prohibits our directors, executive officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired
        or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business combination with a target business that is affiliated with our sponsor, our directors or executive officers, although we
        do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between
        their interests and ours.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The personal and financial interests of our directors and officers may influence their motivation in timely identifying and selecting a target business and completing a business combination. Consequently, our
        directors’ and officers’ discretion in identifying and selecting a suitable target business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate and in
        our stockholders’ best interest. If this were the case, it would be a breach of their fiduciary duties to us as a matter of Delaware law and we or our stockholders might have a claim against such individuals for infringing on our stockholders’
        rights. However, we might not ultimately be successful in any claim we may make against them for such reason.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">We may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated with our sponsor, executive officers,
        directors or existing holders which may raise potential conflicts of interest.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In light of the involvement of our sponsor, executive officers and directors with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, executive officers, directors or existing
        holders. Our directors also serve as officers and board members for other entities. Such entities may compete with us for business combination opportunities. Although we will not be specifically focusing on, or targeting, any transaction with any
        affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria for a business combination and such transaction was approved by a majority of our independent and disinterested directors. Despite
        our agreement to obtain an opinion from an independent investment banking firm which is a member of FINRA or a valuation or appraisal firm regarding the fairness to our company from a financial point of view of a business combination with one or
        more domestic or international businesses affiliated with our sponsor, executive officers, directors or existing holders, potential conflicts of interest still may exist and, as a result, the terms of the business combination may not be as
        advantageous to our public stockholders as they would be absent any conflicts of interest.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">44</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <a id="Item1B."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold; white-space: nowrap;">Item 1B.</td>

    <td style="vertical-align: top; width: auto;">
              <div style="font-weight: bold;">Unresolved Staff Comments</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">None.</div>

      <div>&nbsp;</div>

      <a id="Item2."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 2.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Property</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We currently maintain our executive offices at 628 Middlefield Road, Palo Alto, CA, 94301. The cost for the space is included in the up to $10,000 monthly fee that we pay our sponsor for office space, secretarial and
        administrative services. We consider our current office space adequate for our current operations.</div>

      <div>&nbsp;</div>

      <a id="Item3."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 3.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Legal Proceedings</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.</div>

      <div>&nbsp;</div>

      <a id="Item4."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 4.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Mine Safety Disclosure</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Not Applicable.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">45</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-align: center; font-weight: bold;"><a id="PARTII"><!--Anchor--></a>PART II</div>

      <div>&nbsp;</div>

      <a id="Item5."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 5.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt; font-weight: bold;">(a) Market Information</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our Class A common stock is traded on the Nasdaq under the symbol “JYAC”. Our common stock commenced public trading on November 19, 2020.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; font-weight: bold;">(b) Holders</div>

      <div>&nbsp;</div>

      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: 18pt;">On April 15, 2022, there were two record holders of our Class A common stock and ten record holders of our Class B
          common stock.</div>

      </div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; font-weight: bold;">(c) Dividends</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have not paid any cash dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of a business combination. The payment of cash dividends in the future will be dependent
        upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of a business combination. The payment of any cash dividends subsequent to a business combination will be within the discretion of
        our Board of Directors at such time.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; font-weight: bold;">(d) Securities Authorized for Issuance Under Equity Compensation Plans</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">None.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; font-weight: bold;">(e) Performance Graph</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Not applicable.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; font-weight: bold;">(f) Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; font-style: italic;">Unregistered Sales</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">
        <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
          <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On September 9, 2020, our sponsor purchased an aggregate of 4,312,500 founder shares in exchange for a capital
            contribution of $25,000, or approximately $0.006 per share. On October 30, 2020, our sponsor forfeited 1,437,500 founder shares for no consideration. Prior to the initial investment in the company of $25,000 by the sponsor, the company had no
            assets, tangible or intangible.&nbsp; In connection with the partial exercise of the underwriters’ over-allotment option, our sponsor forfeited an additional 286,990 founder shares, such that at December 31, 2021 and 2020 there were an aggregate of
            2,588,010 founder shares. The number of founder shares outstanding was determined based on the expectation that the total size of our initial public offering would be a maximum of 11,500,000 shares if the underwriters’ over-allotment option
            were exercised in full, and therefore that such founder shares would represent 20% of the outstanding shares after our initial public offering.</div>

          <div>&nbsp;</div>

        </div>

      </div>

      <div style="text-indent: 18pt;">
        <div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Prior to our initial public offering, our sponsor transferred 200,000 shares of our Class B common stock to our Chief Executive
          Officer, 48,000 shares of our Class B common stock to our VP, Corporate Development and 30,000 shares of our Class B common stock to each of Srinivas Akkaraju, M.D., Ph.D., Richard Van Doren, Cory Freedland, Ph.D., Daniel Spiegelman, Perry
          Karsen, Pamela Klein and Steve Kelsey. On September 23, 2021, Perry Karsen resigned from the Board effective immediately, and such, forfeited their Class B shares back to the sponsor. On September 24, 2021, the Company announced that Dr. Lori
          Friedman was appointed to serve as a Class I director of the Company and was granted 30,000 Class B shares of the Company, which were granted from the sponsor. No new Class B shares were issued as part of Dr. Friedman’s appointment or Perry
          Karsen’s resignation.</div>

        <div>&nbsp;</div>

      </div>

      <div style="text-indent: 18pt;">In addition, concurrently with our initial public offering and the partial exercise of the underwriters’ over-allotment option, our sponsor purchased an aggregate of 507,041 private placement shares, at a price of
        $10.00 per share, for an aggregate purchase price of $5,070,410.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">46</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="margin-left: 18pt; font-style: italic;">Use of Proceeds</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Of the proceeds we received from our initial public offering and the sale of the private placement shares, a total of $103,520,402, including $3,623,214 payable to the underwriter for deferred underwriting commissions,
        was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">There has been no material change in the planned use of proceeds from such use as described in the Company’s Registration Statement on Form S-1, dated November 13, 2020 (File No. 333-249808), which was declared
        effective by the SEC on November 18, 2020.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">(g) Purchases of Equity Securities by the Issuer and Affiliated Purchasers</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">None.</div>

      <div>&nbsp;</div>

      <a id="Item6."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 6.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">[Reserved]</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">47</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <a id="Item7."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 7.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Management’s Discussion and Analysis of Financial Condition and Results of Operations</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-align: justify;">The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with our audited financial statements and the notes related thereto which are
        included in “Item 8. Financial Statements and Supplementary Data” of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ
        materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under “Special Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere in this Annual Report on
        Form 10-K.</div>

      <div><br>
      </div>

      <div style="font-weight: bold;">Overview</div>

      <div><br>
      </div>

      <div style="text-align: justify;">We are a blank check company formed under the laws of the State of Delaware on August 27, 2020 for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization,
        reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”). We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of
        the Private Placement Shares, our capital stock, debt or a combination of cash, stock and debt.</div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify; margin-right: 0.7pt;">We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.</div>

      <div><br>
      </div>

      <div style="text-align: justify; font-weight: bold;">Results of Operations</div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="font-weight: bold;"> </span><br>
      </div>

      <div style="text-align: justify;">We have neither engaged in any operations nor generated any revenues to date. Our only activities from August 27, 2020 (inception) through December 31, 2021 were organizational activities, those necessary to prepare
        for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating
        income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence
        expenses.</div>

      <div><br>
      </div>

      <div style="text-align: justify;">
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For the year ended December 31, 2021, we had a net loss of $1,923,038, which consists of general and administrative expenses of
          $1,763,483 and stock compensation expense of $180,000, offset by interest income on marketable securities held in the Trust Account of $20,445.</div>

      </div>

      <div><br>
      </div>

      <div style="text-align: justify;">For the period from August 27, 2020 (inception) through December 31, 2020, we had a net loss of $264,719, which consists of operating costs of $244,346, stock compensation expense of $22,500, and an unrealized loss
        on marketable securities held in our Trust Account of $981, offset by interest income on marketable securities held in the Trust Account of $3,108.</div>

      <div><br>
      </div>

      <div style="text-align: justify; font-weight: bold;">Liquidity and Capital Resources</div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="font-weight: bold;"> </span><br>
      </div>

      <div style="text-align: justify; margin-right: 0.7pt;">On November 23, 2020, we consummated the Initial Public Offering of 10,000,000 Public Shares at a price of $10.00 per Public Share, generating gross proceeds of $100,000,000. Simultaneously with
        the closing of the Initial Public Offering, we consummated the sale of 500,000 Private Placement Shares at a price of $10.00 per Private Placement Share in a private placement to our Sponsor, generating gross proceeds of $5,000,000.</div>

      <div><br>
      </div>

      <div style="text-align: justify;">On December 10, 2020, we consummated the sale of an additional 352,040 Shares, at $10.00 per Share, and the sale of an additional 7,041 Private Placement Shares, at $10.00 per Private Placement Share, generating
        total gross proceeds of $3,590,810. Following the Initial Public Offering and the sale of the Private Placement Shares, a total of $103,520,402 of the net proceeds was deposited into the Trust Account.</div>

      <div><br>
      </div>

      <div style="text-align: justify;">
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For the year ended December 31, 2021, cash used in operating activities was $1,208,074. Net loss of $1,923,038 was affected by stock
            compensation expense of $180,000, interest earned on marketable securities held in the Trust Account of $20,445, and changes in operating assets and liabilities provided $555,409 of cash for operating activities.</div>

          <div>&nbsp;</div>

        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">48</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; margin-right: 0.7pt;">For the period from August 27, 2020 (inception) through December 31, 2020, cash used in operating activities was $714,521. Net loss of $264,719 was affected by stock-based compensation expense of
        $22,500, interest earned on marketable securities held in the Trust Account of $3,108, an unrealized loss on marketable securities held in our Trust Account $981. Changes in operating assets and liabilities used $470,175 of cash from operating
        activities.</div>

      <div><br>
      </div>

      <div style="text-align: justify;">As of December 31, 2021, we had marketable securities held in the Trust Account of $103,542,974 (including approximately $22,572 of interest income and unrealized losses, net) consisting of U.S. Treasury Bills with a
        maturity of 185 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through December 31, 2021, we have not withdrawn any interest earned from the Trust Account.</div>

      <div><br>
      </div>

      <div style="text-align: justify; margin-right: 0.7pt;">We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete our Business Combination. We may
        withdraw interest to pay franchise and income taxes. During the period ended December 31, 2020, we did not withdraw any interest earned on the Trust Account. To the extent that our capital stock or debt is used, in whole or in part, as
        consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth
        strategies.</div>

      <div><br>
      </div>

      <div style="text-align: justify; margin-right: 0.7pt;">As of December 31, 2021, we had cash of $628,006 outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses,
        perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of
        prospective target businesses, and structure, negotiate and complete a Business Combination.</div>

      <div><br>
      </div>

      <div style="text-align: justify;">In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not
        obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust
        Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into shares at a price of $10.00 per share, at the option of the lender. The shares
        would be identical to the Private Placement Shares.</div>

      <div><br>
      </div>

      <div style="text-align: justify; font-weight: bold;">Going Concern</div>

      <div><br>
      </div>

      <div style="text-align: justify;">
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In connection with the our assessment of going concern considerations in accordance with Financial Accounting Standards Board’s
            Accounting Standards Codification Topic 205-40, “Presentation of Financial Statements – Going Concern,” we have until November 23, 2022, to consummate an initial business combination. It is uncertain that we will be able to consummate an
            initial business combination by this time. If an initial business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Additionally, the we may not have sufficient
            liquidity to fund the working capital needs of the Company through one year from the issuance of these financial statements. We have determined that the liquidity condition and mandatory liquidation, should an initial business combination not
            occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to
            liquidate after November 23, 2022.</div>

        </div>

      </div>

      <div><br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">49</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="font-weight: bold;">Off-Balance Sheet Financing Arrangements</div>

      <div style="text-indent: 34.1pt;"> <br>
      </div>

      <div style="text-align: justify;">We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of December 31, 2021. We do not participate in transactions that create relationships with unconsolidated
        entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing
        arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.</div>

      <div><br>
      </div>

      <div style="text-align: justify; font-weight: bold;">Contractual Obligations</div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify;">We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $10,000 for office space, secretarial
        and administrative support. We began incurring these fees on November 18, 2020 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation.</div>

      <div><br>
      </div>

      <div style="text-align: justify;">The underwriters are entitled to a deferred fee of $0.35 per Share, or $3,623,214 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the
        event that we complete a Business Combination, subject to the terms of the underwriting agreement.</div>

      <div><br>
      </div>

      <div style="text-align: justify;">We intend to enter into forward purchase agreements pursuant to which Samsara BioCapital has agreed to purchase an aggregate of up to 2,500,000 shares (the “forward purchase shares”), for a purchase price of $10.00
        per share, or an aggregate of $25,000,000, in a private placement to close concurrently with the closing of a Business Combination. The obligations under the forward purchase agreements will not depend on whether any Public Shares are redeemed by
        the public stockholders. The Sponsor’s obligation to purchase forward purchase shares will, among other things, be conditioned on the Business Combination (including the target assets or business, and the terms of the Business Combination) being
        reasonably acceptable to the Sponsor and on a requirement that such initial Business Combination is approved by a unanimous vote of the Company’s Board of Directors. The forward purchase shares will be identical to the shares of Class A common
        stock included in the Public Shares being sold in the Initial Public Offering, except that they will be subject to certain registration rights.</div>

      <div style="text-align: justify; margin-right: 0.7pt;"> <br>
      </div>

      <div style="text-align: justify; font-weight: bold;">Critical Accounting Policies</div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="font-weight: bold;"> </span><br>
      </div>

      <div style="text-align: justify;">The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that
        affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those
        estimates. We have identified the following critical accounting policies:</div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify; margin-right: 0.7pt; font-style: italic;">Class A Common Stock Subject to Possible Redemption</div>

      <div><br>
      </div>

      <div style="text-align: justify; margin-right: 0.7pt;">We account for our shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities
        from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that
        are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity.
        Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the Class A common stock subject to possible redemption is presented as
        temporary equity, outside of the stockholders’ deficit section of our balance sheets.</div>

      <div><br>
      </div>

      <div style="text-align: justify; margin-right: 0.7pt; font-style: italic;">Net Loss per Common Share</div>

      <div><br>
      </div>

      <div style="text-align: justify;">We calculate earnings per share to allocate net income (loss) evenly to Class A and Class B ordinary shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both
        classes of common stock share pro rata in the income (loss) of the Company.</div>

      <div style="text-align: justify;"><span style="font-style: italic;"> </span><br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">50</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-style: italic;">Recent Accounting Standards</div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify;">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging —
        Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features
        from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and
        freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is
        effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its
        financial position, results of operations or cash flows.</div>

      <div><br>
      </div>

      <div style="text-align: justify;">Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.</div>

      <div><br>
      </div>

      <a id="Item7A."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold; white-space: nowrap;">Item 7A.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Quantitative and Qualitative Disclosures about Market Risk</div>
            </td>

  </tr>


</tbody></table>
      <div style="text-indent: 15.4pt;"> <br>
      </div>

      <div style="text-align: justify;">Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in U.S. government treasury bills, notes or bonds
        with a maturity of 185 days or less or in certain money market funds that invest solely in US treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.</div>

      <div style="text-indent: 36pt;"><br>
      </div>

      <a id="Item8."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold; white-space: nowrap;">Item 8.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Financial Statements and Supplementary Data</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div>This information appears following Item 15 of this Report and is included herein by reference.</div>

      <div><br>
      </div>

      <a id="Item9."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 9.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div>None.</div>

      <div><br>
      </div>

      <a id="Item9A."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold; white-space: nowrap;">Item 9A.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Controls and Procedures.</div>
            </td>

  </tr>


</tbody></table>
      <div> <br>
      </div>

      <div style="text-align: justify; font-weight: bold;">Evaluation of Disclosure Controls and Procedures</div>

      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>

      <div style="text-align: justify;">Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized, and
        reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive
        officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.</div>

      <div><br>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an
        evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure
        controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective, due&nbsp; to the material weaknesses in our internal control over financial reporting related to the Company’s accounting for complex
        financial instruments and review of the Company’s liabilities. As a result, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with GAAP. Accordingly, management believes that
        the financial statements included in this Annual Report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.</div>

      <div>&nbsp;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Management has identified a material weakness in internal controls related to the accounting for complex financial instruments and review
        of the Company’s liabilities. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to continue to enhance our system of evaluating and implementing the accounting standards that apply to our
        financial statements, including through enhanced analyses by our personnel and third-party professionals with whom we consult regarding complex accounting applications. While we have a control to reconcile accrued liabilities, we plan to continue
        to enhance our control around the search of unrecorded liabilities. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.</div>

      <div style="text-align: justify;"><span style="font-weight: bold;"> </span><br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">51</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Management’s Report on Internal Controls Over Financial Reporting</div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify;">As required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our
        internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our consolidated financial statements for external reporting purposes in accordance with
        GAAP. Our internal control over financial reporting includes those policies and procedures that:</div>

      <div style="text-align: justify;"> <br>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(1)</td>

    <td style="width: auto; vertical-align: top;">
              <div>pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company,</div>
            </td>

  </tr>


</tbody></table>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 18pt;"> <br>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(2)</td>

    <td style="width: auto; vertical-align: top;">
              <div>provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with
                authorizations of our management and directors, and</div>
            </td>

  </tr>


</tbody></table>
      <div style="text-align: justify;"> <br>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(3)</td>

    <td style="width: auto; vertical-align: top;">
              <div>provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the consolidated financial statements.</div>
            </td>

  </tr>


</tbody></table>
      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our consolidated financial statements. Also, projections of any evaluation of
        effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of
        our internal control over financial reporting at December 31, 2021. In making these assessments, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated
        Framework (2013). Based on our assessments and those criteria, management determined that we did not maintain effective internal control over financial reporting as of December 31, 2021.</div>

      <div style="text-align: justify;">
        <div>&nbsp;</div>

        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Management has implemented remediation steps to improve our internal control over financial reporting. Specifically, we expanded and
          improved our review process for complex securities and related accounting standards, as well as our review and reconciliation of the Company’s liabilities. We plan to further improve this process by enhancing access to accounting literature,
          identification of third-party professionals with whom to consult regarding complex accounting applications, and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.</div>

      </div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify;">This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.</div>

      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>

      <div style="text-align: justify; font-weight: bold;">Changes in Internal Control over Financial Reporting</div>

      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>

      <div style="text-align: justify;">There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over
        financial reporting.</div>

      <div><br>
      </div>

      <a id="Item9B."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold; white-space: nowrap;">Item 9B.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Other Information.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">None.</div>

      <div>&nbsp;</div>

      <a id="Item9C."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold; white-space: nowrap;">Item 9C.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">52</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-align: center; font-weight: bold;"><a id="PARTIII"><!--Anchor--></a>PART III</div>

      <div>&nbsp;</div>

      <a id="Item10."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 10.</td>

    <td style="vertical-align: top;">
              <div style="font-weight: bold;">Directors, Executive Officers and Corporate Governance</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="font-weight: bold;">Officers and Directors</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 39%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Name</div>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><br>
            </td>

    <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Age</div>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><br>
            </td>

    <td style="width: 49%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Position</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Srinivas Akkaraju, M.D., Ph.D.</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">54</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 49%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Chairman</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top;">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Rekha Hemrajani</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: center;">52</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 49%; vertical-align: top;">
              <div>Director and Chief Executive Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Richard Van Doren</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">45</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 49%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Director, Secretary and Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top;">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Cory Freedland, Ph.D.</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: center;">46</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 49%; vertical-align: top;">
              <div>Director and Chief Investment Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Dr. Pamela Klein</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">60<br>
              </div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 49%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top;">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Daniel Spiegelman</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: center;">63</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 49%; vertical-align: top;">
              <div>Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Dr. Steve Kelsey</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">61<br>
              </div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 49%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top;">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Dr. Lori Friedman, Ph.D.</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: center;">57<br>
              </div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 49%; vertical-align: top;">
              <div>Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Mayank Gandhi, M.D.</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">44</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 49%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Vice President, Corporate Development</div>
            </td>

  </tr>


</tbody></table>
      <div><br>
      </div>

      <div style="text-indent: 18pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Srinivas Akkaraju, M.D., Ph.D., </span><span style="color: rgb(0, 0, 0);">is Founder and Managing General Partner at Samsara BioCapital since he founded the firm
          in 2017, and is our Chairman. Dr. Akkaraju previously served as a General Partner of Sofinnova Ventures from 2013 – 2017. Prior to Sofinnova, Dr. Akkaraju served as Managing Director of New Leaf Venture Partners from 2009 – 2013. Previously, he
          served as a Managing Director at Panorama Capital, LLC, a private equity firm from 2006 – 2008. Prior to co-founding Panorama Capital, from 2001 – 2006, he was with J.P. Morgan Partners, which he joined in 2001 and of which he became a Partner in
          2005. Prior to J.P. Morgan Partners, from 1998 – 2001, Dr. Akkaraju was in Business and Corporate Development at Genentech, Inc. (now a wholly owned member of The Roche Group), a biotechnology company, most recently as Senior Manager. Dr.
          Akkaraju serves as a director of Intercept Pharmaceuticals (Nasdaq: ICPT), Syros Pharmaceuticals </span>(Nasdaq: SYRS)<span style="color: rgb(0, 0, 0);">, Chinook Therapeutics (Nasdaq: KDNY), Tentarix Biotherapeutics, Synthekine, Dewpoint
          Therapeutics, and several other private companies. Previously, Dr. Akkaraju served as a director on the Boards of Seattle Genetics </span>(Nasdaq: SGEN)<span style="color: rgb(0, 0, 0);">, Principia Biopharma </span>(Nasdaq: PRNB announced sale
        to Sanofi for $3.7 billion)<span style="color: rgb(0, 0, 0);">, Aravive, Inc.</span> (Nasdaq: ARAV)<span style="color: rgb(0, 0, 0);">, Barrier Therapeutics </span>(Nasdaq: BTRX sold to Stiefel Laboratories for $148 million)<span style="color: rgb(0, 0, 0);">, Eyetech Pharmaceuticals (Nasdaq: ETEX sold to OSIP for $935 million), ZS Pharma </span>(Nasdaq: ZSPH sold to AstraZeneca for $2.7 billion)<span style="color: rgb(0, 0, 0);">, Synageva Biopharma Corp.</span> (Nasdaq: GEVA sold to
        ALXN for $8.4 billion)<span style="color: rgb(0, 0, 0);"> and Amarin Corporation </span>(Nasdaq: AMRN)<span style="color: rgb(0, 0, 0);">. Dr. Akkaraju received his M.D. and a Ph.D. in Immunology from Stanford University, and holds undergraduate
          degrees in Biochemistry and Computer Science from Rice University.</span></div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;"><span style="font-weight: bold;">Rekha Hemrajani</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">has been our Chief Executive Officer since our
          inception in August 2020 and serves on our Board of Directors. Ms. Hemrajani is an experienced strategic leader helping biotech companies with corporate strategy and corporate finance, as well as building product pipelines through corporate
          development. She has extensive senior management experience within public and private biopharmaceutical companies, and bulge bracket investment banks. Ms. Hemrajani recently served as President &amp; Chief Executive Officer of Aravive, Inc.
          (Nasdaq: ARAV) from Jan 2020 – April 2020. Ms. Hemrajani previously served as Chief Financial Officer &amp; Chief Operating Officer of Arcus Biosciences in 2019, leading finance, investor relations, corporate communications, business and
          corporate development, strategic planning and human resources. Prior to Arcus, from 2016 – 2019, Ms. Hemrajani served as Chief Operating Officer of RAPT Therapeutics (Nasdaq: RAPT), Chief Financial Officer of Sagimet Biosciences from 2015 – 2016,
          consultant to biopharma companies and investment funds during 2014, VP - Head of Licensing and M&amp;A at Onyx Pharmaceuticals (Nasdaq: ONXX, acquired by Amgen in 2013 for $10.4 billion) from 2012 – 2013, and VP of Business Development at
          Exelixis (Nasdaq: EXEL) from 2003 – 2011. Ms. Hemrajani is currently on the Board of ALX Oncology (Nasdaq: ALXO),</span>&nbsp;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">MaxCyte Inc. (Nasdaq: MXCT; LSE:
          MXCT, MXCN) and BioAge Labs. Ms. Hemrajani holds an MBA from the Kellogg School of Management at Northwestern University and a Bachelor of Science from University of Michigan.</span></div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">53</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;"><span style="font-weight: bold;">Richard Van Doren</span> has been our Chief Financial Officer and Secretary since our inception in August 2020 and serves on our Board of Directors. Mr. Van Doren
        has been the Chief Financial Officer of Samsara BioCapital since joining the firm in 2016. He oversees accounting and finance for Samsara as well the fund’s day-to-day trade operations. Prior to joining Samsara, Mr. Van Doren was the Chief
        Operating Officer and Chief Financial Officer of Pacific Grove Capital from 2014 – 2016.&nbsp; Prior to Pacific Grove, Mr. Van Doren was the Chief Financial Officer of Marcato Capital Management from 2010 – 2014 where he was responsible for building out
        the front and back office, accounting &amp; finance, trade operations, and the firm’s compliance program. From 2002 to 2010, Mr. Van Doren was the Chief Financial Officer of Cannell Capital where he was responsible for multi-state business
        operations, finance, compliance, and investor relations. Mr. Van Doren graduated from the University of San Francisco with a B.S. in Finance and earned a Graduate Certificate in Tax from Golden Gate University.<br>
      </div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;"><span style="font-weight: bold;">Cory S. Freedland, Ph.D.</span> has been our Chief Investment Officer since our inception in August 2020 and serves on our Board of Directors. Dr. Freedland joined
        Samsara BioCapital in 2017 where he currently serves as a Partner. At Samsara, he has led several of the firm’s investments in the biotechnology sector and serves as a director on a number of private company boards. Dr. Freedland was previously a
        Principal at Sofinnova Ventures from 2014 – 2017, Principal at Novo Ventures in 2013, and a Vice President in the healthcare investment banking practice at Morgan Stanley from 2010 – 2013. Prior to Morgan Stanley, Dr. Freedland led a preclinical
        research group focused on novel targets for central nervous system diseases at Roche Palo Alto. Dr. Freedland received his Ph.D. in Pharmacology from Wake Forest University School of Medicine, an MBA from the Kellogg School of Management at
        Northwestern University, and a B.A. in Psychology and Religious Studies from Connecticut College.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;"><span style="font-weight: bold;">Dr. Pamela Klein</span> has served on our Board of Directors since the completion of our initial public offering. Dr. Pamela M. Klein is Founder and Principal of PMK BioResearch
        offering advisory and strategic consulting for the biotechnology industry.&nbsp; She is a member of the Board of Directors of Argenx, Patrys, F-Star Therapeutics, I-Mab Biopharma as well as a member of several Scientific Advisory Boards.&nbsp; Dr. Klein was
        Chief Medical Officer (consulting) of Olema Oncology from 2018 – January 2022 and has served as Chief Medical Officer for multiple successful biotech companies including Intellikine which was acquired by Takeda.&nbsp;&nbsp; From 2001-2008, Dr. Klein held
        increasing positions of responsibility at Genentech lastly as Vice President, Development where she led the development for the HER2, EGFR, Apoptosis and Hematology Franchises.&nbsp; Prior to this, Dr. Klein was the co-founder and Research Director for
        the National Cancer Institute-Navy Breast Care Center.&nbsp;&nbsp; Dr. Klein received her Bachelor’s degree in biology from California State University at Northridge and her Medical Degree from Stritch School of Medicine, Loyola University Chicago. She
        trained in internal medicine at Cedars-Sinai Medical Center in Los Angeles and medical oncology at the National Cancer Institute in Bethesda, Maryland where she served as Chief Fellow.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;"><span style="font-weight: bold;">Daniel Spiegelman </span>has served on our Board of Directors since the completion of our initial public offering. Mr. Spiegelman currently provides consulting and
        board services to various life sciences companies, including Tizona Therapeutics, where he is Board Chairman and Myriad Genetics, Spruce Biosciences and Opthea Limited where he serves as a member of the Board of Directors and Audit Committee
        Chairman and Kyverna Therapeutics, where he serves as a member of the Board of Directors. From May 2012 to January 2020, Mr. Spiegelman was the Executive Vice President, Chief Financial Officer of BioMarin Pharmaceutical, during its growth to $2
        Billion in annual revenues and a $15 Billion market capitalization.&nbsp; From January 1998 to May 2009, Mr. Spiegelman was the Chief Financial Officer of CV Therapeutics, Inc., a biopharmaceutical company that developed and marketed novel
        Cardiovascular drugs prior to its sale to Gilead Sciences. From July 1991 to January 1998, Mr. Spiegelman served in various roles at Genentech, Inc., (now a member of the Roche Group) most recently as Treasurer. Mr. Spiegelman has been a director
        of a number of other biopharmaceutical companies, including Cascadian Therapeutics, Inc. (formerly Oncothyreon, Inc.) from October 2008 until its merger with Seattle Genetics, Inc. in March 2018, Relypsa, Inc. from June 2014 until its merger with
        Galenica AG in September, 2016, Anthera Pharmaceuticals, Inc. from February 2010 to June 2014, Affymax, Inc. from October 2006 to June 2013, Omeros Corporation from December 2009 to June 2012, and Cyclacel Pharmaceuticals, Inc. from September 2004
        to June 2012. Mr. Spiegelman received a Bachelor of Arts degree from Stanford University and an MBA from the Stanford Graduate School of Business.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">54</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;"><span style="font-weight: bold;">Dr. Steve Kelsey</span> has served on our Board of Directors since the completion of our initial public offering. Since 2017, Dr. Kelsey has been the President of
        Research and Development at Revolution Medicines, a precision oncology company based in Redwood City, California. Dr. Kelsey has more than 20 years of experience in the biopharmaceutical industry, working with conventional small molecules, beyond
        rule of five molecules, antibodies, antibody-drug conjugates, DNA oligonucleotides and mRNA platforms, and has driven multiple industry and industry-academia collaborations to provide better drugs for patients with cancer. Prior to joining
        Revolution Medicines, he was President of Onkaido Therapeutics, a Moderna Venture focused on the discovery and development of mRNA therapeutics for cancer from 2014 – 2017. Dr. Kelsey is the former Head of Research and Development and Chief Medical
        Officer of Geron, where he led the development of imetelstat, a first-in-class telomerase inhibitor for hematologic myeloid malignancies. He previously served as Vice President of Hematology/Oncology at Genentech where he played a significant role
        in the development of key products including Perjeta®, Kadcyla® and Erivedge® as well as other molecules in the company’s oncology portfolio; and led clinical development for Pharmacia/SUGEN’s Sutent®. Kelsey graduated with a bachelor of medicine
        and a bachelor of surgery degrees (MB ChB), as well as a doctorate of medicine (MD) from the University of Birmingham, U.K. He is a fellow of both the Royal College of Physicians (FRCP) of London and the Royal College of Pathologists (FRCPath),
        U.K. He has over 100 peer-reviewed publications spanning cell biology, drug discovery, drug development and patient care, and is a named inventor on several patents.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;"><span style="font-weight: bold;">Dr. Lori Friedman, Ph.D</span>. has served on our Board of directors since September, 2021. Dr. Friedman brings over 20 years of experience in cancer research,
        including expertise in target discovery and validation, drug discovery, pharmacology and biomarkers. She is currently the Chief Scientific Officer at ORIC Pharmaceuticals where she leads discovery research, preclinical development sciences and
        manufacturing. Prior to ORIC, Lori spent 15 years at Genentech, where she held roles of increasing responsibility including head of translational oncology for Genentech Research and Early Development (gRED), where her team advanced more than 20
        programs into clinical development. Dr. Friedman also sat on multiple cross-functional leadership teams tasked with strategic and technical review of Genentech’s oncology research and development pipeline projects as well as in-licensing
        opportunities. Prior to Genentech, Dr. Friedman held various scientific leadership roles at Exelixis. She completed post-doctoral work at the University of Washington and at Cambridge University, and a PhD in molecular and cell biology from the
        University of California, Berkeley.</div>

      <div>&nbsp;</div>

      <div style="color: rgb(0, 0, 0); text-indent: 18pt;"><span style="font-weight: bold;">Mayank Gandhi, M.D.</span> joined us in September 2020 as VP, Corporate Development. Mayank brings with him nearly 15 years of biopharmaceutical industry and
        capital markets experience. From April 2013 to May 2020, Mayank worked at Genentech/Roche in several strategic and operational roles spanning business development, commercial operations and medical affairs. Prior to joining Genentech, Mayank was an
        equity research analyst covering biopharmaceutical and medical technology companies at Citigroup (May 2006 – Mar 2009), Cowen &amp; Co. (Mar 2009 – Mar 2011) and Avet Capital (Nov 2011 – Mar 2013). Mayank earned his medical degree from University
        of Mumbai, India in 2001 and MBA from Case Western Reserve University in 2003.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Number and Terms of Office of Officers and Directors</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our Board of Directors consists of eight members divided into three classes with only one class of directors being elected in each year, and with each class (except for those directors appointed prior to our first
        annual meeting of stockholders) serving a three-year term. In accordance with Nasdaq corporate governance requirements, we are not required to hold an annual meeting until one year after our first fiscal year end following our listing on Nasdaq.
        The term of office of the first class of directors, which will consist of Pamela Klein, Lori Friedman<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">10</sup> and Steve Kelsey, will expire at our first annual meeting of
        stockholders. The term of office of the second class of directors, which will consist of Daniel Spiegelman, Cory S. Freedland and Rekha Hemrajani, will expire at the second annual meeting of stockholders. The term of office of the third class of
        directors, which will consist of Srinivas Akkaraju and Richard Van Doren, will expire at the third annual meeting of stockholders.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our officers are appointed by the Board of Directors and serve at the discretion of the Board of Directors, rather than for specific terms of office. Our Board of Directors is authorized to appoint officers as it deems
        appropriate pursuant to our amended and restated certificate of incorporation.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">55</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="font-weight: bold;">Director Independence</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Nasdaq listing standards require that a majority of our Board of Directors be independent within one year of our initial public offering. Our Board of Directors has determined that Srinivas Akkaraju, M.D., Ph.D.,
        Daniel Spiegelman, Lori Friedman, Pamela Klein and Steve Kelsey are “independent directors” as defined in the Nasdaq listing standards and applicable SEC rules.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Committees of the Board of Directors</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our Board of Directors has three standing committees: an audit committee, a compensation committee and a nominating committee. Subject to phase-in rules and a limited exception, the rules of Nasdaq and Rule 10A-3 of
        the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors. Subject to phase-in rules and a limited exception, the rules of Nasdaq require that the compensation committee of a listed company
        be comprised solely of independent directors.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Audit Committee</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have established an audit committee of the Board of Directors. Daniel Spiegelman, Lori Friedman and Pamela Klein serve as members of our audit committee. Under the Nasdaq listing standards and applicable SEC rules,
        we are required to have three members of the audit committee, all of whom must be independent, subject to the exception described below.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Daniel Spiegelman serves as the chairman of the audit committee. Each member of the audit committee is financially literate and our Board of Directors has determined that Mr. Spiegelman qualifies as an “audit committee
        financial expert” as defined in applicable SEC rules.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have adopted an audit committee charter, which details the principal functions of the audit committee, including:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent auditor’s qualifications and independence, and (4) the performance of our internal
                audit function and independent auditors; the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with
                the independent auditors all relationships the auditors have with us in order to evaluate their continued independence;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent auditors describing (1) the independent auditor’s internal
                quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the
                preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent auditor, including reviewing our specific disclosures under “Management’s Discussion and
                Analysis of Financial Condition and Results of Operations”; reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such
                transaction; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">56</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or
                published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other
                regulatory authorities.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Compensation Committee</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have established a compensation committee of our Board of Directors. The members of our compensation committee are be Steve Kelsey, Daniel Spiegelman and Lori Friedman<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"></sup>, and Lori Friedman serves as chairman of the compensation committee. We have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>reviewing and approving on an annual basis the corporate goals and objectives relevant to our chief executive officer’s compensation, evaluating our chief executive officer’s performance in light of such goals and objectives and
                determining and approving the remuneration (if any) of our chief executive officer’s based on such evaluation;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>reviewing and approving the compensation of all of our other Section 16 executive officers;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>reviewing our executive compensation policies and plans;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>implementing and administering our incentive compensation equity-based remuneration plans;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>assisting management in complying with our proxy statement and annual report disclosure requirements;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>producing a report on executive compensation to be included in our annual proxy statement; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Notwithstanding the foregoing, as indicated above, other than the payment to an affiliate of our sponsor of up to $10,000 per month, for up to 24 months, for office space, utilities and secretarial and administrative
        support and reimbursement of expenses, no compensation of any kind, including finders, consulting or other similar fees, will be paid to any of our existing shareholders, officers, directors or any of their respective affiliates, prior to, or for
        any services they render in order to effectuate the consummation of an initial business combination. Accordingly, it is likely that prior to the consummation of an initial business combination, the compensation committee will only be responsible
        for the review and recommendation of any compensation arrangements to be entered into in connection with such initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the
        appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the
        independence of each such adviser, including the factors required by Nasdaq and the SEC.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Nominating Committee</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have established a nominating committee of our Board of Directors. The members of our nominating committee are Steve Kelsey, Daniel Spiegelman and Pamela Klein, and Pamela Klein serves as chairman of the nominating
        committee. We have adopted a nominating committee charter, which details the principal functions of the nominating committee, including:</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">57</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the board, and recommending to the board of directors candidates for nomination for appointment at the annual general
                meeting or to fill vacancies on the board of directors;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>developing and recommending to the board of directors and overseeing implementation of our corporate governance guidelines;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance of the company; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The charter also provides that the nominating committee may, in its sole discretion, retain or obtain the advice of, and terminate, any search firm to be used to identify director candidates, and is directly
        responsible for approving the search firm’s fees and other retention terms.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, our Board
        of Directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our stockholders.</div>

      <div>&nbsp;</div>

      <div style="margin-left: 9.35pt; font-style: italic; font-weight: bold;">Compensation Committee Interlocks and Insider Participation</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">None of our executive officers currently serves, and in the past year has not served, as a member of the compensation committee of any entity that has one or more executive officers serving on our Board of Directors.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Code of Ethics</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have adopted a Code of Business Conduct and Ethics applicable to our directors, officers and employees, which is available on our website. If we make any amendments to our Code of Business Conduct and Ethics other
        than technical, administrative or other non-substantive amendments, or grant any waiver, including any implicit waiver, from a provision of the Code of Business Conduct and Ethics applicable to our principal executive officer, principal financial
        officer principal accounting officer or controller or persons performing similar functions requiring disclosure under applicable SEC or Nasdaq rules, we will disclose the nature of such amendment or waiver on our website. The information included
        on our website is not incorporated by reference into this Annual Report or in any other report or document we file with the SEC, and any references to our website are intended to be inactive textual references only.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Conflicts of Interest</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In general, officers and directors of a corporation incorporated under the laws of the State of Delaware are required to present business opportunities to a corporation if:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>the corporation could financially undertake the opportunity;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>the opportunity is within the corporation’s line of business; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>it would not be fair to our company and its stockholders for the opportunity not to be brought to the attention of the corporation.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">58</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">Each of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations to another entity pursuant to which such officer or director is or will be
        required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current
        fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, and may only decide to present it to us if such entity rejects the
        opportunity and consummating the same would not violate any restrictive covenants to which such officers and directors are subject. Our amended and restated certificate of incorporation will provide that we renounce our interest in any corporate
        opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company and such opportunity is one we are legally and contractually permitted
        to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation. We do not believe, however, that the fiduciary
        duties or contractual obligations of our officers or directors will materially affect our ability to complete our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Below is a table summarizing the entities to which our executive officers and directors currently have fiduciary duties or contractual obligations:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 24%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Individual</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 25%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Entity</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 26%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Entity’s Business</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 22%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Affiliation</div>
              </div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" style="width: 25%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" style="width: 26%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Srinivas Akkaraju, M.D., Ph.D.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Samsara BioCapital, LLC</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Investment Adviser</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Managing Member</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Samsara BioCapital GP, LLC</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Investment Adviser</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Managing Member</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">A2 Biotherapeutics, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Autobahn Labs, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biotech incubator</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Chinook Therapeutics, Inc. (NASD:&nbsp; KDNY)</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Codex Health, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Digital Health</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Chairman of the Board</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Dewpoint Therapeutics, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Intercept Pharmaceutical, Inc. (NASD:&nbsp; ICPT)</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">MiroBio, Ltd</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Synthekine, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Syros Pharmaceuticals, Inc. (NASD:&nbsp; SYRS)</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Tentarix Biotherapeutics, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Theia Therapeutics, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Rekha Hemrajani</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">MaxCyte Inc (NASD: MXCT; LSE: MXCT, MXCN)</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">MaxCyte<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #464445;">&nbsp;</span>is a cell-engineering company providing
                enabling platform technologies to advance innovative cell-based research, cell therapeutic discovery, development and commercialization<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #464445;">.&nbsp;</span></div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">
              <div>BioAge Labs <br>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">BioAge Labs is a private, clinical-stage biotechnology company and global leader in using artificial intelligence (AI) and machine
                learning (ML) to develop drugs that target the molecular causes of aging</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">Director</td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">ALX Oncology (NASD: ALXO)</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">ALX Oncology is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune
                system.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Hemmo Pharma LLP</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Private company based in India - supplier &amp; manufacturer of synthetic peptide APIs</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Partner</div>
            </td>

  </tr>


</tbody></table>
      <div><br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">59</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Individual</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Entity</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Entity’s Business</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Affiliation</div>
              </div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" style="width: 25%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" style="width: 26%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Cory Freedland, Ph.D.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Neurogene, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Preclinical gene therapy company targeting neurological diseases</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Board Member</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div>Nura Bio, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div>Preclinical company targeting neurodegeneration</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div>Board Member</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Palvella Therapeutics</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Clinical stage company developing novel therapies for rare dermatological diseases</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Board Member</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div>Nalo Therapeutics</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div>Preclinical oncology company</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div>Board Member</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Tentarix Biotherapeutics</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Start-up targeting novel multi-domain protein therapeutics</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Board Member</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div>Omniox, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div>Developing novel therapies for diseases characterized by hypoxia</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div>Board Member</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Richard Van Doren</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Samsara BioCapital, LLC</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Investment Adviser</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Nalo Therapeutics, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Autobahn Labs, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biotech incubator</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Theia Therapeutics, Inc.</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Dr. Lori Friedman</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">ORIC Pharmaceuticals</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Chief Scientific Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">Dr. Pamela Klein</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Argenx</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Independent Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">F-Star Therapeutics</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Independent Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Patrys</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Independent Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">I-Mab Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Independent Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Daniel Spiegelman</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Tizona Therapeutics</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Independent Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Myriad Genetics</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Independent Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Spruce Biosciences</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Independent Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Opthea Ltd</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Independent Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Recardia</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biopharma</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Independent Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&nbsp;</td>

    <td style="width: 25%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Kyverna Therapeutics</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&nbsp;</td>

    <td style="width: 26%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">Biopharma</td>

    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&nbsp;</td>

    <td style="width: 22%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">Independent Director</td>

  </tr>

  <tr>

    <td style="width: 24%; vertical-align: top;">
              <div style="text-indent: -9.35pt; margin-right: 9.35pt; margin-left: 9.35pt;">Dr. Steve Kelsey</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 25%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Revolution Medicines</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 26%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Biotechnology Co</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">President</div>
            </td>

  </tr>


</tbody></table>
      <div><br></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">60</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">Notwithstanding the foregoing, we may pursue an acquisition opportunity jointly with our Sponsor, or one or more of its affiliates, which we refer to as an “Affiliated Joint Acquisition.” Such entities may co-invest
        with us in the target business at the time of our initial business combination, or we could raise additional proceeds to complete the acquisition by issuing to such entity a class of equity or equity-linked securities. For example, we entered into
        a forward purchase agreement with Samsara BioCapital pursuant to which Samsara BioCapital agreed to purchase an aggregate of up to 2,500,000 forward purchase shares, for $10.00 per share, or an aggregate maximum amount of $25,000,000, in a private
        placement that may close simultaneously with the closing of our initial business combination. Samsara BioCapital’s commitment under the forward purchase agreement is subject to, among other conditions, the business combination (including the target
        assets or business, and the terms of the initial business combination) being reasonably acceptable to Samsara BioCapital. Each of our officers and directors presently has, and any of them in the future, may have additional fiduciary or contractual
        obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination
        opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such other entity. We do not
        believe, however, that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our business combination. In addition, we may pursue an Affiliated Joint Acquisition opportunity with
        an entity to which an officer or director has a fiduciary or contractual obligation. Any such entity may co-invest with us in the target business at the time of our initial business combination, or we could raise additional proceeds to complete the
        acquisition by issuing to such entity a class of equity or equity-linked securities. Our amended and restated certificate of incorporation provides that we renounce our interest in any corporate opportunity offered to any director or officer unless
        such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us
        to pursue. In addition, the Company and its affiliates, including our officers and directors who are affiliated with the Company, may sponsor or form other blank check companies similar to ours during the period in which we are seeking an initial
        business combination. Any such companies may present additional conflicts of interest in pursuing an acquisition target. However, we do not believe that any such potential conflicts would materially affect our ability to complete our initial
        business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Potential investors should also be aware of the following other potential conflicts of interest:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business
                combination and their other businesses. Each of our executive officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our executive officers are not obligated to contribute any
                specific number of hours per week to our affairs.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>Our initial stockholders purchased founder shares prior to the date of this Annual Report and purchased private placement shares in a transaction that closed simultaneously with the closing of our initial public offering. Our initial
                stockholders have entered into agreements with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, private placement shares and any public shares they hold in connection with the
                completion of our initial business combination. The other members of our management team have entered into agreements similar to the one entered into by our initial stockholders with respect to any public shares acquired by them in or after
                our initial public offering. Additionally, our initial stockholders have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our initial business
                combination within the prescribed time frame. Furthermore, our initial stockholders have agreed not to transfer, assign or sell any of their founder shares until the earlier to occur of: (i) one year after the completion of our initial
                business combination and (ii) the date following the completion of our initial business combination on which we complete a liquidation, merger, capital stock exchange or other similar transaction that results in all of our stockholders
                having the right to exchange their common stock for cash, securities or other property. Notwithstanding the foregoing, if the closing price of our Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock
                capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 120 days after our initial business combination, the founder shares will be released from the
                lockup. Because each of our executive officers and director nominees will own common stock directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with
                which to effectuate our initial business combination.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition
                to any agreement with respect to our initial business combination.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">61</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">We are not prohibited from pursuing an initial business combination with a business combination target that is affiliated with our sponsor, officers or directors or completing the business combination through a joint
        venture or other form of shared ownership with our sponsor, officers or directors. In the event we seek to complete our initial business combination with a business combination target that is affiliated with our sponsor, executive officers or
        directors, we, or a committee of independent directors, would obtain an opinion from an independent investment banking which is a member of FINRA or a valuation or appraisal firm, that such initial business combination is fair to our company from a
        financial point of view. We are not required to obtain such an opinion in any other context. Furthermore, in no event will our sponsor or any of our existing officers or directors, or any of their respective affiliates, be paid by the company any
        finder’s fee, consulting fee or other compensation prior to, or for any services they render in order to effectuate, the completion of our initial business combination. Further, commencing on the date our securities are first listed on Nasdaq, we
        will also pay our sponsor or an affiliate up to $10,000 per month for office space, secretarial and administrative services provided to members of our management team.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We cannot assure you that any of the above-mentioned conflicts will be resolved in our favor.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In the event that we submit our initial business combination to our public stockholders for a vote, our initial stockholders have agreed to vote their founder shares, private placement shares and any public shares
        purchased during or after our initial public offering in favor of initial business combination.</div>

      <div>&nbsp;</div>

      <a id="Item11."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 11.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Executive Officer and Director Compensation.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Prior to our initial public offering, we paid a total of approximately $22,500 to our Chief Executive Officer and $18,750 to our VP, Corporate Development as cash compensation, which payments were funded against the
        promissory note we entered into with our sponsor on September 9, 2020. Commencing on the date that our securities are first listed on Nasdaq through the earlier of consummation of our initial business combination and our liquidation, we will pay
        (i) Jiya management approximately $495,000 for base salaries annually for their services and (ii) our sponsor or an affiliate up to $10,000 per month for office space, secretarial and administrative services provided to members of our management
        team. In addition, our sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target
        businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, executive officers or directors, or our or their affiliates. Any such
        payments prior to an initial business combination will be made from funds held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional controls in place governing our
        reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying and consummating an initial business combination. Other than
        these payments and reimbursements, and those payments and benefits described below pursuant to the offer letters we have entered into with our Chief Executive Officer and our Vice President, Corporate Development, no compensation of any kind,
        including finder’s and consulting fees, will be paid by the company to our sponsor, executive officers and directors, or any of their respective affiliates, prior to completion of our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We have entered into an offer letter on October 30, 2020 with Ms. Hemrajani, our Chief Executive Officer, pursuant to which Ms. Hemrajani has agreed to provide up to 60% of her normal working time to the Company in her
        capacity as Chief Executive Officer. In connection with her services, Ms. Hemrajani will receive an annual base salary of $270,000 and will be eligible to participate in the Company’s benefit programs in effect from time to time. In addition, prior
        to our initial public offering, our sponsor transferred to Ms. Hemrajani 200,000 Class B shares, which will vest 25% on the first anniversary of the grant date, with the remaining 75% vesting in equal monthly installments over 36 months, in each
        case, subject to Ms. Hemrajani’s continued employment with the Company. Ms. Hemrajani’s offer letter also provides that, in the event Ms. Hemrajani’s employment is terminated by the Company without “cause” or Ms. Hemrajani resigns for “good reason”
        (such terms are defined in the offer letter), then Ms. Hemrajani will be entitled to receive (i) base salary continuation and payment of monthly COBRA premiums, in each case for three months following the date of her termination and (ii) an
        additional three months of vesting for purposes of her Class B shares (or, if such termination of employment occurs prior to August 24, 2021, acceleration of 25% of her Class B shares). Payment of the severance benefits is contingent on Ms.
        Hemrajani’s execution and non-revocation of a release of claims, as a well as her continued compliance with customary confidentiality and non-solicitation restrictions set forth in her offer letter. In addition, in the event Ms. Hemrajani is not
        offered a position as an executive officer of the target business following the initial business combination, then 100% of Ms. Hemrajani’s Class B shares will become fully vested.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">62</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">We have entered into an offer letter on November 4, 2020 with Mayank Gandhi, our Vice President, Corporate Development, pursuant to which Mr. Gandhi will receive an annual base salary of $225,000 and will be eligible
        to participate in the Company’s benefit programs in effect from time to time. In addition, prior to our initial public offering, our sponsor transferred to Mr. Gandhi 40,000 Class B shares, which will vest 25% on the first anniversary of the
        transfer date, with the remaining 75% vesting in equal monthly installments over 36 months, in each case subject to Mr. Gandhi’s continued employment with the Company.<span style="font-weight: bold;">&nbsp;</span> Our sponsor will transferred 8,000
        Class B shares to Mr. Gandhi prior to our initial public offering that will vest on the second anniversary of the consummation of the initial business combination, subject to Mr. Gandhi’s continued employment through such date. In the event Mr.
        Gandhi is not offered an ongoing role with the target business following the initial business combination, then 100% of Mr. Gandhi’s Class B shares will become fully vested.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
          <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For the year ended December 31, 2021, the Company incurred a total of approximately $548,000 for executive payroll
            related expense, which was comprised of approximately $352,000 related to the annual salary of Ms. Hemrajani and $196,000 related to the annual salary of Mr. Gandhi. As of December 31, 2020, the Company incurred a total of approximately
            $155,000 for executive payroll related expenses, which was comprised of approximately $95,800 related to the annual salary of Ms. Hemrajani and $59,200 related to the annual salary of Mr. Gandhi. At December 31, 2021 and 2020, $0 and $20,093 of
            payroll expenses was unpaid and recorded in accrued expenses, respectively.</div>

          <div>&nbsp;</div>

        </div>

      </div>

      <div style="text-indent: 18pt;">In addition, prior to our initial public offering, our sponsor transferred 30,000 Class B Shares to each of Srinivas Akkaraju, M.D., Ph.D., Richard Van Doren, Cory Freedland, Ph.D., Daniel Spiegelman, Pamela Klein and
        Steve Kelsey, which are subject to forfeiture if he or she is removed from office as a director or he or she voluntarily resigns from his or her position with the Company at any time before the consummation of our initial business combination. On
        September 23, 2021, Perry Karsen resigned from the Board effective immediately, and such, forfeited their Class B shares back to the sponsor. On September 24, 2021, the Company announced that Dr. Lori Friedman was appointed to serve as a Class I
        director of the Company and was granted 30,000 Class B shares of the Company, which were granted from the sponsor. No new Class B shares were issued as part of Dr. Friedman’s appointment or Perry Karsen’s resignation.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be
        fully disclosed to stockholders, to the extent then known, in the proxy solicitation materials or tender offer materials furnished to our stockholders in connection with a proposed business combination. We have not established any limit on the
        amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the proposed business combination, because the directors of the
        post-combination business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive officers will be determined, or recommended to the Board of Directors for determination, either
        by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our Board of Directors.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of
        our executive officers and directors may negotiate employment or consulting arrangements to remain with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions
        with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a
        determining factor in our decision to proceed with any potential business combination.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">63</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <a id="Item12."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 12.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The following table sets forth information regarding the beneficial ownership of our common stock available to us at April 15, 2022, with respect to our common stock held by:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>each of our executive officers and directors; and</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt;"><br>
            </td>

    <td style="width: 18pt; vertical-align: top;">•</td>

    <td style="width: auto; vertical-align: top;">
              <div>all our executive officers and directors as a group.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all of our common stock beneficially owned by them.</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tbody><tr>

    <td valign="bottom" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div>
                <div style="text-align: center; font-weight: bold;">Name and Address of Beneficial Owner<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" rowspan="2"><br>
            </td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Class A Common Stock</div>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Class B Common Stock<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Number of</div>
                <div style="text-align: center; font-weight: bold;">Shares</div>
                <div style="text-align: center; font-weight: bold;">Beneficially</div>
                <div style="text-align: center; font-weight: bold;">Owned</div>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Approximate</div>
                <div style="text-align: center; font-weight: bold;">Percentage</div>
                <div style="text-align: center; font-weight: bold;">of Class</div>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Number of</div>
                <div style="text-align: center; font-weight: bold;">Shares</div>
                <div style="text-align: center; font-weight: bold;">Beneficially</div>
                <div style="text-align: center; font-weight: bold;">Owned</div>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Approximate</div>
                <div style="text-align: center; font-weight: bold;">Percentage</div>
                <div style="text-align: center; font-weight: bold;"> of Class</div>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Glazer Capital, LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup><br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>976,766</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>8.99</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>%</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Citadel<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>784,610</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>7.2</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Acuta Capital Partners, LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup><br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>562,500</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>5.2</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>%</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Sculptor Capital<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup><br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>560,226</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>5.16</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Aristeia Capital, L.L.C.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> (7)</sup></div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>551,099</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>5.08</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>%</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Jiya Holding Company LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup><br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>507,041</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>4.7</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>2,130,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>82.3</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Srinivas Akkaraju, M.D., Ph.D.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> (8)</sup><br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>507,041</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>4.7</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>%</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>2,160,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>83.5</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Rekha Hemrajani<br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>200,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>7.7</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Richard Van Doren<br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>30,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>1.2</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Cory Freedland, Ph.D. <br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>30,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>1.2</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Lori Friedman, Ph.D. <br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>30,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>1.2</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Dr. Pamela Klein<br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>30,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>1.2</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Daniel Spiegelman <br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>30,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>1.2</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Dr. Steve Kelsey<br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>30,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>1.2</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Mayank Gandhi, M.D.<br>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>—</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>48,000</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div>1.9</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">All executive officers and directors as a group, (8 individuals)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>507,041</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>4.7</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>2,588,010</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div>98.1</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>%</div>
            </td>

  </tr>


</tbody></table>
      <div>
        <div style="margin-right: 396pt;">
<div><br></div>

          <div>
            <div>
              <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto 0px 0px; height: 2px; width: 25%; color: rgb(0, 0, 0); text-align: left; margin-left: 0px; margin-right: auto;"></div>

          </div>

        </div>

      </div>

      <div> <br>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">*</td>

    <td style="width: auto; vertical-align: top;">
              <div>Less than one percent.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(1)</td>

    <td style="width: auto; vertical-align: top;">
              <div>Unless otherwise noted, the business address of each of the following is 628 Middlefield Road, Palo Alto, CA 94301.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(2)</td>

    <td style="width: auto; vertical-align: top;">
              <div>Interests shown consist solely of founder shares, classified as Class B common stock. Such shares will automatically convert into Class A common stock concurrently with or immediately following the consummation of our initial business
                combination on a one-for-one basis, subject to adjustment. Excludes forward purchase shares that will only be issued, if at all, at the time of our initial business combination.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(3)</td>

    <td style="width: auto; vertical-align: top;">
              <div>The information in the table above is based solely on information contained in this shareholder’s Schedule 13G under the Exchange Act filed by such shareholder with the SEC. Includes shares of Class A common stock held by certain funds
                and managed accounts to which Glazer Capital, LLC serves as investment manager. Mr. Paul J. Glazer, serves as the Managing Member of Glazer Capital. The address of Glazer Capital, LLC is 250 West 55th Street, Suite 30A, New York, New York
                10019.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">64</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(4)</td>

    <td style="width: auto; vertical-align: top;">
              <div>The information in the table above is based solely on information contained in this shareholder’s Schedule 13G under the Exchange Act filed by such shareholder with the SEC. Includes shares held by Citadel Equity Fund Ltd. (“CEFL”),
                Citadel Multi-Strategy Equities Master Fund Ltd. (“CM”) and Citadel Securities LLC (“Citadel Securities”). Citadel Advisors LLC (“Citadel Advisors”) is the portfolio manager for CEFL and CM. Citadel Advisors Holdings LP (“CAH”) is the sole
                member of Citadel Advisors. Citadel GP LLC (“CGP”) is the general partner of CAH. CALC IV LP (“CALC4”) is the non-member manager of Citadel Securities. Citadel Securities GP LLC (“CSGP”) is the general partner of CALC4. Mr. Griffin is the
                President and Chief Executive Officer of CGP, and owns a controlling interest in CGP and CSGP. Includes 770,300 shares that may be deemed to be beneficially owned by Citadel Advisors, CAH and CGP, and 57 shares that may be deemed to be
                beneficially owned by CALC4 and CSGP.&nbsp; Kenneth Griffin may be deemed to beneficially own 770,357 shares of Class A common stock. The address of Citadel is 628 Middlefield Road, Palo Alto, California 94301.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(5)</td>

    <td style="width: auto; vertical-align: top;">
              <div>The information in the table above is based solely on information contained in this shareholder’s Schedule 13G under the Exchange Act filed by such shareholder with the SEC. The funds managed by Acuta Capital Partners LLC (“Acuta”) hold
                Class A common stock for the benefit of their investors and have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Class A common stock. Acuta is the general partner and
                investment adviser of investment funds. Dr. Anupam Dalal is the control person of Acuta. Acuta and Dr. Anupam Dalal each disclaims beneficial ownership of the Class A common stock except to the extent of their pecuniary interest therein.&nbsp;
                The address of Acuta is 1301 Shoreway Road, Suite 350, Belmont, CA 94002.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(6)</td>

    <td style="width: auto; vertical-align: top;">
              <div>The information in the table above is based solely on information contained in this shareholder’s Schedule 13G under the Exchange Act filed by such shareholder with the SEC. Includes shares held by a number of private funds and
                discretionary accounts for which Sculptor Capital LP (“Sculptor”) and Sculptor Capital II LP (“Sculptor-II”) serve as investment managers. Sculptor Capital Holding Corporation (“SCHC”) serves as the general partner of Sculptor, and Sculptor
                Capital Holding II LLC (“SCHC-II”), a limited liability company that is wholly owned by Sculptor, serves as the general partner of Sculptor-II. Sculptor Capital Management, Inc. (“SCU”) is a holding company that is the sole shareholder of
                SCHC and the ultimate parent company of Sculptor and Sculptor-II. Sculptor is the investment adviser to Sculptor Master Fund, Ltd. (“SCMF”), Sculptor Credit Opportunities Master Fund, Ltd. (“SCCO”), a Cayman Islands company, and Sculptor
                Enhanced Master Fund, Ltd. (“SCEN”), a Cayman Islands company. Sculptor-II is the investment adviser to Sculptor SC II LP (“NJGC”). Sculptor Special Funding, LP (“NRMD”) is a Cayman Islands exempted limited partnership that is wholly owned
                by SCMF. The address of Sculptor, Sculptor-II, SCHC, SCHC-II, SCU, SCMF, NRMD, SCEN, SCCO and NJGC is 9 West 57 Street, 39 Floor, New York, NY 10019.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">&nbsp;(7)</td>

    <td style="width: auto; vertical-align: top;">
              <div>The information in the table above is based solely on information contained in this shareholder’s Schedule 13G under the Exchange Act filed by such shareholder with the SEC. Aristeia Capital, L.L.C. is the investment manager of, and has
                voting and investment control with respect to the securities described above held by, one or more private investment funds. The address of Aristeia Capital is One Greenwich Plaza, 3rd Floor, Greenwich, CT 06830.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 18pt; vertical-align: top;">(8)</td>

    <td style="width: auto; vertical-align: top;">
              <div>Jiya Holding Company LLC is wholly owned by Samsara BioCapital, L.P. Dr. Srinivas Akkaraju, M.D., Ph.D, has voting and dispositive control over these shares via his control of Samsara BioCapital, L.P.’s general partner, Samsara
                BioCapital GP, LLC.&nbsp; Dr. Akkaraju disclaims beneficial ownership of these shares except to the extent of any pecuniary interest in such shares.</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Immediately after our initial public offering, our initial stockholders beneficially owned approximately 20.0% of the then issued and outstanding common stock. Because of this ownership block, our initial stockholders
        may be able to effectively influence the outcome of all other matters requiring approval by our stockholders, including amendments to our amended and restated certificate of incorporation and approval of significant corporate transactions including
        our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Jiya Holding Company LLC, our sponsor, and our executive officers are deemed to be our “promoters” as such term is defined under the federal securities laws.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Transfers of Founder Shares and Private Placement Shares</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The founder shares, private placement shares and any shares of Class A common stock issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreements
        entered into by our initial stockholders and management team. Those lock-up provisions provide that such securities are not transferable or salable in the case of the founder shares, until the earlier of (A) one year after the completion of our
        initial business combination or earlier if, subsequent to our initial business combination, the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations,
        recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 120 days after our initial business combination and (B) the date following the completion of our initial business combination on which we
        complete a liquidation, merger, capital stock exchange or other similar transaction that results in all of our stockholders having the right to exchange their Class A common stock for cash, securities or other property.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">65</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">The forward purchase shares may be transferred or assigned, at any time and from time to time, in whole or in part, to one or more third parties, provided that upon such transfer the forward transferees assume the
        rights and obligations of Samsara BioCapital under the forward purchase agreement.</div>

      <div>&nbsp;</div>

      <div style="font-weight: bold;">Registration Rights</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">
        <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of our initial
          public offering, (ii) private placement shares, which will be issued in a private placement simultaneously with the closing of the offering, have registration rights to require us to register a sale of any of our securities held by them pursuant
          to a registration rights agreement. The number of shares of Class A common stock included (i) up to 2,588,010 shares of Class A common stock to be issued upon conversion of the founder shares, (ii) up to 507,041 shares of Class A common stock
          issued as part of the private placement shares. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back”
          registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements.</div>

        <div><br></div>

      </div>

      <div>
        <a id="Item13."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tbody><tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 45pt;">
                <div style="text-align: left; font-weight: bold;">Item 13.</div>
              </td>

    <td style="vertical-align: top; width: auto;">
                <div style="text-align: left; font-weight: bold;">Certain Relationships and Related Transactions, and Director Independence</div>
              </td>

  </tr>


</tbody></table>
      </div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">
        <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On September 9, 2020, our sponsor purchased an aggregate of 4,312,500 founder shares in exchange for a capital
          contribution of $25,000, or approximately $0.006 per share. On October 30, 2020, our sponsor forfeited 1,437,500 founder shares for no consideration. Prior to the initial investment in the company of $25,000 by the sponsor, the company had no
          assets, tangible or intangible.&nbsp; In connection with the partial exercise of the underwriters’ over-allotment option, our sponsor forfeited an additional 286,990 founder shares, such that at December 31, 2021 and 2020 there were an aggregate of
          2,588,010 founder shares outstanding. The number of founder shares outstanding was determined based on the expectation that the total size of our initial public offering would be a maximum of 11,500,000 shares if the underwriters’ over-allotment
          option is exercised in full, and therefore that such founder shares would represent 20% of the outstanding shares after our initial public offering.</div>

        <div>&nbsp;</div>

      </div>

      <div style="text-indent: 18pt;">Prior to our initial public offering, our sponsor transferred 200,000 shares of our Class B common stock to our Chief Executive Officer, 48,000 shares of our Class B common stock to our VP, Corporate Development and
        30,000 shares of our Class B common stock to each of Srinivas Akkaraju, M.D., Ph.D., Richard Van Doren, Cory Freedland, Ph.D., Daniel Spiegelman, Pamela Klein and Steve Kelsey. On September 23, 2021, Perry Karsen resigned from the Board effective
        immediately, and such, forfeited their Class B shares back to the sponsor. On September 24, 2021, the Company announced that Dr. Lori Friedman was appointed to serve as a Class I director of the Company and was granted 30,000 Class B shares of the
        Company, which were granted from the sponsor. No new Class B shares were issued as part of Dr. Friedman’s appointment or Perry Karsen’s resignation.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Our sponsor, pursuant to a written agreement concurrently with our initial public offering, purchased an aggregate of up to 500,000 private placement shares at a price of $10.00 per share, for an aggregate purchase
        price of $5,000,000. The private placement shares may not, subject to certain limited exceptions, be transferred, assigned or sold until 30 days after the completion of our initial business combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We currently utilize office space at 628 Middlefield Road, Palo Alto, CA 94301 from our sponsor. Since November 19, 2020, we have paid our sponsor or an affiliate up to $10,000 per month for office space, secretarial
        and administrative services provided to members of our management team. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">No compensation of any kind, including finder’s and consulting fees, will be paid by the company to our sponsor, executive officers and directors, or any of their respective affiliates, for services rendered prior to
        or in connection with the completion of an initial business combination. However, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target
        businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their affiliates.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">66</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-indent: 18pt;">In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not
        obligated to, loan us funds as may be required on a non-interest basis. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of
        the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into shares of the post business combination
        entity at a price of $10.00 per share at the option of the lender. Except as set forth above, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our
        initial business combination, we do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to
        seek access to funds in our trust account. Any of the foregoing payments to our sponsor, repayments of loans from our sponsor or repayments of working capital loans prior to our initial business combination will be made using funds held outside the
        trust account.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We entered into a forward purchase agreement pursuant to which Samsara BioCapital agreed to purchase an aggregate of up to 2,500,000 forward purchase shares for $10.00 per share, or an aggregate maximum amount of
        $25,000,000, in a private placement that may close simultaneously with the closing of our initial business combination. Samsara BioCapital will purchase a number of forward purchase shares, if any, that we expect will result in gross proceeds to us
        necessary to enable us to consummate our initial business combination and pay related fees and expenses, after first applying amounts available to us from the trust account (after paying the deferred underwriting discount and giving effect to any
        redemptions of public shares) and any other financing source obtained by us for such purpose at or prior to the consummation of our initial business combination, plus any additional amounts mutually agreed by us and Samsara BioCapital to be
        retained by the post-business combination company for working capital or other purposes. Samsara BioCapital’s obligation to purchase forward purchase shares will, among other things, be conditioned on the business combination (including the target
        assets or business, and the terms of the business combination) being reasonably acceptable to Samsara BioCapital and on a requirement that such initial business combination is approved by a unanimous vote of our Board of Directors. In determining
        whether a target is reasonably acceptable to Samsara BioCapital, we expect that Samsara BioCapital would consider many of the same criteria as we will consider, but will also consider whether the investment is an appropriate investment for Samsara
        BioCapital. Samsara BioCapital has the right to transfer a portion of its obligation to purchase the forward purchase shares to third parties.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The forward purchase agreement also provides that Samsara BioCapital and any forward transferees will be entitled to certain registration rights with respect to their forward purchase shares. Samsara BioCapital’s
        commitment to purchase securities pursuant to the forward purchase agreement is intended to provide us with a minimum funding level for our initial business combination. The proceeds from the sale of the forward purchase shares, if any, may be used
        as part of the consideration to the sellers in the initial business combination, expenses in connection with our initial business combination or for working capital in the post-transaction company. Subject to the conditions in the forward purchase
        agreement, the purchase of the forward purchase shares will be a binding obligation of Samsara BioCapital, regardless of whether any shares of Class A common stock are redeemed by our public stockholders in connection with our initial business
        combination.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">After our initial business combination, members of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all amounts being fully disclosed to our
        stockholders, to the extent then known, in the proxy solicitation or tender offer materials, as applicable, furnished to our stockholders. It is unlikely the amount of such compensation will be known at the time of distribution of such tender offer
        materials or at the time of a stockholder meeting held to consider our initial business combination, as applicable, as it will be up to the directors of the post-combination business to determine executive and director compensation.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">In connection with our initial public offering, we also entered into a registration rights agreement with respect to the founder shares and private placement shares.</div>

      <div>&nbsp;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">67</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="font-weight: bold;">Policy for Approval of Related Party Transactions</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">The audit committee of our Board of Directors adopted a policy setting forth the policies and procedures for its review and approval or ratification of “related party transactions.” A “related party transaction” is any
        consummated or proposed transaction or series of transactions: (i) in which the company was or is to be a participant; (ii) the amount of which exceeds (or is reasonably expected to exceed) the lesser of $120,000 or 1% of the average of the
        company’s total assets at year end for the prior two completed fiscal years in the aggregate over the duration of the transaction (without regard to profit or loss); and (iii) in which a “related party” had, has or will have a direct or indirect
        material interest. “Related parties” under this policy will include: (i) our directors, nominees for director or executive officers; (ii) any record or beneficial owner of more than 5% of any class of our voting securities; (iii) any immediate
        family member of any of the foregoing if the foregoing person is a natural person; and (iv) any other person who maybe a “related person” pursuant to Item 404 of Regulation S-K under the Exchange Act. Pursuant to the policy, the audit committee
        will consider (i) the relevant facts and circumstances of each related party transaction, including if the transaction is on terms comparable to those that could be obtained in arm’s-length dealings with an unrelated third party, (ii) the extent of
        the related party’s interest in the transaction, (iii) whether the transaction contravenes our code of ethics or other policies, (iv) whether the audit committee believes the relationship underlying the transaction to be in the best interests of
        the company and its stockholders and (v) the effect that the transaction may have on a director’s status as an independent member of the board and on his or her eligibility to serve on the board’s committees. Management will present to the audit
        committee each proposed related party transaction, including all relevant facts and circumstances relating thereto. Under the policy, we may consummate related party transactions only if our audit committee approves or ratifies the transaction in
        accordance with the guidelines set forth in the policy. The policy will not permit any director or executive officer to participate in the discussion of, or decision concerning, a related person transaction in which he or she is the related party.</div>

      <div>&nbsp;</div>

      <a id="Item14."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold;">Item 14</span><span style="font-weight: bold; font-style: italic;">.</span></td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Principal Accountant Fees and Services.</div>
            </td>

  </tr>


</tbody></table>
      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify;">The following is a summary of fees paid or to be paid to Marcum LLP, or Marcum, for services rendered.</div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify;">
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Audit Fees</span>. Audit fees consist
          of fees billed for professional services rendered for the audit of our year-end financial statements and services that are normally provided by Marcum in connection with regulatory filings. The aggregate fees billed by Marcum for professional
          services rendered for the audit of our annual financial statements, review of the financial information included in our Forms 10-Q for the respective periods and other required filings with the SEC for the year ended December 31, 2021 and for the
          period from August 27, 2020 (inception) through December 31, 2020 totaled $96,334 and $55,900, respectively. The above amounts include interim procedures and audit fees, as well as attendance at audit committee meetings.</div>

      </div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify;"><span style="font-style: italic;">Audit-Related Fees.</span> Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our
        financial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We did not pay Marcum for
        consultations concerning financial accounting and reporting standards for the year ended December 31, 2021 and for the period from August 27, 2020 (inception) through December 31, 2020.</div>

      <div><br>
      </div>

      <div style="text-align: justify;"><span style="font-style: italic;">Tax Fees</span>. We did not pay Marcum for tax planning and tax advice for the year ended December 31, 2021 and for the period from August 27, 2020 (inception) through December 31,
        2020.</div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="text-align: justify;"><span style="font-style: italic;">All Other Fees</span>. We did not pay Marcum for other services for the year ended December 31, 2021 and for the period from August 27, 2020 (inception) through December 31, 2020.</div>

      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>

      <div style="text-align: justify; font-weight: bold;">Pre-Approval Policy</div>

      <div style="text-align: justify;"><span style="font-weight: bold;"> </span><br>
      </div>

      <div style="text-align: justify;">Our audit committee was formed upon the consummation of our Initial Public Offering. As a result, the audit committee did not pre-approve all of the foregoing services, although any services rendered prior to the
        formation of our audit committee were approved by our board of directors. Since the formation of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted non-audit services
        to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit committee prior to the completion of the audit).</div>

      <div style="text-align: justify;"> <br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">68</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <div style="text-align: center; font-weight: bold;"><a id="PARTIV"><!--Anchor--></a>PART IV</div>

      <div>&nbsp;</div>

      <a id="Item15."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold;">Item 15</span><span style="font-weight: bold; font-style: italic;">.</span></td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Exhibits, Financial Statement Schedules</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">(a) The following documents are filed as part of this Form 10-K:</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; margin-left: 18pt;">(1) Financial Statements:</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 90%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>

    <td style="width: 10%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Page</div>
              </div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 90%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" style="width: 10%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Report of Independent Registered Public Accounting Firm</div>
            </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">F-2</div>
            </td>

  </tr>

  <tr>

    <td style="width: 90%; vertical-align: top;">
              <div>Balance Sheets</div>
            </td>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: center;">F-3</div>
            </td>

  </tr>

  <tr>

    <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Statements of Operations</div>
            </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">F-4</div>
            </td>

  </tr>

  <tr>

    <td style="width: 90%; vertical-align: top;">
              <div>Statements of Changes in Shareholders’ Equity</div>
            </td>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: center;">F-5</div>
            </td>

  </tr>

  <tr>

    <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Statements of Cash Flows</div>
            </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center;">F-6</div>
            </td>

  </tr>

  <tr>

    <td style="width: 90%; vertical-align: top;">
              <div>Notes to Financial Statements</div>
            </td>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: center;">F-7</div>
            </td>

  </tr>


</tbody></table>
      <div><br>
      </div>

      <div style="text-indent: 18pt; margin-left: 18pt;">(2) Financial Statement Schedules:</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">None.</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt; margin-left: 18pt;">(3) Exhibits</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">We hereby file as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference can be found on the SEC’s website at www.sec.gov.</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 10%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Exhibit</div>
                <div style="text-align: center; font-weight: bold;">No.</div>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><br>
            </td>

    <td style="width: 89%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div>&nbsp;</div>
                <div style="text-align: center; font-weight: bold;">Description</div>
              </div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td rowspan="1" style="width: 89%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000095010320022593/dp141220_ex0301.htm" tabindex="18">3.1</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>First Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K dated November 20, 2020)</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/0001824119/000095010321004989/dp148054_0401.htm" tabindex="18">4.1</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 89%; vertical-align: top;">
              <div>Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended (incorporated herein by reference to Exhibit 4.1 to the Annual Report on Form 10-K dated December 31, 2020)</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000095010320022593/dp141220_ex1001.htm" tabindex="18">10.1</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><span style="color: rgb(0, 0, 0);">Letter Agreement, dated </span>November 18, 2020<span style="color: rgb(0, 0, 0);">, among the Company and its officers, directors and Jiya Holding Company, LLC, dated November 18, 2020 (incorporated
                  by reference to Exhibit 10.1 to the Current Report on Form 8-K dated November 20, 2020).</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000095010320022593/dp141220_ex1002.htm" tabindex="18">10.2</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 89%; vertical-align: top;">
              <div><span style="color: rgb(0, 0, 0);">Investment Management Trust Agreement, dated </span>November 18, 2020<span style="color: rgb(0, 0, 0);">, between the Company and Continental Stock Transfer &amp; Trust Company, as trustee
                  (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K dated November 20, 2020).</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000095010320022593/dp141220_ex1003.htm" tabindex="18">10.3</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><span style="color: rgb(0, 0, 0);">Registration Rights Agreement, dated </span>November 18, 2020<span style="color: rgb(0, 0, 0);">, between the Company and certain security holders (incorporated by reference to Exhibit 10.3 to the
                  Current Report on Form 8-K dated November 20, 2020).</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000095010320022593/dp141220_ex1004.htm" tabindex="18">10.4</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 89%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Private Placement Purchase Agreement, dated November 18, 2020, between the Company and Jiya Holding Company, LLC (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K dated November 20,
                2020).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000095010320022593/dp141220_ex1005.htm" tabindex="18">10.5</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Administrative Services Agreement, dated November 18, 2020, between the Company and Jiya Holding Company, LLC (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K dated November 20,
                2020).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/0001824119/000095010320021293/dp139824-ex1009.htm" tabindex="18">10.6</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 89%; vertical-align: top;">
              <div>Offer Letter between Jiya Acquisition Corp. and Rekha Hemrajani, dated October 30, 2020 (incorporated herein by reference to Exhibit 10.9 of the Company’s Registration Statement on Form S-1 (File No. 333-249808) filed with the SEC on
                November 2, 2020)</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/0001824119/000095010321004989/dp148054_1007.htm" tabindex="18">10.7</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Offer Letter between Jiya Acquisition Corp. and Mayank Gandhi, dated September 24, 2021 (incorporated herein by reference to Exhibit 10.7 the Annual
                Report on Form 10-K dated December 31, 2020).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000114036122014760/brhc10035402_ex31-1.htm" tabindex="18">31.1</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 89%; vertical-align: top;">
              <div>Certification of the Registrant’s Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of
                2002.*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000114036122014760/brhc10035402_ex31-2.htm" tabindex="18">31.2</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Certification of the Registrant’s Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the
                Sarbanes-Oxley Act of 2002.*</div>
            </td>

  </tr>


</tbody></table>
      <div><br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">69</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 10%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Exhibit</div>
              </div>
              <div style="text-align: center; font-weight: bold;">No.</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: center; width: 1%; padding-bottom: 2px;"><br>
            </td>

    <td style="width: 89%; vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; vertical-align: top;">&nbsp;</td>

    <td rowspan="1" colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td rowspan="1" style="width: 89%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000114036122014760/brhc10035402_ex32-1.htm" tabindex="18">32.1</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Certification of the Registrant’s Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right;"><a href="https://www.sec.gov/Archives/edgar/data/1824119/000114036122014760/brhc10035402_ex32-2.htm" tabindex="18">32.2</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 89%; vertical-align: top;">
              <div>Certification of the Registrant’s Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">101.INS</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>XBRL Instance Document</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right;">101.SCH</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 89%; vertical-align: top;">
              <div>XBRL Taxonomy Extension Schema</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">101.CAL</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>XBRL Taxonomy Extension Calculation Linkbase</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right;">101.DEF</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 89%; vertical-align: top;">
              <div>XBRL Taxonomy Extension Definition Linkbase</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">101.LAB</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);"><br>
            </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>XBRL Taxonomy Extension Label Linkbase</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right;">101.PRE</div>
            </td>

    <td colspan="1" style="vertical-align: top; width: 1%;"><br>
            </td>

    <td style="width: 89%; vertical-align: top;">
              <div>XBRL Taxonomy Extension Presentation Linkbase</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tbody><tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                <div>*</div>
              </td>

    <td style="vertical-align: top; width: auto;">
                <div>Filed herewith.</div>
              </td>

  </tr>


</tbody></table>
      </div>

      <div>&nbsp;</div>

      <a id="Item16."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tbody><tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 16.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Form 10-K Summary</div>
            </td>

  </tr>


</tbody></table>
      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Not applicable.</div>

      <div> <br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">70</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%71%%%-->
      <div style="text-align: center; font-weight: bold;">SIGNATURES</div>

      <div>&nbsp;</div>

      <div style="text-indent: 18pt;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934, as amended, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto
        duly authorized, on April 15, 2022.</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 50%; vertical-align: top;" rowspan="1"><br>
            </td>

    <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="font-weight: bold;">Jiya Acquisition Corp.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;" rowspan="1"><br>
            </td>

    <td style="vertical-align: top;" rowspan="1" colspan="2"><br>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" rowspan="1"><br>
            </td>

    <td style="vertical-align: top; width: 3%; padding-bottom: 2px;" rowspan="1">By:</td>

    <td style="vertical-align: top; width: 47%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
              <div style="margin-left: 9pt;">/s/&nbsp; Rekha Hemrajani</div>
            </td>

  </tr>


</tbody></table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 50%; vertical-align: top;"><br>
            </td>

    <td style="vertical-align: top; width: 3%;">
              <div><br>
              </div>
            </td>

    <td style="vertical-align: top; width: 5%;">Name:</td>

    <td style="vertical-align: top; width: 42%;">Rekha Hemrajani</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;"><br>
            </td>

    <td style="vertical-align: top; width: 3%;">
              <div><br>
              </div>
            </td>

    <td style="vertical-align: top; width: 5%;">Title:</td>

    <td style="vertical-align: top; width: 42%;">Chief Executive Officer</td>

  </tr>


</tbody></table>
      <div><br>
      </div>

      <div style="text-indent: 18pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed by the following persons in the capacity and on the dates indicated.</div>

      <div>&nbsp;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 24.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Name</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 61%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;">
                <div style="font-weight: bold;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Position</div>
                </div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&nbsp;</td>

    <td style="width: 12%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Date</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 61%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 12%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Srinivas Akkaraju</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 61%; vertical-align: middle;">
              <div>Chairman</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 12%; vertical-align: middle;">
              <div style="text-align: right;">April 15, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">
              <div>Srinivas Akkaraju</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 61%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 12%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/&nbsp; Rekha Hemrajani</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 61%; vertical-align: middle;">
              <div>Chief Executive Officer and Director</div>
              <div>(Principal Executive Officer)</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 12%; vertical-align: middle;">
              <div style="text-align: right;">
                <div style="text-align: right;">April 15, 2022</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">
              <div>Rekha Hemrajani</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 61%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 12%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/&nbsp; Richard Van Doren</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 61%; vertical-align: middle;">
              <div>Chief Financial Officer, Secretary and Director</div>
              <div>(Principal Accounting Officer)</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 12%; vertical-align: middle;">
              <div style="text-align: right;">
                <div style="text-align: right;">April 15, 2022</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">
              <div>Richard Van Doren</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 61%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 12%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Cory Freedland</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 61%; vertical-align: middle;">
              <div>Chief Investment Officer and Director</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 12%; vertical-align: middle;">
              <div style="text-align: right;">
                <div style="text-align: right;">April 15, 2022</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">
              <div>Cory Freedland</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 61%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 12%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Lori Friedman</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 61%; vertical-align: middle;">
              <div>Director</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 12%; vertical-align: middle;">
              <div style="text-align: right;">
                <div style="text-align: right;">April 15, 2022</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">
              <div>Lori Friedman</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 61%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 12%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Dr. Pamela Klein</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 61%; vertical-align: middle;">
              <div>Director</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 12%; vertical-align: middle;">
              <div style="text-align: right;">
                <div style="text-align: right;">April 15, 2022</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">
              <div>Dr. Pamela Klein</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 61%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 12%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Daniel Spiegelman</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 61%; vertical-align: middle;">
              <div>Director</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 12%; vertical-align: middle;">
              <div style="text-align: right;">
                <div style="text-align: right;">April 15, 2022</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">
              <div>Daniel Spiegelman</div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 61%; vertical-align: top;">&nbsp;</td>

    <td colspan="1" style="width: 1%; vertical-align: top;">&nbsp;</td>

    <td style="width: 12%; vertical-align: top;">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Dr. Steve Kelsey</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 61%; vertical-align: middle;">
              <div>Director</div>
            </td>

    <td colspan="1" rowspan="2" style="width: 1%; vertical-align: middle;">&nbsp;</td>

    <td rowspan="2" style="width: 12%; vertical-align: middle;">
              <div style="text-align: right;">
                <div style="text-align: right;">April 15, 2022</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 24.69%; vertical-align: top;">
              <div>Dr. Steve Kelsey</div>
            </td>

  </tr>


</tbody></table>
      <div><br>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">71</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div>
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;">JIYA ACQUISITION CORP.</span></div>

          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;"> <br>
            </span></div>

          <div><span style="font-weight: bold;"> </span></div>

          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a id="INDEXTOFINANCIALSTATEMENT"><!--Anchor--></a>INDEX TO FINANCIAL <a id="STATEMENTS"><!--Anchor--></a>STATEMENTS</div>

          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tbody><tr>

    <td style="width: 89.86%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#REPORTOFINDEPENDENTREGIST" tabindex="18">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID Number <span style="-sec-ix-hidden:Fact_4712fd7049bb4d76a00ab7336be1d6a1"><span><ix:nonnumeric name="dei:AuditorFirmId" id="fact-identifier-35" contextref="c20210101to20211231" isadditionalitemsonly="true" ishiddenelement="true" inside-table="true" data-original-id="Fact_4712fd7049bb4d76a00ab7336be1d6a1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isstandardonly="true" iscustomonly="false">688</ix:nonnumeric></span></span>)</div>
                </td>

    <td style="width: 10.14%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">F-2</div>
                </td>

  </tr>

  <tr>

    <td style="width: 89.86%; vertical-align: top;">
                  <div style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Financial Statements: <br>
                  </div>
                </td>

    <td style="width: 10.14%; vertical-align: top; color: rgb(0, 0, 0);">&nbsp;</td>

  </tr>

  <tr>

    <td style="width: 89.86%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); margin-left: 9pt;"><a href="#BALANCESHEET" tabindex="18">Balance Sheets<br>
                    </a></div>
                </td>

    <td style="width: 10.14%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">F-3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 89.86%; vertical-align: top;">
                  <div style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); margin-left: 9pt;"><a href="#STATEMENTOFOPERATIONS" tabindex="18">Statements of Operations<br>
                    </a></div>
                </td>

    <td style="width: 10.14%; vertical-align: top;">
                  <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">F-4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 89.86%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); margin-left: 9pt;"><a href="#STATEMENTOFCHANGESINSTOCK" tabindex="18">Statements of Changes in Stockholders’ Equity<br>
                    </a></div>
                </td>

    <td style="width: 10.14%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">F-5</div>
                </td>

  </tr>

  <tr>

    <td style="width: 89.86%; vertical-align: top;">
                  <div style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); margin-left: 9pt;"><a href="#STATEMENTOFCASHFLOWS" tabindex="18">Statements of Cash Flows<br>
                    </a></div>
                </td>

    <td style="width: 10.14%; vertical-align: top;">
                  <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">F-6</div>
                </td>

  </tr>

  <tr>

    <td style="width: 89.86%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 9pt;"><a href="#NOTESTOFINANCIALSTATEMENT" tabindex="18">Notes to Financial Statements</a></div>
                </td>

    <td style="width: 10.14%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; margin-left: 1.2pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">F-7 to F-17</div>
                </td>

  </tr>


</tbody></table>
          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFPageNumberArea"><span style="font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">F-1</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

              </div>

            </div>

          </div>

          <!--PROfilePageNumberReset%Num%2%F-%%--> </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="BKMK_74"></a><a id="REPORTOFINDEPENDENTREGIST"><!--Anchor--></a>REPORT OF INDEPENDENT REGISTERED PUBLIC
            ACCOUNTING FIRM</div>

          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;">To the Stockholders and the Board of Directors of</div>

          <div style="margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;">Jiya Acquisition Corp.</div>

          <div style="margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">Opinion on the Financial Statements</div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;">We have audited the accompanying balance sheets of Jiya Acquisition Corp. (the “Company”) as of December 31, 2021 and 2020, the related
            statements of operations, changes in stockholders’ deficit and cash flows for the year ended December 31, 2021 and for the period from August 27, 2020 (inception) through December 31, 2020, and the related notes (collectively referred to as the
            “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the
            year ended December 31, 2021 and for the period from August 27, 2020 (inception) through December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.</div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"> <br>
          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"> Going Concern</div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;">
            <div><br>
            </div>

            <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more
                fully described in Note 1 to the financial statements, the Company has until November 23, 2022, to complete a business combination or the Company will cease all operations except for the purpose of liquidating. Further, the Company’s cash
                and working capital as of December 31, 2021 are not sufficient to complete its planned activities for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These conditions raise
                substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the
                outcome of this uncertainty.</div>

            </div>

          </div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">Basis for Opinion</div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;">These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s
            financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (the “PCAOB”) and are required to be independent with respect to the Company in accordance
            with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
            reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
            reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial
            reporting. Accordingly, we express no such opinion.</div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
            fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting
            principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-variant: small-caps;">/s/</span> <span><ix:nonnumeric name="dei:AuditorName" id="fact-identifier-36" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_3dc9ac51876b4cc5b2c35a32f54ce95b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Marcum LLP</ix:nonnumeric></span></div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span><ix:nonnumeric name="dei:AuditorName" id="fact-identifier-37" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_c51f4dee9a4145069cdaf3aa85d496ef" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">Marcum LLP</ix:nonnumeric></span><br>
          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">We have served as the Company’s auditor since 2020<span style="font-weight: bold;">.</span></div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span><ix:nonnumeric name="dei:AuditorLocation" id="fact-identifier-38" contextref="c20210101to20211231" inside-table="false" data-original-id="Fact_23d38eed5b28498f8a481515f09e8e2b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">New York, NY</ix:nonnumeric></span><br>
          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> April 15, 2022<br>
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">F-2</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

              </div>

            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="BKMK_75"></a>JIYA ACQUISITION CORP.</div>

          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="BALANCESHEET"><!--Anchor--></a>BALANCE SHEETS</div>

          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: middle; text-align: center; font-weight: bold;" rowspan="1" colspan="2"> December 31,<br>
                </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="2"> December 31,<br>
                </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: middle; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">2021<br>
                </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: middle; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="2">2020<br>
                </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">ASSETS</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Current assets</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Cash</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:Cash" id="fact-identifier-39" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_268365d96d9b4149bb189f52649365ce" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">628,006</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:Cash" id="fact-identifier-40" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_08ceb4ec6f8e429485778196c7be9cee" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,889,565</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Prepaid expenses</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:PrepaidExpenseCurrent" id="fact-identifier-41" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_30fc15612bbf4ee28d00227bd1b5d59c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">256,768</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:PrepaidExpenseCurrent" id="fact-identifier-42" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a28058afe6044495937e42319bcbaf85" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">521,067</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Total Current Assets</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AssetsCurrent" id="fact-identifier-43" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_abec236c55aa43ee98cf93b29bed7470" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">884,774</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:AssetsCurrent" id="fact-identifier-44" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_1d96cffe5d564add8a07abf19735ed00" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,410,632</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Cash and Marketable securities held in Trust Account</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AssetsHeldInTrustNoncurrent" id="fact-identifier-45" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_fb27653f24214f0bb321d2636f3a01bb" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,542,974</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:AssetsHeldInTrustNoncurrent" id="fact-identifier-46" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_fbe37cf0726d4c81aa12ac69e63417ca" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,522,529</ix:nonfraction></span><br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">TOTAL ASSETS</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:Assets" id="fact-identifier-47" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e5bde7766c9e48b880f45dd56bb8defb" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">104,427,748</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:Assets" id="fact-identifier-48" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_86f8807d4e7643f48ca88df42e02fc64" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">105,933,161</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">LIABILITIES, AND STOCKHOLDERS’ DEFICIT</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Current liabilities</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Accrued expenses</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AccruedLiabilitiesCurrent" id="fact-identifier-49" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_fdb53dd71c8a4145a74ac689e60a1ebe" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">342,002</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:AccruedLiabilitiesCurrent" id="fact-identifier-50" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_8e3bc9c647db428697b151ffd442ac45" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">50,892</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Accrued offering costs</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent" id="fact-identifier-51" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_a9a05cc5005f4f1db48331e9120e02a9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent" id="fact-identifier-52" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_66d43b666d62423f959d2a3f3a7f69e3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">50,832</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Due to Sponsor</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AccountsPayableRelatedPartiesCurrent" id="fact-identifier-53" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_e6790dbb904a4371b033ecaeb4034896" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:AccountsPayableRelatedPartiesCurrent" id="fact-identifier-54" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e0fb76baf88b45efb7d43c084bbb3866" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,305</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Promissory note – related party</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" id="fact-identifier-55" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_9b5726c339b5434dbe2e15399143ed7f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" id="fact-identifier-56" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f8c6d5c7a0b542c0ad6fe94a6332323f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">348</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Total Current Liabilities</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:LiabilitiesCurrent" id="fact-identifier-57" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_6150dbe715de4cc5acd8dd85e1993984" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">342,002</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:LiabilitiesCurrent" id="fact-identifier-58" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_9ebc1623e7004899ad704187128823d3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">104,377</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="margin-left: 9pt;">&nbsp;</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Deferred underwriting payable</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:DeferredUnderwritingFeePayableNonCurrent" id="fact-identifier-59" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a3c93e7cd3684298b8938e026a3459d6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">3,623,214</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="jyac:DeferredUnderwritingFeePayableNonCurrent" id="fact-identifier-60" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_63f8659a2c4342a381204fda34417f77" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">3,623,214</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Total Liabilities</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:Liabilities" id="fact-identifier-61" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_ec7629c3226a42a9b6c12a898de762dc" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,965,216</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:Liabilities" id="fact-identifier-62" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_627ca2034a784dc7a66fc240cee59d5c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,727,591</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Commitments<br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><span><ix:nonfraction name="us-gaap:CommitmentsAndContingencies" id="fact-identifier-63" contextref="c20211231" unitref="U001" xsi:nil="true" format="ixt:nocontent" inside-table="true" data-original-id="Fact_936ca4d22e1d4ed0968c6930edc3e941" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"></ix:nonfraction></span><br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"> <br>
                  <span><ix:nonfraction name="us-gaap:CommitmentsAndContingencies" id="fact-identifier-64" contextref="c20201231" unitref="U001" xsi:nil="true" format="ixt:nocontent" inside-table="true" data-original-id="Fact_00c259e9290143f588d2b2ead9d80831" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"></ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><br>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Class A common stock subject to possible redemption <span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:TemporaryEquitySharesOutstanding" id="fact-identifier-65" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_1a55e66184f0405fb5e1f8683355e4a9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:TemporaryEquitySharesOutstanding" id="fact-identifier-66" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_6cca4dbbcb914a629bc8b98c888345ce" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,352,040</ix:nonfraction></span></ix:nonfraction></span></span>
                    shares at redemption value at December 31, <span style="text-indent: 0pt;">2021</span> and <span style="text-indent: 0pt;">2020</span></div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" id="fact-identifier-67" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3d91cf704ddd4862b4887f7d1f56e0d3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,520,402</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" id="fact-identifier-68" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d9ff28293200479e8fe2ff4822d51c10" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,520,402</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Stockholders’ Deficit</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Preferred stock, $<span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="fact-identifier-69" contextref="c20201231" unitref="U003" decimals="4" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_0fdb93e4e60b459c86df4b67f5831743" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="fact-identifier-70" contextref="c20211231" unitref="U003" decimals="4" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3a3798127f8241c28c1e92ab0c8372ea" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0001</ix:nonfraction></span></ix:nonfraction></span></span> par value; <span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" id="fact-identifier-71" contextref="c20201231" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a81954f403b643428a114b94662f7905" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" id="fact-identifier-72" contextref="c20211231" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_7487fecb0eb34cec8b1072eece27da97" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,000,000</ix:nonfraction></span></ix:nonfraction></span></span> shares authorized; <span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" id="fact-identifier-73" contextref="c20201231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="true" data-original-id="Fact_601f8d3f208549cdb7ce44173fc3b00a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" id="fact-identifier-74" contextref="c20201231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="true" data-original-id="Fact_7baccba65b6348b9970d9bf6a10caf32" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" id="fact-identifier-75" contextref="c20211231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="true" data-original-id="Fact_1dfa8b52e52e460683cb27a01620b9e4" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" id="fact-identifier-76" contextref="c20211231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="true" data-original-id="Fact_f0fc36c8f0954c24bf8402501721704c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">none</ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></span>
                    issued or outstanding</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:PreferredStockValue" id="fact-identifier-77" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_782a700956854ee2a83309f57e5b15d1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:PreferredStockValue" id="fact-identifier-78" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_4158e87dce414010b2a4d173c122783f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Class A common stock, $<span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="fact-identifier-79" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="4" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_2aeacd8731f444169793afa78481ea73" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="fact-identifier-80" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="4" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_61db7ef73ea649f9a0039fe42f9da19c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0001</ix:nonfraction></span></ix:nonfraction></span></span> par
                    value; <span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" id="fact-identifier-81" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f93289aca3604fb4b15ce189cb217b7b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" id="fact-identifier-82" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f3e24fff2aca419bae026aebdd6fda1b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">100,000,000</ix:nonfraction></span></ix:nonfraction></span></span> shares authorized; <span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-83" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_35bc227f838a406295d148d7569f7f14" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-84" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_5e7e3803a9d7411e93549a58db2cc267" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-85" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_506414051fb94169a4c56dacfedbe5b3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-86" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_fac2d68f48a74b60bda48086bc468e83" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">507,041</ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></span> shares issued and outstanding at December 31, <span style="text-indent: 0pt;">2021</span> and <span style="text-indent: 0pt;">2020</span></div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:CommonStockValue" id="fact-identifier-87" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_9ac641710724461f9e26dae9a843fd20" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">51</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:CommonStockValue" id="fact-identifier-88" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a7b7a2f38c1a48938d9f0130026a1ca6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">51</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Class B common stock, $<span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="fact-identifier-89" contextref="c20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="4" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_dd6c265abd9e4e26825ccda1e90cdd64" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="fact-identifier-90" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="4" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a735725e850249c196a4043b71e8a438" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0001</ix:nonfraction></span></ix:nonfraction></span></span> par
                    value; <span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" id="fact-identifier-91" contextref="c20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f04b73fd748d4e37ad82377af1f5035a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" id="fact-identifier-92" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_225eac22e1f542ed8dcdbd47b21c370a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,000,000</ix:nonfraction></span></ix:nonfraction></span></span> shares authorized; <span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-93" contextref="c20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a2a4bf566b8e46ba88b1f37d4c36ea81" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-94" contextref="c20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_0fdbf5a9a76f46ddb26999e0e37f0241" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-95" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_1548c6c367374b2ba606f999f0478ca9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-96" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_fbeaeccf178143478f866cc118395cc5" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,588,010</ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></span> shares issued and outstanding at December 31, <span style="text-indent: 0pt;">2021</span> and <span style="text-indent: 0pt;">2020</span></div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:CommonStockValue" id="fact-identifier-97" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e5767a89740d4885a7ea24a9a2de826b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">259</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:CommonStockValue" id="fact-identifier-98" contextref="c20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f31b1f5fa6ee43ad85d5d4347727d68e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">259</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Additional paid-in capital</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AdditionalPaidInCapital" id="fact-identifier-99" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e957ff4bb78645ec959214be4a7e07f0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">202,500</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:AdditionalPaidInCapital" id="fact-identifier-100" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_4453524b4af84cd1a346708a973ed2e2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">22,500</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Accumulated deficit</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="fact-identifier-101" contextref="c20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_6c6e52cc6ed04d9ca3dcf809590d6913" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,260,680</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="fact-identifier-102" contextref="c20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3957839e29df4944a981f236a96a2475" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,337,642</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Total Stockholders’ Deficit</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-103" contextref="c20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a2e30ca1eced4590b7adf11a66c5a2e0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,057,870</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-104" contextref="c20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f0473f7a1b1643b5a6f128ff15830502" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,314,832</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">TOTAL LIABILITIES, AND STOCKHOLDERS’ DEFICIT</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="fact-identifier-105" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_666ecaec9ca44859ab9fdb23fde4a1b2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">104,427,748</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="fact-identifier-106" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_fed54678050c42988e2e07e643341197" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">105,933,161</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>


</tbody></table>
          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-size: 10pt;">The accompanying notes are an integral part of the financial statements.</div>

          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFPageNumberArea"><span style="font-size: 8pt; font-weight: normal; font-style: normal; font-family: 'Times New Roman';" class="DSPFPageNumber">F-3</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

              </div>

            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="BKMK_76"></a>JIYA ACQUISITION CORP.</div>

          <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="STATEMENTOFOPERATIONS"><!--Anchor--></a>STATEMENTS OF OPERATIONS</div>

          <div><br></div>

          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><a id="BKMK_82"></a><span style="font-family: 'Times New Roman';"></span><br>
          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: middle; text-align: center; font-weight: bold;" rowspan="1" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="2"> For the Period</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: middle; text-align: center; font-weight: bold;" rowspan="1" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="2"> from August 27,</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: middle; text-align: center; font-weight: bold;" rowspan="1" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="2">2020 (Inception)<br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: middle; text-align: center; font-weight: bold;" rowspan="1" colspan="2">Year Ended <br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="2">through<br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: middle; text-align: center; font-weight: bold;" rowspan="1" colspan="2">December 31 <br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="2"> December 31, <br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: middle; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold;" rowspan="1" colspan="2">2021<br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" rowspan="1" colspan="2"> 2020<br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">General and administrative expenses<br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:OperatingExpenses" id="fact-identifier-107" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_8e2c5dbc06bc4887b56b0db619402bfc" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,763,483</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:OperatingExpenses" id="fact-identifier-108" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_0e6b9c1b7fb34037a3b27d9421375721" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">244,346</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Stock-based compensation expense</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ShareBasedCompensation" id="fact-identifier-109" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_6769e0f4e1c64a349d0656919118fb63" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">180,000</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:ShareBasedCompensation" id="fact-identifier-110" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_7a79b3acdcca429f9a9375422e8a2942" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">22,500</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman'; font-weight: bold;">Loss from operations</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:OperatingIncomeLoss" id="fact-identifier-111" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_27ff8e21507442b98bc394c08781467c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,943,483</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:OperatingIncomeLoss" id="fact-identifier-112" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_926d529997534b61b706b94bf0529b91" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">266,846</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: bold; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Other income:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Interest earned on investments held in Trust Account</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:InvestmentIncomeInterest" id="fact-identifier-113" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_b1e27eddba3c4c4584a1a7fc465c9534" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">20,445</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:InvestmentIncomeInterest" id="fact-identifier-114" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_6f5057a327104c2f8a5fe80eac293808" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,108</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Unrealized loss on investments held in Trust Account</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:GainLossOnInvestments" id="fact-identifier-115" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_e0d11adc7e2144c6967e85c2d9f7862a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';"></div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:GainLossOnInvestments" id="fact-identifier-116" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_c264057d83b44f70951db53ba0db5ca4" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">981</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Total other income, net</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: normal;"><span><ix:nonfraction name="us-gaap:OtherNonoperatingIncomeExpense" id="fact-identifier-117" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_11e4e8aa9be947ccbbe7bb4bf5255bd9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">20,445</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; font-weight: normal; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:OtherNonoperatingIncomeExpense" id="fact-identifier-118" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_cc74e85d6cd14140a441165e314ea7d0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,127</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Net loss</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-weight: bold;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-119" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a77b1eb4a7bd40d98cf5bbcbd2b2780a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,923,038</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-weight: bold; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-120" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_2b85b7235b184dbd9e5fbbdb0c67de6e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">264,719</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-weight: bold; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Basic and diluted weighted average shares outstanding, Class A common stock</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="fact-identifier-121" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_417b78a0c4bb4fc39445a900500fd735" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="fact-identifier-122" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_0f061ac964a1404d86009d699ef30f37" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,859,081</ix:nonfraction></span></ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="fact-identifier-123" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_ac11a2843d1a44edb5c8d6b2f4076070" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="fact-identifier-124" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_173f5d4a074a4485b4de79471e330560" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,398,183</ix:nonfraction></span></ix:nonfraction></span><br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Basic and diluted net loss per share, Class A common stock</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:EarningsPerShareDiluted" id="fact-identifier-125" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_30296069c111438ebfac3974c6255d95" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:EarningsPerShareBasic" id="fact-identifier-126" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_9954e3a0329b4dbbb48f2d6a5246ffaa" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.14</ix:nonfraction></span></ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-weight: bold; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:EarningsPerShareDiluted" id="fact-identifier-127" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_6226262747e4449b974813a656f7fa5e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:EarningsPerShareBasic" id="fact-identifier-128" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_09561e4fd232482e89304b7835ad8a1b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.04</ix:nonfraction></span></ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-weight: bold; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Basic and diluted weighted average shares outstanding, Class B common stock</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="fact-identifier-129" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_bf0ba0cd0f444796a68e49104bf74d2f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="fact-identifier-130" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_88e4a838cdc84e8e905acc5736aac02b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,588,010</ix:nonfraction></span></ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="fact-identifier-131" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f6f2bdaaccfa41209cca6e0e00a0fccc" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="fact-identifier-132" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_520f5f00f7134898bafd40578fbc673f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,684,176</ix:nonfraction></span></ix:nonfraction></span><br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Basic and diluted net loss per share, Class B common stock</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-weight: bold;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:EarningsPerShareDiluted" id="fact-identifier-133" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_b19f89213d894bb6af583b15006d6161" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:EarningsPerShareBasic" id="fact-identifier-134" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_713857c54e5c443f9233db74d2d2f989" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.14</ix:nonfraction></span></ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-weight: bold; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:EarningsPerShareDiluted" id="fact-identifier-135" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_0ba8164f10744db998355c9f2f178d8e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:EarningsPerShareBasic" id="fact-identifier-136" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_0ea0f32b36f54d2cacfb68283f521c7a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.04</ix:nonfraction></span></ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-weight: bold; white-space: nowrap;" colspan="1">)</td>

  </tr>


</tbody></table>
          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-size: 10pt;">The accompanying notes are an integral part of the financial statements.</div>

          <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFPageNumberArea"><span style="font-size: 8pt; font-weight: normal; font-style: normal; font-family: 'Times New Roman';" class="DSPFPageNumber">F-4</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

              </div>

            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <div style="text-align: center; margin-right: 0.6pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="BKMK_77"></a>JIYA ACQUISITION CORP.</div>

          <div style="text-align: center; margin-right: 0.6pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="STATEMENTOFCHANGESINSTOCK"><!--Anchor--></a>STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT</div>

          <div><br></div>

          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Class A</div>
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Common Stock</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Class B</div>
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Common Stock</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Additional</div>
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Paid-in</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Accumulated</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Total</div>
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Stockholders’</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Shares</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Amount</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Shares</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Amount</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Capital</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Deficit</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Deficit</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Balance – August 27, 2020 (Inception)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:SharesOutstanding" id="fact-identifier-137" contextref="c20200826_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="INF" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_df31bc1405684c78b002f56b8f95fbef" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-138" contextref="c20200826_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_edb42075b06c4489bf7070ad9ab171aa" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:SharesOutstanding" id="fact-identifier-139" contextref="c20200826_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="INF" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_b32159df67714a00b58a41f68c3c0c8e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-140" contextref="c20200826_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_cf38b6db24b24800b024c8c03c7d8a70" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-141" contextref="c20200826_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_665be30f09c849cf926fd00fb3a5a878" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-142" contextref="c20200826_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_2c3a901e554a41118cb107a80ba0bfd0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-143" contextref="c20200826" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_e431aabd46c546e29d9d5f9aac7aa4d5" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 16%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Issuance of Class B common stock</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-144" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="INF" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_96a2dbeef9ee4382825fd3c89ca1cb80" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" id="fact-identifier-145" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_bf9892ed78c9464d991b57581316badc" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-146" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e41a099639c14621a4c59c9386e7012f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875,000</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" id="fact-identifier-147" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_623ab0099294497583d6caad7f3bf911" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">287</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" id="fact-identifier-148" contextref="c20200827to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_b05fb239cb334dd18848b740a42bcaca" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">24,713</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" id="fact-identifier-149" contextref="c20200827to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_01e671c7fa9541a0a613c190636a59c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span><br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" id="fact-identifier-150" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_ba9f19b74b964cdab87299dd042de17e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">25,000</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 16%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Sale of <span style="text-indent: 0pt;"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fact-identifier-151" contextref="c20200827to20201231_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_429d597c60364e0fb64263b97670eb77" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">507,041</ix:nonfraction></span></span> Private Placement Shares</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:SaleOfSharesToSponsorInPrivatePlacementShares" id="fact-identifier-152" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_83121ba3f14249699286edce3e70defb" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">507,041</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:SaleOfSharesToPrivatePlacementValue" id="fact-identifier-153" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3ce55db057124bc7a5f5d7ada31c6860" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">51</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:SaleOfSharesToSponsorInPrivatePlacementShares" id="fact-identifier-154" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="INF" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_2b0736ba5c31437f9edbb7a2dab3bf38" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:SaleOfSharesToPrivatePlacementValue" id="fact-identifier-155" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_6ee421e1d0724ec68d805a36dd9c3ee0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:SaleOfSharesToPrivatePlacementValue" id="fact-identifier-156" contextref="c20200827to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d654bbe4a5d049269446ec31fae627d8" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">5,070,359</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><span><ix:nonfraction name="jyac:SaleOfSharesToPrivatePlacementValue" id="fact-identifier-157" contextref="c20200827to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_e0886da45071477c91192d8999b7868c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span><br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:SaleOfSharesToPrivatePlacementValue" id="fact-identifier-158" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_6b656aa9bd2a47c7aa8722147aba192d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">5,070,410</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 16%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Forfeiture of Founder Shares</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" id="fact-identifier-159" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="INF" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_ede0e8f3a9ae4001a6d762d2aa53a627" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" id="fact-identifier-160" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_a32d9fc57c3a448f9161bec2f6e42ffa" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" id="fact-identifier-161" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_60c829d6e9a44038a8cbc4d7e0cd411f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">286,990</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">(<span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" id="fact-identifier-162" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_fc03a8e7548f4223ba8dd2d261c95e11" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">28</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" id="fact-identifier-163" contextref="c20200827to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_9935437093bb4b6f9b2eadddefe2871a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">28</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" id="fact-identifier-164" contextref="c20200827to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_728ee5d25d1647c599d119ba9982d475" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span><br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" id="fact-identifier-165" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_0e7fcb63315e41a29966ac219b28ff55" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 16%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Accretion for Class A common stock to redemption amount<br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">—</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:RedeemableOrdinarySharesAccretionToRedemptionValue" id="fact-identifier-166" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_b2c163ee1cd649d0851272393569f85a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">—<br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:RedeemableOrdinarySharesAccretionToRedemptionValue" id="fact-identifier-167" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_0eb90f5a12294172a1b92c8b71980bb3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="jyac:RedeemableOrdinarySharesAccretionToRedemptionValue" id="fact-identifier-168" contextref="c20200827to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d0950633bb014cd490d3be0f8932577c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">5,095,100</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="jyac:RedeemableOrdinarySharesAccretionToRedemptionValue" id="fact-identifier-169" contextref="c20200827to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e3555f7c15c5475b8a8bc3ac4e36ff80" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">1,072,923</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="jyac:RedeemableOrdinarySharesAccretionToRedemptionValue" id="fact-identifier-170" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d3f01c01407a4c719f994ba80ef4949f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">6,168,023</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 16%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Stock Compensation Expense<br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">—</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-171" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_62d21bed103747c79ac8bcc02792fec7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">—<br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-172" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_6e7d804b11ff43279a3a61ceb24b951e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-173" contextref="c20200827to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_fa8010ceadfa415190ad21683ad9ea16" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">22,500</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-174" contextref="c20200827to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_59edbc9896634eb78d4734f7553f0ee4" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-175" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_82f32be55388469b82e300c06f695466" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">22,500</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 16%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Net loss</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">—</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-176" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_f49bb74a44da45fc97c15c1ed65a9e0b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">—<br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-177" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_d78b5bddf2db4bb8b4f091e5babccae8" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1"><span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-178" contextref="c20200827to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_c05ac3cef4394f5e8718ab49610c23f6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span><br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-179" contextref="c20200827to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_c2f0269f238c4e15aaadd86717ff058f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">264,719</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-180" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_ca954c460c2447969690e30647e4c704" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">264,719</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Balance – <span style="text-indent: 0pt;">December 31, 2020</span></div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:SharesOutstanding" id="fact-identifier-181" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_c11ca11b413d42a482fb118962fc7187" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">507,041</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-182" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f293c7c32beb434daafef779a62a4887" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">51</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:SharesOutstanding" id="fact-identifier-183" contextref="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_ef4f9b38e63e437caa9f1ca498f2d6a2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,588,010</ix:nonfraction></span><br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-184" contextref="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_eeeed4d4c2534b498a1b0a9e5b6df5a1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">259</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-185" contextref="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d39c85be834e4cbea20ea7e38396f060" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">22,500</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-186" contextref="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_07000821e801408fa88d2fb8c7d8ee07" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,337,642</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-187" contextref="c20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_b55d5cbd1b01436c8e7d09c4a4e79091" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,314,832</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 16%; background-color: #CCEEFF;" rowspan="1">
                  <div style="margin-left: 9pt;">Stock Compensation Expense</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">—<br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-188" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_99de39f3704e447783e903027dc9ffef" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span><br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">—<br>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-189" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_610d2c5f6c794323974bc95aa16a23ad" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-190" contextref="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_eb073bf625e24b79bd6ec57ac6911c47" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">180,000</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-191" contextref="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_4f1322e158434945bd4c78aa37138139" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="fact-identifier-192" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_98767f1ff3014753b88912f26c153df5" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">180,000</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 16%;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" rowspan="1">Net loss<br>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">—</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-193" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_ce7585ae077a44658874fac8eb1cb426" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">—</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-194" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_02bff86e647447dfbe7877be0a854b51" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-195" contextref="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_26e37a8eb10243a88541ca7f644c539b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-196" contextref="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a79c03417d064d5b9b51d5e087cdd87b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,923,038</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-197" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_4432e6c881e44a32ac8149bc73b9c6f1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,923,038</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; width: 16%; padding-bottom: 4px;" rowspan="1">
                  <div>Balance - December 31, 2021</div>
                </td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:SharesOutstanding" id="fact-identifier-198" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_026311367a1d4cf3aebc5aff1e6be4a4" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">507,041</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-199" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_65fed6c5d25c40c8a1d0bf343346e088" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">51</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:SharesOutstanding" id="fact-identifier-200" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_728de45a92cd458383ee16a8cbde8c33" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,588,010</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-201" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_7bde7b4a118f45cb80f2654ee1eff9ab" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">259</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1"><span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-202" contextref="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_65e6b3199f2349e0a70b1b312fd3a33d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">202,500</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">(<span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-203" contextref="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_dcf693d00d324bf78ba7f31b622a9f29" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,260,680</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">(<span><ix:nonfraction name="us-gaap:StockholdersEquity" id="fact-identifier-204" contextref="c20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_49bd2f42cb3e4f0fb10c94089dd4f926" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,057,870</ix:nonfraction></span></td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>


</tbody></table>
          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-style: italic; font-size: 10pt;">The accompanying notes are an integral part of the financial statements.</div>

          <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFPageNumberArea"><span style="font-size: 8pt; font-weight: normal; font-style: normal; font-family: 'Times New Roman';" class="DSPFPageNumber">F-5</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

              </div>

            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <div style="text-align: center; margin-right: 0.6pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="BKMK_78"></a>JIYA ACQUISITION CORP.</div>

          <div style="text-align: center; margin-right: 0.6pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="STATEMENTOFCASHFLOWS"><!--Anchor--></a>STATEMENTS OF CASH FLOWS</div>

          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><a id="BKMK_84"></a><span style="font-family: 'Times New Roman';"></span><br>
          </div>

          <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tbody><tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;"> For the <br>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;">Period from </td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;"> August 27,</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;">2020 (Inception)<br>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center;"> Year Ended </td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="text-align: center; vertical-align: middle; font-weight: bold; white-space: nowrap;">Through <br>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px;"> December 31,<br>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="text-align: center; vertical-align: middle; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;"> December 31,</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: middle; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;"> 2021</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="text-align: center; vertical-align: middle; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;"> 2020</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Cash Flows from Operating Activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Net loss</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-205" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_ad85eab1260944a88cdd197fc183e8f4" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,923,038</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">(<span><ix:nonfraction name="us-gaap:NetIncomeLoss" id="fact-identifier-206" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_c65e350a0e764217afd6a412a9b7bc19" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">264,719</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="font-family: 'Times New Roman';">Adjustments to reconcile net loss net cash used in operating activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Stock-based compensation expense</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ShareBasedCompensation" id="fact-identifier-207" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_7667c2574ee84b54b4b5ff436aeb13df" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">180,000</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:ShareBasedCompensation" id="fact-identifier-208" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_dbdec22a8ecb40bf9aea031f58ad38e8" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">22,500</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Interest earned on investments held in Trust Account</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:InvestmentIncomeInterest" id="fact-identifier-209" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3ed801d90db64dbfa07465cf7ad6b608" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">20,445</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<span><ix:nonfraction name="us-gaap:InvestmentIncomeInterest" id="fact-identifier-210" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_53df5877481a4332b0fc471b01387fb8" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,108</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Unrealized loss on investment held in Trust Account</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:GainLossOnInvestments" id="fact-identifier-211" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_c2f0823479c54774a5cb416a71045bbc" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:GainLossOnInvestments" id="fact-identifier-212" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_fbce2023690c4b9abea20f6d370ae246" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">981</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Changes in operating assets and liabilities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Prepaid expenses</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" id="fact-identifier-213" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_7af804bbe1f64672859f7664967c7529" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">264,299</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">(<span><ix:nonfraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" id="fact-identifier-214" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_20aa77acbd45474c8296c4a16c627dc6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">521,067</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Accounts payable and accrued expenses</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" id="fact-identifier-215" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_b248c0e8a7994ff69efb389802bad57a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">291,110</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" id="fact-identifier-216" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_96a78898c9fa48658fca69d75f4f4786" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">50,892</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 34.2pt; font-family: 'Times New Roman'; font-weight: bold;">Net cash used in operating activities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="fact-identifier-217" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_1aba2c9d9b964c7ea63e76b895de905a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,208,074</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">(<span><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="fact-identifier-218" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_c316b6a144f74497afe486801f25eb1a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">714,521</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Cash Flows from Investing Activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Investment of cash into trust Account</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:PaymentsToAcquireMarketableSecurities" id="fact-identifier-219" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_c7e77c499d4c4aa9a78a56a80d264509" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">(<span><ix:nonfraction name="us-gaap:PaymentsToAcquireMarketableSecurities" id="fact-identifier-220" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_84163c6b470f4db29024cc4ca55f7882" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,520,402</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 34.2pt; font-family: 'Times New Roman'; font-weight: bold;">Net cash used in investing activities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="fact-identifier-221" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_5f3f32a132324710bac4b54e49910775" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">(<span><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="fact-identifier-222" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_4b1d82af752c4944a4c4113201968662" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,520,402</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Cash Flows from Financing Activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Proceeds from issuance of Class B common stock to Sponsor</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="fact-identifier-223" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_ce33804e37824edca12ee3558c37b7a1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="fact-identifier-224" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_5baefc6e09ab4b189da5b65d782042e9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">25,000</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Proceeds from sale of Units, net of underwriting discounts paid</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" id="fact-identifier-225" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_706389b04a8844a68834201fa124b05a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" id="fact-identifier-226" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d587800f6a1b40228a6fdd599ff330e1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">101,449,992</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Proceeds from sale of Private Placement Units</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" id="fact-identifier-227" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_e0c7e3abd46043d6a6e2a0817f46cb05" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" id="fact-identifier-228" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_063fb0a247854f23985a809d37eeedb7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">5,070,410</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Funds sent to SPAC instead of Sponsor</div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><span><ix:nonfraction name="jyac:FundsSentToSPACInsteadOfSponsor" id="fact-identifier-229" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_485da34b86c542a3b1c1371d17dd3c7f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">174</ix:nonfraction></span><br>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><span><ix:nonfraction name="jyac:FundsSentToSPACInsteadOfSponsor" id="fact-identifier-230" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_bf61ff747dac43c4a24ac96335e534f9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,305</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Repayment of Funds to Sponsor</div>
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="jyac:RepaymentOfFundsToSponsor" id="fact-identifier-231" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_df99eb2deffd4f16892b5e1533b69fc4" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,479</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><span><ix:nonfraction name="jyac:RepaymentOfFundsToSponsor" id="fact-identifier-232" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_ece7ce1f04f84c8aa0258123f0d2456d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Proceeds from promissory note – related party</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ProceedsFromRelatedPartyDebt" id="fact-identifier-233" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_bde022ea2f564514b546f91fa185f51a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:ProceedsFromRelatedPartyDebt" id="fact-identifier-234" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3f1dded827384139917faf0b55bdb722" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">175,348</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Repayment of promissory note – related party</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:RepaymentsOfRelatedPartyDebt" id="fact-identifier-235" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_8925ebd2396a42d8963be302e55513f3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">348</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<span><ix:nonfraction name="us-gaap:RepaymentsOfRelatedPartyDebt" id="fact-identifier-236" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f538d2374dae4ec28ff53e9363052b09" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">175,000</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Payment of offering costs</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:PaymentsOfStockIssuanceCosts" id="fact-identifier-237" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_220d427597ce4dd6890fd7f3f8e8d78a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">50,832</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">(<span><ix:nonfraction name="us-gaap:PaymentsOfStockIssuanceCosts" id="fact-identifier-238" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_eafd86d8566c415596fac44efbc3f074" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">423,567</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -7.2pt; margin-left: 43.2pt; font-family: 'Times New Roman'; font-weight: bold;">Net cash (used in) provided by financing activities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="fact-identifier-239" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_8eb9c979dba249918dae4f48f36dbff2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">53,485</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="fact-identifier-240" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a9f1e342619f48a8af8bcf5248fe3be1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">106,124,488</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Net Change in Cash</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">(<span><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="fact-identifier-241" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e4337884753e403bbb14f54ca6da7ee0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,261,559</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="fact-identifier-242" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_684b3aecd32f4978beef647e02a3962b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,889,565</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Cash – Beginning of period</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="fact-identifier-243" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_18842607cba84ccdab10b24f05d265ce" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,889,565</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"><span><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="fact-identifier-244" contextref="c20200826" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_91a1d66986f54686ae0400b6d2ec8902" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Cash – End of period</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="fact-identifier-245" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3c21e10c389d41399c33d47e5080d85b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">628,006</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="fact-identifier-246" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_6acf1752b1c74f23963376985e6dd475" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,889,565</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">Non-Cash investing and financing activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">Offering costs included in accrued offering costs</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><span><ix:nonfraction name="jyac:OfferingCostsIncludedInAccruedOfferingCosts" id="fact-identifier-247" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_924758c0e0ef44fbaa9e48a1bff684f7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><span><ix:nonfraction name="jyac:OfferingCostsIncludedInAccruedOfferingCosts" id="fact-identifier-248" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_edddcd304a4c4f54a4a7ef34ae98aad1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">50,832</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Initial classification of Class A common stock subject to possible redemption</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:InitialClassificationOfCommonStockSubjectToRedemption" id="fact-identifier-249" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_94ac64825cff4f5889afc4016aa5b742" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><span><ix:nonfraction name="jyac:InitialClassificationOfCommonStockSubjectToRedemption" id="fact-identifier-250" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_67b2fd043f894ec3bf403d7f397571a3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">103,520,402</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Deferred underwriting fee payable</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:DeferredUnderwritingFeeChargedToAdditionalPaidInCapital" id="fact-identifier-251" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_6814291a512446ff94d13b567a3b91d2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><span><ix:nonfraction name="jyac:DeferredUnderwritingFeeChargedToAdditionalPaidInCapital" id="fact-identifier-252" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a19e226453ef466780f6e5c487a5e9fd" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">3,623,214</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Forfeiture of Founder Shares<br>
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:ForfeitureOfFounderShares" id="fact-identifier-253" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_36bc79b52f9440359f5df93a127e4560" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">(<span><ix:nonfraction name="jyac:ForfeitureOfFounderShares" id="fact-identifier-254" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_800a1292e4e9480cbdf0b5cd2828c7e7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">28</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">)</td>

  </tr>


</tbody></table>
          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-style: italic; font-size: 10pt;">The accompanying notes are an integral part of the financial statements.</div>

          <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFPageNumberArea"><span style="font-size: 8pt; font-weight: normal; font-style: normal; font-family: 'Times New Roman';" class="DSPFPageNumber">F-6</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

              </div>

            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="BKMK_79"></a></div>

          <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
            <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.<a id="BKMK_85"></a></div>

            <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"><a id="NOTESTOFINANCIALSTATEMENT"></a>NOTES TO FINANCIAL STATEMENTS</div>

            <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

          </div>

          <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;"> <br>
          </div>


          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="fact-identifier-255" contextref="c20210101to20211231" escape="true" continuedat="Text_6bd90ace863a4195b4a35c959da8e6591" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_8489738fd5fc4557b2ce6fde58712259" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTE 1 — ORGANIZATION AND PLAN OF BUSINESS OPERATIONS</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e6591" continuedat="Text_6bd90ace863a4195b4a35c959da8e6592" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e6592" continuedat="Text_6bd90ace863a4195b4a35c959da8e6593" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Jiya Acquisition Corp. (formerly known as SMSR Holding Co.) (the “Company”) was incorporated in Delaware on August 27, 2020. The Company is a
            blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (the
            “Business Combination”).</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e6593" continuedat="Text_6bd90ace863a4195b4a35c959da8e6594" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e6594" continuedat="Text_6bd90ace863a4195b4a35c959da8e6595" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage
            and emerging growth companies.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e6595" continuedat="Text_6bd90ace863a4195b4a35c959da8e6596" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e6596" continuedat="Text_6bd90ace863a4195b4a35c959da8e6597" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">As of December 31, 2021, the Company had not commenced any operations. All activity through December 31, 2021 relates to the Company’s
            formation, initial public offering (the “Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating
            revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income on cash and cash equivalents in the form of interest income from the proceeds derived from the Initial Public
            Offering.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e6597" continuedat="Text_6bd90ace863a4195b4a35c959da8e6598" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e6598" continuedat="Text_6bd90ace863a4195b4a35c959da8e6599" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The registration statement for the Company’s Initial Public Offering became effective on November 18, 2020. On November 23, 2020, the Company
            consummated the Initial Public Offering of <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fact-identifier-264" contextref="c20201123to20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_04757eb4992f4f208e4700b6c1a417fe" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,000,000</ix:nonfraction></span> shares of Class A common stock (the “Public Shares”), at $<span><ix:nonfraction name="us-gaap:SharesIssuedPricePerShare" id="fact-identifier-265" contextref="c20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_4c07ca09c6374962a1f7821bd6cad9a6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span> per Public Share, generating gross proceeds of $<span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" id="fact-identifier-266" contextref="c20201123to20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_5b11d3a2969b45c9a7d5a57d6f3ebd9a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">100,000,000</ix:nonfraction></span>
            which is described in Note 3.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e6599" continuedat="Text_6bd90ace863a4195b4a35c959da8e65910" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65910" continuedat="Text_6bd90ace863a4195b4a35c959da8e65911" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fact-identifier-269" contextref="c20201123to20201123_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_aad328a049b242e881e03842403a0878" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">500,000</ix:nonfraction></span> shares (the “Private Placement Shares”) at a price of $<span><ix:nonfraction name="us-gaap:SharesIssuedPricePerShare" id="fact-identifier-270" contextref="c20201123_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_44505571909c4c4ebe5499f056b99926" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span>
            per Private Placement Share in a private placement to Jiya Holding Company LLC (the “Sponsor”), generating gross proceeds of $<span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" id="fact-identifier-271" contextref="c20201123to20201123_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_a95ad22394fa4a8093d6136c429eae43" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">5,000,000</ix:nonfraction></span>,
            which is described in Note 4.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65911" continuedat="Text_6bd90ace863a4195b4a35c959da8e65912" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65912" continuedat="Text_6bd90ace863a4195b4a35c959da8e65913" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Following the closing of the Initial Public Offering on November 23, 2020, an amount of $<span><ix:nonfraction name="us-gaap:PaymentsToAcquireMarketableSecurities" id="fact-identifier-274" contextref="c20201123to20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_6a33b695edde4760946753dc99bb11e4" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">100,000,000</ix:nonfraction></span> ($<span><ix:nonfraction name="jyac:CashDepositedInTrustAccountPerUnit" id="fact-identifier-275" contextref="c20201123to20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_6703af9b60dc47ffadfaa51f0d95328a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">10.00</ix:nonfraction></span> per Public Share) from the net proceeds of the sale of
            the Public Shares in the Initial Public Offering and the sale of the Private Placement Shares was placed in a trust account (the “Trust Account”), located in the United States and invested only in U.S. government securities, within the meaning
            set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by
            the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account, as
            described below.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65913" continuedat="Text_6bd90ace863a4195b4a35c959da8e65914" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65914" continuedat="Text_6bd90ace863a4195b4a35c959da8e65915" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">On December 10, 2020, the Company consummated the sale of an additional <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fact-identifier-278" contextref="c20201210to20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_ad52dabee8a1466bba241b568915de33" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">352,040</ix:nonfraction></span> Shares, at $<span><ix:nonfraction name="us-gaap:SharesIssuedPricePerShare" id="fact-identifier-279" contextref="c20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_7821d1b5e76a468ab506d43fb9796b54" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span> per Share, and the sale of an additional <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fact-identifier-280" contextref="c20201210to20201210_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_615c74ea0f7c462a802cd1494eaf8490" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">7,041</ix:nonfraction></span> Private Placement Shares, at $<span><ix:nonfraction name="us-gaap:SharesIssuedPricePerShare" id="fact-identifier-281" contextref="c20201210_ClassOfWarrantOrRightAxis_PrivatePlacementUnitsMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_2565a30edc0941dbbaafffeafabad14c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span>
            per Private Placement Share, generating total gross proceeds of $<span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="fact-identifier-282" contextref="c20201210to20201210" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_81152156a41f406881afe869c5bdef69" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,590,810</ix:nonfraction></span>. A total of $<span><ix:nonfraction name="us-gaap:PaymentsToAcquireMarketableSecurities" id="fact-identifier-283" contextref="c20201210to20201210" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_a3be7c36e3884550bf8dacc044c69463" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,520,402</ix:nonfraction></span> of the net proceeds was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $<span><ix:nonfraction name="us-gaap:AssetsHeldInTrustNoncurrent" id="fact-identifier-284" contextref="c20201210" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_934ab704cae1474c87295685052ef3ed" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,520,402</ix:nonfraction></span>.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65915" continuedat="Text_6bd90ace863a4195b4a35c959da8e65916" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.6pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65916" continuedat="Text_6bd90ace863a4195b4a35c959da8e65917" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Transaction costs amounted to $<span><ix:nonfraction name="us-gaap:DeferredOfferingCosts" id="fact-identifier-287" contextref="c20201123" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_7bbc6e933e884ba89719d3df91fa49ec" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">6,168,021</ix:nonfraction></span>,
            consisting of $<span><ix:nonfraction name="us-gaap:PaymentsForUnderwritingExpense" id="fact-identifier-288" contextref="c20201123to20201123" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_b26e96fc2a1f4f47aa948bcc1da4715d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,070,408</ix:nonfraction></span> of underwriting fees, $<span><ix:nonfraction name="jyac:UnderwritingFeesDeferred" id="fact-identifier-289" contextref="c20201123" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_84bd440ce5744169893c0cf2184ad37f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">3,623,214</ix:nonfraction></span> of deferred underwriting fees and $<span><ix:nonfraction name="jyac:OtherOfferingCosts" id="fact-identifier-290" contextref="c20201123" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_f8de3b4db3354440a944a60daebe869f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">474,399</ix:nonfraction></span> of other offering
            costs.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65917" continuedat="Text_6bd90ace863a4195b4a35c959da8e65918" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65918" continuedat="Text_6bd90ace863a4195b4a35c959da8e65919" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and
            the sale of the Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business
            Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least <span><ix:nonfraction name="jyac:FairMarketValueOfBusinessCombinationMinimumPercentageOfTrustAccountValue" id="fact-identifier-293" contextref="c20210101to20211231" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_a3ae0119aabf4575945850eb00feb9b3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">80</ix:nonfraction></span>% of
            the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only
            complete a Business Combination if the post-transaction company owns or acquires <span><ix:nonfraction name="jyac:MinimumRequiredPostTransactionOwnershipPercentageOfAcquiredBusiness" id="fact-identifier-294" contextref="c20210101to20211231" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_f80628d15cc24a73887df2240460c91c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">50</ix:nonfraction></span>% or more of the outstanding voting securities of
            the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65919" continuedat="Text_6bd90ace863a4195b4a35c959da8e65920" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65920" continuedat="Text_6bd90ace863a4195b4a35c959da8e65921" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a
            portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the
            Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of
            the amount then in the Trust Account (initially $<span><ix:nonfraction name="jyac:RedemptionPricePerShare" id="fact-identifier-297" contextref="c20211231" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_b17ff0501be942b0a528668ff870007f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">10.00</ix:nonfraction></span> per Public Share, plus any pro rata interest earned on the funds held in the
            Trust Account and not previously released to the Company to pay its tax obligations).</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65921" continuedat="Text_6bd90ace863a4195b4a35c959da8e65922" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div><br></div>
</ix:continuation></span>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">F-7</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                    </a></span></div>

                <div>
                  <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                    <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                  </div>

                  <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

              </div>

            </div>

          </div>

          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65922" continuedat="Text_6bd90ace863a4195b4a35c959da8e65923" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company will proceed with a Business Combination if the Company has net tangible assets of at least $<span><ix:nonfraction name="jyac:NetTangibleAssetsThresholdValueForRedeemingPublicShares" id="fact-identifier-300" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_68224d9f27944e10bcd88343c8c33287" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">5,000,001</ix:nonfraction></span> immediately prior to or upon consummation of the Business Combination and, solely if the Company seeks stockholder approval, a majority of
            the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its
            Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer
            documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company
            decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks
            stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), Private Placement Shares and any Public Shares purchased during or after the Initial Public Offering (a)
            in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination.
            Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all and whether or not they are a holder of record on the record date to
            be established by the Company to determine who can vote on the proposed Business Combination.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65923" continuedat="Text_6bd90ace863a4195b4a35c959da8e65924" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65924" continuedat="Text_6bd90ace863a4195b4a35c959da8e65925" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to
            the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a
            “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of <span><ix:nonfraction name="jyac:PercentageOfPublicSharesThatCanBeRedeemedWithoutPriorConsent" id="fact-identifier-303" contextref="c20210101to20211231" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_dc8aa871a1de437eb799426fccf67079" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">15</ix:nonfraction></span>% or more of the Public Shares, without the prior consent of the Company.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65925" continuedat="Text_6bd90ace863a4195b4a35c959da8e65926" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65926" continuedat="Text_6bd90ace863a4195b4a35c959da8e65927" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares, Private Placement Shares and Public Shares held by
            it in connection with the completion of a Business Combination, (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the
            Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem <span><ix:nonfraction name="jyac:PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod" id="fact-identifier-306" contextref="c20210101to20211231" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_2a72ddd870ed4476b479d85ff07d52c9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">100</ix:nonfraction></span>% of
            its Public Shares if the Company does not complete a Business Combination within the time period required by its Amended and Restated Certificate of Incorporation, unless the Company provides the public stockholders with the opportunity to
            redeem their Public Shares in conjunction with any such amendment and (c) waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period (defined below).</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65927" continuedat="Text_6bd90ace863a4195b4a35c959da8e65928" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65928" continuedat="Text_6bd90ace863a4195b4a35c959da8e65929" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company will have until November 23, 2022 to complete a Business Combination (the “Combination Period”). If the Company is unable to
            complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:Fact_347ad5ef7ca34f2393a389714c1eaab8"><span><ix:nonnumeric name="jyac:PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod" id="fact-identifier-309" contextref="c20210101to20211231" isadditionalitemsonly="true" ishiddenelement="true" inside-table="false" data-original-id="Fact_347ad5ef7ca34f2393a389714c1eaab8" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isstandardonly="false" iscustomonly="true">ten</ix:nonnumeric></span></span> business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
            interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $<span><ix:nonfraction name="jyac:InterestOnTrustAccountToBeHeldToPayDissolutionExpenses" id="fact-identifier-310" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_8b6ff11002c94d3da3f72bad0d7eca1f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">100,000</ix:nonfraction></span>
            of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating
            distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s Board of Directors, dissolve and
            liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65929" continuedat="Text_6bd90ace863a4195b4a35c959da8e65930" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65930" continuedat="Text_6bd90ace863a4195b4a35c959da8e65931" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Sponsor has agreed to waive its liquidation rights with respect to the Private Placement Shares if the Company fails to complete a Business
            Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to
            complete a Business Combination within the Combination Period. The underwriters will agree to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a
            Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution,
            it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Public Share ($<span><ix:nonfraction name="jyac:CashDepositedInTrustAccountPerUnit" id="fact-identifier-313" contextref="c20201123to20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_67af491f3d934b0487493e88b42c71b0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">10.00</ix:nonfraction></span>).</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65931" continuedat="Text_6bd90ace863a4195b4a35c959da8e65932" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div><br></div>
</ix:continuation></span>
          <div style="text-align: justify; font-family: 'Times New Roman';">
            <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65932" continuedat="Text_6bd90ace863a4195b4a35c959da8e65933" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
              by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the
              lesser of (i) $<span><ix:nonfraction name="jyac:CashDepositedInTrustAccountPerUnit" id="fact-identifier-316" contextref="c20201123to20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_8a5702f5aa4042588b249a0774d393c9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">10.00</ix:nonfraction></span> per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the
              liquidation of the Trust Account, if less than $<span><ix:nonfraction name="jyac:CashDepositedInTrustAccountPerUnit" id="fact-identifier-317" contextref="c20201123to20201123_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_b3a0e704e1b949a88155fa086a601d5a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">10.00</ix:nonfraction></span> per Public Share due to reductions in the value of the trust assets, less
              taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is
              enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
              Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the
              possibility that Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute
              agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account, except for the Company’s auditors.</div>
</ix:continuation></span>
            <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65933" continuedat="Text_6bd90ace863a4195b4a35c959da8e65934" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;"> <br>
            </div>
</ix:continuation></span>
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">F-8</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                    </a></span></div>

                <div>
                  <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                    <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                  </div>

                  <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

              </div>

            </div>

          </div>

          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65934" continuedat="Text_6bd90ace863a4195b4a35c959da8e65935" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; font-family: 'Times New Roman'; font-style: italic;">Liquidity and Going Concern</span><br>
          </div>
</ix:continuation></span>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65935" continuedat="Text_6bd90ace863a4195b4a35c959da8e65936" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div><span style="font-weight: bold;"> </span><br></div>
</ix:continuation></span>
            <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65936" continuedat="Text_6bd90ace863a4195b4a35c959da8e65937" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders prior to the Initial Public Offering and such amount of proceeds from the Initial Public
              Offering that were placed in an account outside of the Trust Account for working capital purposes. At December 31, 2021, the Company had cash outside the trust of $<span><ix:nonfraction name="us-gaap:Cash" id="fact-identifier-322" contextref="c20211231_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_54292486a03842c7b09652bf944df107" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">628,006</ix:nonfraction></span> and working capital of $<span><ix:nonfraction name="jyac:WorkingCapital" id="fact-identifier-323" contextref="c20211231_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_42c703f03f6a4d40828afce1330e23af" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">565,344</ix:nonfraction></span>. The Company has incurred and
              expects to continue to incur significant costs in pursuit of its financing and acquisition plans.</div>
</ix:continuation></span>
            <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65937" continuedat="Text_6bd90ace863a4195b4a35c959da8e65938" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br>
              </span></div>
</ix:continuation></span>
            <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65938" continuedat="Text_6bd90ace863a4195b4a35c959da8e65939" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target
              businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.</div>
</ix:continuation></span>
            <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65939" continuedat="Text_6bd90ace863a4195b4a35c959da8e65940" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">&nbsp;</div>
</ix:continuation></span>
            <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65940" continuedat="Text_6bd90ace863a4195b4a35c959da8e65941" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></span>
            <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65941" continuedat="Text_6bd90ace863a4195b4a35c959da8e65942" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The Company will need to raise further additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not
              obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain
              additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the
              pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. <br>
            </div>
</ix:continuation></span>
            <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65942" continuedat="Text_6bd90ace863a4195b4a35c959da8e65943" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"> <br>
            </div>
</ix:continuation></span>
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">
              <div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">
                  <div>
                    <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65943" continuedat="Text_6bd90ace863a4195b4a35c959da8e65944" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting
                      Standards Board’s Accounting Standards Codification Topic 205-40, “Presentation of Financial Statements – Going Concern,” the Company has until November 23, 2022, to consummate an initial business combination. It is uncertain that the
                      Company will be able to consummate an initial business combination by this time. If an initial business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company.
                      Additionally, the Company may not have sufficient liquidity to fund the working capital needs of the Company through one year from the issuance of these financial statements. Management has determined that the liquidity condition and
                      mandatory liquidation, should an initial business combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the
                      carrying amounts of assets or liabilities should the Company be required to liquidate after November 23, 2022.</div>
</ix:continuation></span>
                  </div>

                </div>

              </div>

            </div>
<span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65944" continuedat="Text_6bd90ace863a4195b4a35c959da8e65945" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
            <br></div>
</ix:continuation></span>
          </div>

          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65945" continuedat="Text_6bd90ace863a4195b4a35c959da8e65946" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Risks and Uncertainties</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65946" continuedat="Text_6bd90ace863a4195b4a35c959da8e65947" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_6bd90ace863a4195b4a35c959da8e65947" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
            have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do
            not include any adjustments that might result from the outcome of this uncertainty.</div>
</ix:continuation></span>

          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="fact-identifier-335" contextref="c20210101to20211231" escape="true" continuedat="Text_1d0f484c1d174afe866f51b0b972fc561" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_1b4a5e4df95f4e9ca99b60344a6d21f2" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc561" continuedat="Text_1d0f484c1d174afe866f51b0b972fc562" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc562" continuedat="Text_1d0f484c1d174afe866f51b0b972fc563" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="fact-identifier-338" contextref="c20210101to20211231" escape="true" continuedat="Text_141b347e25184ae8898a3c0146e413a51" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_476fa386e0974d5a8649eacc2d78a516" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Basis of Presentation</div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc563" continuedat="Text_1d0f484c1d174afe866f51b0b972fc564" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_141b347e25184ae8898a3c0146e413a51" continuedat="Text_141b347e25184ae8898a3c0146e413a52" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc564" continuedat="Text_1d0f484c1d174afe866f51b0b972fc565" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_141b347e25184ae8898a3c0146e413a52" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America
            (“GAAP”) and pursuant to the rules and regulations of the SEC.</div>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc565" continuedat="Text_1d0f484c1d174afe866f51b0b972fc566" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc566" continuedat="Text_1d0f484c1d174afe866f51b0b972fc567" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Emerging Growth Company</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc567" continuedat="Text_1d0f484c1d174afe866f51b0b972fc568" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc568" continuedat="Text_1d0f484c1d174afe866f51b0b972fc569" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business
            Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not
            being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy
            statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc569" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5610" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5610" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5611" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
            accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the
            new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt
            out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an
            emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an
            emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5611" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5612" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFPageNumberArea"><span style="font-size: 8pt; font-weight: normal; font-style: normal; font-family: 'Times New Roman';" class="DSPFPageNumber">F-9</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                    </a></span></div>

                <div>
                  <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                    <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                  </div>

                  <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

              </div>

            </div>

          </div>


          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5612" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5613" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:UseOfEstimates" id="fact-identifier-351" contextref="c20210101to20211231" escape="true" continuedat="Text_ec7701ab349d4a97b7629ab8311638ad1" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_a76777960a624f5598c1f9b4f3ec13e7" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Use of Estimates</div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5613" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5614" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_ec7701ab349d4a97b7629ab8311638ad1" continuedat="Text_ec7701ab349d4a97b7629ab8311638ad2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5614" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5615" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_ec7701ab349d4a97b7629ab8311638ad2" continuedat="Text_ec7701ab349d4a97b7629ab8311638ad3" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that
            affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5615" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5616" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_ec7701ab349d4a97b7629ab8311638ad3" continuedat="Text_ec7701ab349d4a97b7629ab8311638ad4" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5616" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5617" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_ec7701ab349d4a97b7629ab8311638ad4" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a
            condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the
            more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and,
            accordingly, the actual results could differ significantly from those estimates.</div>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5617" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5618" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5618" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5619" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="fact-identifier-362" contextref="c20210101to20211231" escape="true" continuedat="Text_ba816f2d779c4905a3ded2b90b9618aa1" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_41d507463fdf4968b3b0f45f5a43ce3a" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Cash and Cash Equivalents</div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5619" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5620" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_ba816f2d779c4905a3ded2b90b9618aa1" continuedat="Text_ba816f2d779c4905a3ded2b90b9618aa2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5620" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5621" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_ba816f2d779c4905a3ded2b90b9618aa2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The
            Company did <span><ix:nonfraction name="us-gaap:CashEquivalentsAtCarryingValue" id="fact-identifier-367" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_a01fb9df38d94e96bd25ef98ec47986a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CashEquivalentsAtCarryingValue" id="fact-identifier-368" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_8c95516a0d97448bb94d7ca6215d3a30" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">no</ix:nonfraction></span></ix:nonfraction></span>t have any cash equivalents as of December 31, 2021 and 2020.</div>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5621" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5622" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5622" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5623" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" id="fact-identifier-371" contextref="c20210101to20211231" escape="true" continuedat="Text_a4dcba3d3ee64f3da8233a760f7502c01" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_01bb79f0c955476c8c61a3f424f0592f" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Class A Common Stock Subject to Possible Redemption<br>
          </div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5623" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5624" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_a4dcba3d3ee64f3da8233a760f7502c01" continuedat="Text_a4dcba3d3ee64f3da8233a760f7502c02" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5624" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5625" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_a4dcba3d3ee64f3da8233a760f7502c02" continuedat="Text_a4dcba3d3ee64f3da8233a760f7502c03" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards
            Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common
            stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary
            equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of
            uncertain future events. Accordingly, at December 31, 2021 and 2020, Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance
            sheets. The common stock subject to possible redemption of <span><ix:nonfraction name="us-gaap:TemporaryEquitySharesOutstanding" id="fact-identifier-376" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_94e87624aa58447db0bd7d36c1492513" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,352,040</ix:nonfraction></span> shares excludes the <span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-377" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_806deaae4c774424bac2f0efd65ef9f9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">507,041</ix:nonfraction></span> Private Placement Shares that are classified as Class A common stock but are not redeemable.</div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5625" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5626" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_a4dcba3d3ee64f3da8233a760f7502c03" continuedat="Text_a4dcba3d3ee64f3da8233a760f7502c04" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5626" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5627" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_a4dcba3d3ee64f3da8233a760f7502c04" continuedat="Text_a4dcba3d3ee64f3da8233a760f7502c05" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal
            the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. Increases or decreases in the
            carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.<br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5627" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5628" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_a4dcba3d3ee64f3da8233a760f7502c05" continuedat="Text_a4dcba3d3ee64f3da8233a760f7502c06" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5628" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5629" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_a4dcba3d3ee64f3da8233a760f7502c06" continuedat="Text_a4dcba3d3ee64f3da8233a760f7502c07" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:TemporaryEquityTableTextBlock" id="fact-identifier-386" contextref="c20210101to20211231" escape="true" continuedat="Text_3853d0bd4a4b474ba0b5ed9862afad461" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_3a0a22edc87947fcb09574198e555e61" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">At December 31, 2021, the Class A common stock reflected in the balance sheets are reconciled in the following table:</div>
</ix:nonnumeric></span></ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5629" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5630" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_a4dcba3d3ee64f3da8233a760f7502c07" continuedat="Text_a4dcba3d3ee64f3da8233a760f7502c08" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_3853d0bd4a4b474ba0b5ed9862afad461" continuedat="Text_3853d0bd4a4b474ba0b5ed9862afad462" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5630" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5631" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_a4dcba3d3ee64f3da8233a760f7502c08" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_3853d0bd4a4b474ba0b5ed9862afad462" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" border="0" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;" class="cfttable">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Gross proceeds</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" id="fact-identifier-393" contextref="c20210101to20211231_SubsidiarySaleOfStockAxis_IPOMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_9036a02c53624ccbb8c7b79ba23714fa" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,520,402</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Less:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; margin-left: 9pt;">Class A common stock issuance costs</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:PaymentsOfStockIssuanceCosts" id="fact-identifier-394" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_712c812eef07434798904c97b1c05ada" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">6,168,023</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Plus:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; margin-left: 9pt;">Accretion of carrying value to redemption value</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" id="fact-identifier-395" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f50dac4dfcc040acbaea50cff520d947" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">6,168,023</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman'; font-weight: bold;">Class A common stock subject to possible redemption</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" id="fact-identifier-396" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_2b666cf559e240ef853ed239159e41c8" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,520,402</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>


</tbody></table>
</ix:continuation></span></ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5631" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5632" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">F-10</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                    </a></span></div>

                <div>
                  <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                    <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                  </div>

                  <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

              </div>

            </div>

          </div>

          <div style="font-family: 'Times New Roman'; font-size: 10pt;">
            <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5632" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5633" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:InvestmentPolicyTextBlock" id="fact-identifier-399" contextref="c20210101to20211231" escape="true" continuedat="Text_74e3229296084d93a00d122664f2a7141" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_191bbf8190774567bc9217f4cabf12c7" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.6pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Marketable Securities Held in Trust Account</div>
</ix:nonnumeric></span></ix:continuation></span>
            <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5633" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5634" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_74e3229296084d93a00d122664f2a7141" continuedat="Text_74e3229296084d93a00d122664f2a7142" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.6pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
            </div>
</ix:continuation></span></ix:continuation></span>
            <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5634" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5635" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_74e3229296084d93a00d122664f2a7142" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">At December 31, 2021 and 2020, substantially all of the assets held in the Trust Account were held in money market funds, which are invested
              primarily in U.S. Treasury securities. The Company accounts for its marketable securities as Trading Securities under ASC 320, where securities are presented at fair value on the balance sheet and with unrealized gains or losses, if any,
              presented on the statement of operations.</div>
</ix:continuation></span></ix:continuation></span>

          </div>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5635" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5636" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5636" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5637" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="fact-identifier-406" contextref="c20210101to20211231" escape="true" continuedat="Text_cabc29d6eb284ce689e9315a1c567d1b1" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_48ba09c388e949848c24c10699ee6127" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Share-Based Payment Arrangements</div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5637" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5638" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_cabc29d6eb284ce689e9315a1c567d1b1" continuedat="Text_cabc29d6eb284ce689e9315a1c567d1b2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5638" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5639" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_cabc29d6eb284ce689e9315a1c567d1b2" continuedat="Text_cabc29d6eb284ce689e9315a1c567d1b3" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company accounts for stock awards in accordance with ASC 718, “Compensation - Stock Compensation,” which requires that all equity awards be
            accounted for at their “fair value.” Fair value is measured on the grant date and is equal to the underlying value of the stock.</div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5639" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5640" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_cabc29d6eb284ce689e9315a1c567d1b3" continuedat="Text_cabc29d6eb284ce689e9315a1c567d1b4" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 32.4pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5640" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5641" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_cabc29d6eb284ce689e9315a1c567d1b4" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to
            vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the
            Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited.</div>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5641" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5642" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5642" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5643" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:IncomeTaxPolicyTextBlock" id="fact-identifier-417" contextref="c20210101to20211231" escape="true" continuedat="Text_4b4ae68f57124531bdbbaa22fd0976be1" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_bb6e6892867c475e87f566814414a7c2" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Income Taxes</div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5643" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5644" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_4b4ae68f57124531bdbbaa22fd0976be1" continuedat="Text_4b4ae68f57124531bdbbaa22fd0976be2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5644" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5645" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_4b4ae68f57124531bdbbaa22fd0976be2" continuedat="Text_4b4ae68f57124531bdbbaa22fd0976be3" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and
            liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and
            liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax
            rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. At December 31, 2021 and 2020, the Company
            had deferred tax assets with a full valuation allowance recorded against them.</div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5645" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5646" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_4b4ae68f57124531bdbbaa22fd0976be3" continuedat="Text_4b4ae68f57124531bdbbaa22fd0976be4" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5646" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5647" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_4b4ae68f57124531bdbbaa22fd0976be4" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
            taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
            related to unrecognized tax benefits as income tax expense. There were <span><ix:nonfraction name="us-gaap:UnrecognizedTaxBenefits" id="fact-identifier-426" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_ecbf4e1542124bbc91afd4068928ea4d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">no</ix:nonfraction></span> unrecognized tax benefits and <span><ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="fact-identifier-427" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_f2b34029a6104b4684978a6c6c69d70e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">no</ix:nonfraction></span> amounts accrued for interest and penalties as of December 31, 2021 and 2020. The Company is currently not aware of any issues under review that
            could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The effective tax rate differs from the statutory tax rate of
            <span><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="fact-identifier-428" contextref="c20210101to20211231" unitref="U004" decimals="2" sign="-" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_a384ec9ff601415fb7da73a753fb60f6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">21</ix:nonfraction></span>% for the year ended December 31, 2021, due to the valuation allowance recorded on the Company’s net operating losses.</div>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5647" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5648" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5648" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5649" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:EarningsPerSharePolicyTextBlock" id="fact-identifier-431" contextref="c20210101to20211231" escape="true" continuedat="Text_131f02d8856547408a5bf2f061462d0f1" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_439ce4eb22224e2f950076b182e8c000" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Net Loss per Common Share<br>
          </div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5649" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5650" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_131f02d8856547408a5bf2f061462d0f1" continuedat="Text_131f02d8856547408a5bf2f061462d0f2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5650" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5651" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_131f02d8856547408a5bf2f061462d0f2" continuedat="Text_131f02d8856547408a5bf2f061462d0f3" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock
            is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of
            Class A common stock is excluded from earnings&nbsp; per share as the redemption value approximates fair value.</div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5651" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5652" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_131f02d8856547408a5bf2f061462d0f3" continuedat="Text_131f02d8856547408a5bf2f061462d0f4" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 14.55pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5652" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5653" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_131f02d8856547408a5bf2f061462d0f4" continuedat="Text_131f02d8856547408a5bf2f061462d0f5" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public
            Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2021 and 2020, the Company did <span><ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="fact-identifier-440" contextref="c20200827to20201231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_8579a0b4b99742f7b0de6cde9840d045" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="fact-identifier-441" contextref="c20210101to20211231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_2ab6024710474e6ea0402ca562772499" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">no</ix:nonfraction></span></ix:nonfraction></span>t have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company.
            As a result, diluted net loss per common stock is the same as basic net loss per common stock for the periods presented.</div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5653" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5654" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_131f02d8856547408a5bf2f061462d0f5" continuedat="Text_131f02d8856547408a5bf2f061462d0f6" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 14.55pt; margin-right: 30.45pt; margin-left: 30.45pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
            <br>
          </div>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5654" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5655" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_131f02d8856547408a5bf2f061462d0f6" continuedat="Text_131f02d8856547408a5bf2f061462d0f7" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" id="fact-identifier-446" contextref="c20210101to20211231" escape="true" continuedat="Text_7b38c573d4cc4d0a9c1b2f72ba6427721" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_4cfa0b41026c4f11872bbd8adb59da41" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</div>
</ix:nonnumeric></span></ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5655" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5656" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_131f02d8856547408a5bf2f061462d0f7" continuedat="Text_131f02d8856547408a5bf2f061462d0f8" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_7b38c573d4cc4d0a9c1b2f72ba6427721" continuedat="Text_7b38c573d4cc4d0a9c1b2f72ba6427722" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5656" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5657" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_131f02d8856547408a5bf2f061462d0f8" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_7b38c573d4cc4d0a9c1b2f72ba6427722" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="6" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center;"> <span style="font-weight: bold;">Year Ended<br>
                    </span></div>
                  <div style="text-align: center;"><span style="font-weight: bold;">December 31, 2021</span> </div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">
                    <div>
                      <div>For the Period from August 27,</div>
                      2020 (Inception) Through</div>
                    December 31, 2020</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"> <span style="font-weight: bold;">Class A</span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"> <span style="font-weight: bold;">Class B</span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Class A</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Class B</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-style: italic;">Basic and diluted net loss per common stock</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Numerator:</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Allocation of net loss, as adjusted</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<span><ix:nonfraction name="us-gaap:UndistributedEarnings" id="fact-identifier-453" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_1966c98cad3343e39ebb39544f0a5925" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,552,933</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<span><ix:nonfraction name="us-gaap:UndistributedEarnings" id="fact-identifier-454" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_b4c6e1493a024bc6b4726899bf8cc7f6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">370,105</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:UndistributedEarnings" id="fact-identifier-455" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_670451932ea14949a9d9d367447bb4f9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">147,897</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:UndistributedEarnings" id="fact-identifier-456" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_9fe5932dc0c946c08fbe7f21cb44f4ed" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">116,822</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
                  <div style="font-family: 'Times New Roman';">Denominator:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Basic and diluted weighted average common shares outstanding</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="fact-identifier-457" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d1be33d8236148169e1d23983e6b97ef" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="fact-identifier-458" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_bd316b7126d94bc0b0f3e1723e0baf51" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,859,081</ix:nonfraction></span></ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="fact-identifier-459" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_232a543ba24a4349946ce79ce2c06606" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="fact-identifier-460" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_38e214fe5df14fdc824531e1251b6fa6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,588,010</ix:nonfraction></span></ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="fact-identifier-461" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f1da1f543576429f96e12a217a5eb0a9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="fact-identifier-462" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3ef0ee04d56e4534b6fdf2e6cf8892cb" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,398,183</ix:nonfraction></span></ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="fact-identifier-463" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_9070c4ae66014e2ca4e5ef91e26d255c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="fact-identifier-464" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3f1cd2d073e347a798276807b925ef33" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,684,176</ix:nonfraction></span></ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Basic and diluted net loss per common stock</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">$ <br>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">(<span><ix:nonfraction name="us-gaap:EarningsPerShareBasic" id="fact-identifier-465" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d884d2b4225c404ebe77968b12eed148" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:EarningsPerShareDiluted" id="fact-identifier-466" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_28db6bfefcc4427e840fc3513b3885b7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.14</ix:nonfraction></span></ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">$ <br>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">(<span><ix:nonfraction name="us-gaap:EarningsPerShareDiluted" id="fact-identifier-467" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f828fc46531d41a88171e8e84260082b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:EarningsPerShareBasic" id="fact-identifier-468" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_4c9e29a8d2b642e78531c5a286b4c40e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.14</ix:nonfraction></span></ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:EarningsPerShareDiluted" id="fact-identifier-469" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_14061608e64c45499e6c7d624f7e23b1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:EarningsPerShareBasic" id="fact-identifier-470" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e7a84018683b46fea49860e4331cbc5e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.04</ix:nonfraction></span></ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:EarningsPerShareDiluted" id="fact-identifier-471" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_38244b20e41642988b6270c75cb87f04" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:EarningsPerShareBasic" id="fact-identifier-472" contextref="c20200827to20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_5891699b975c4ae5ad55f0318492a914" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.04</ix:nonfraction></span></ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

  </tr>


</tbody></table>
</ix:continuation></span></ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5657" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5658" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">F-11</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                    </a></span></div>

                <div>
                  <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                    <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                  </div>

                  <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

              </div>

            </div>

          </div>


          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5658" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5659" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:ConcentrationRiskCreditRisk" id="fact-identifier-475" contextref="c20210101to20211231" escape="true" continuedat="Text_d9d5c9f528c944cf8aa48f137900b8551" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_3136624d346f4c9fb0aec836148b8f1f" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Concentration of Credit Risk</div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5659" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5660" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_d9d5c9f528c944cf8aa48f137900b8551" continuedat="Text_d9d5c9f528c944cf8aa48f137900b8552" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5660" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5661" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_d9d5c9f528c944cf8aa48f137900b8552" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; color: rgb(24, 23, 23); font-family: 'Times New Roman'; font-size: 10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk
            consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.</div>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5661" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5662" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5662" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5663" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="fact-identifier-482" contextref="c20210101to20211231" escape="true" continuedat="Text_cf9095a95e514026a7d0208a1201fc821" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_5af322136e014863aa32229d8538c155" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Fair Value of Financial Instruments</div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5663" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5664" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_cf9095a95e514026a7d0208a1201fc821" continuedat="Text_cf9095a95e514026a7d0208a1201fc822" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5664" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5665" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_cf9095a95e514026a7d0208a1201fc822" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,”
            approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.</div>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5665" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5666" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5666" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5667" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="fact-identifier-489" contextref="c20210101to20211231" escape="true" continuedat="Text_b6e51651540c4195b3feb2d15566a7d31" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_3c29a2c45dfa4a80a72b9a16d7986f9a" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Recent Accounting Standards<br>
          </div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5667" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5668" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_b6e51651540c4195b3feb2d15566a7d31" continuedat="Text_b6e51651540c4195b3feb2d15566a7d32" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5668" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5669" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_b6e51651540c4195b3feb2d15566a7d32" continuedat="Text_b6e51651540c4195b3feb2d15566a7d33" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with
            Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models
            that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The
            new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the
            requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021.&nbsp;
            The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.</div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5669" continuedat="Text_1d0f484c1d174afe866f51b0b972fc5670" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_b6e51651540c4195b3feb2d15566a7d33" continuedat="Text_b6e51651540c4195b3feb2d15566a7d34" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_1d0f484c1d174afe866f51b0b972fc5670" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_b6e51651540c4195b3feb2d15566a7d34" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
            material effect on the Company’s financial statements.</div>
</ix:continuation></span></ix:continuation></span>

          <div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="jyac:InitialPublicOfferingTextBlock" id="fact-identifier-498" contextref="c20210101to20211231" escape="true" continuedat="Text_2290f2350b904c4abce9e7b4e8b409ef1" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_0d482ed9b2624d47b0aef5558bd1b81b" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTE 3 — INITIAL PUBLIC OFFERING</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_2290f2350b904c4abce9e7b4e8b409ef1" continuedat="Text_2290f2350b904c4abce9e7b4e8b409ef2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_2290f2350b904c4abce9e7b4e8b409ef2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Pursuant to the Initial Public Offering on November 23, 2020, the Company sold <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fact-identifier-501" contextref="c20201122to20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_fcb1a1b539094bb28cde0a573eadb498" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,352,040</ix:nonfraction></span> public shares, inclusive of <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fact-identifier-502" contextref="c20201210to20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_44bfd71fea194926a4bf889255dd3b65" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">352,040</ix:nonfraction></span> shares sold
            to the underwriters on December 10, 2020 upon the underwriters’ election to partially exercise their over-allotment option, at a purchase price of $<span><ix:nonfraction name="us-gaap:SharesIssuedPricePerShare" id="fact-identifier-503" contextref="c20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_e73cfc3ca58e48fa8d788f37c2ef61e2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:SharesIssuedPricePerShare" id="fact-identifier-504" contextref="c20201210_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_419850520c254e14ade9d44cf8b94f66" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span></ix:nonfraction></span>
            per share.</div>
</ix:continuation></span>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="jyac:PrivatePlacementTextBlock" id="fact-identifier-505" contextref="c20210101to20211231" escape="true" continuedat="Text_8a3c497be21e4277a39fdd1bcbc119661" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_36dfe506335948e5846d942105c60268" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTE 4 — PRIVATE PLACEMENT</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_8a3c497be21e4277a39fdd1bcbc119661" continuedat="Text_8a3c497be21e4277a39fdd1bcbc119662" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_8a3c497be21e4277a39fdd1bcbc119662" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fact-identifier-508" contextref="c20201123to20201123_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_2ebcee5ae7164e1589b1ba48de8f5e60" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">500,000</ix:nonfraction></span> Private Placement Shares at a price of $<span><ix:nonfraction name="us-gaap:SharePrice" id="fact-identifier-509" contextref="c20201123_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_97464fe3f3d14a96ac03efa4125dbcf8" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span> per
            Private Placement Share, for an aggregate purchase price of $<span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" id="fact-identifier-510" contextref="c20201123to20201123_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_SubsidiarySaleOfStockAxis_PrivatePlacementMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_87b6a7e7193246d3ae0675f4e21740c2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">5,000,000</ix:nonfraction></span>. On December 10, 2020, in connection with the underwriters’
            election to partially exercise their over-allotment option, the Company sold an additional <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fact-identifier-511" contextref="c20201210to20201210_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_8062bb29622a4d2eb692586aaf636e69" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">7,041</ix:nonfraction></span> Private Placement Shares to the
            Sponsor, at a price of $<span><ix:nonfraction name="us-gaap:SharePrice" id="fact-identifier-512" contextref="c20201210_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_be81e0fb395e46c09f528d3daf2a0e2a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span> per Private Placement share, generating gross proceeds of $<span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" id="fact-identifier-513" contextref="c20201210to20201210_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_3a82875bee284360950b5dd50f52eb91" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">70,410</ix:nonfraction></span>. The proceeds from the sale of the Private Placement Shares were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company
            does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Shares held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements
            of applicable law).</div>
</ix:continuation></span>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="fact-identifier-514" contextref="c20210101to20211231" escape="true" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a3211" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_10eca56215df40bb91fa1460f5c983cc" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">NOTE 5 — RELATED PARTY TRANSACTIONS</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a3211" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a3212" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a3212" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a3213" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Founder Shares</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a3213" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a3214" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br>
            </span> </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a3214" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a3215" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a3215" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a3216" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On September 9, 2020, the Sponsor purchased <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-520" contextref="c20200909to20200909_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_5ecb5f5a5aa24a4c89148d1160809608" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">4,312,500</ix:nonfraction></span> shares (the
              “Founder Shares”) of the Company’s Class B common stock for an aggregate price of $<span><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="fact-identifier-521" contextref="c20200909to20200909_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_c1516f0cc28d4d0e8ae46bed4ca51bb9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">25,000</ix:nonfraction></span>. On October 30, 2020, the Sponsor
              forfeited <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" id="fact-identifier-522" contextref="c20201030to20201030_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_13f26d19a6e14c1f80e6f93e74f03eb9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,437,500</ix:nonfraction></span> Founder Shares back to the Company for no consideration, which the Company cancelled, resulting in an
              aggregate of <span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-523" contextref="c20201030_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_cc2085ec63154cf2875d8918e01ca4b3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-524" contextref="c20201030_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_3332939998aa446c925ca336e58a5f20" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,875,000</ix:nonfraction></span></ix:nonfraction></span> Founder Shares issued and outstanding. The Founder Shares included an aggregate of up to <span><ix:nonfraction name="jyac:CommonStockSharesSubjectToForfeiture" id="fact-identifier-525" contextref="c20201030_RangeAxis_MaximumMember_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_f99553eee33d47de8de99aff12c671eb" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">375,000</ix:nonfraction></span> shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment was not exercised in full or in part, so
              that the number of Founder Shares would collectively represent approximately <span><ix:nonfraction name="jyac:OwnershipInterestPercentageThreshold" id="fact-identifier-526" contextref="c20211231_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_6e13ab8da9104c65a364a8df4a3aec4e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">20</ix:nonfraction></span>% of the Company’s issued and outstanding shares
              after the Initial Public Offering. As a result of the underwriters’ election to partially exercise their over-allotment option on December 10, 2020, a total of <span><ix:nonfraction name="jyac:CommonStockSharesNoLongerSubjectToForfeiture" id="fact-identifier-527" contextref="c20201210_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_eb34b9a2f5884913918c24b51f684a89" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">88,010</ix:nonfraction></span> Founder Shares are no longer subject to forfeiture and <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" id="fact-identifier-528" contextref="c20201210to20201210_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_d640646981194a73be4d52fc237c3693" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">286,990</ix:nonfraction></span> Founder Shares were
              forfeited, resulting in an aggregate of <span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-529" contextref="c20201210_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_69a1261e63254f8cac88f2b8cf372776" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-530" contextref="c20201210_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_09aa907bd51e48fd922dab700d242d39" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,588,010</ix:nonfraction></span></ix:nonfraction></span> Founder Shares issued and outstanding.</span> </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a3216" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a3217" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFPageNumberArea"><span style="font-size: 8pt; font-weight: normal; font-style: normal; font-family: 'Times New Roman';" class="DSPFPageNumber">F-12</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                    </a></span></div>

                <div>
                  <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                    <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                  </div>

                  <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

              </div>

            </div>

          </div>

          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a3217" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a3218" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The



















            Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (1) <span><ix:nonnumeric name="jyac:LimitationPeriodToTransferAssignOrSellCommonStock" id="fact-identifier-533" contextref="c20210101to20211231_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassAMember" format="ixt-sec:durwordsen" inside-table="false" data-original-id="Fact_cfa6f26b4ca64656957c27c6379330f0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">one year</ix:nonnumeric></span> after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the closing price of the Class A common stock equals or exceeds $<span><ix:nonfraction name="us-gaap:SharePrice" id="fact-identifier-534" contextref="c20211231_RangeAxis_MinimumMember_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_e0dc1471cce84277b834742e3c3fa11c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">12.00</ix:nonfraction></span> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any <span><ix:nonnumeric name="jyac:NumberOfTradingDays" id="fact-identifier-535" contextref="c20210101to20211231_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassAMember" format="ixt-sec:durday" inside-table="false" data-original-id="Fact_b9fc33a36d0145569cbcad7258da51c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">20</ix:nonnumeric></span> trading days within any <span><ix:nonnumeric name="jyac:TradingDaysThreshold" id="fact-identifier-536" contextref="c20210101to20211231_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassAMember" format="ixt-sec:durday" inside-table="false" data-original-id="Fact_05f598ecd7354a288862c55ddc9b93b2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">30</ix:nonnumeric></span>-trading













            day period commencing at least <span><ix:nonnumeric name="jyac:ThresholdPeriodAfterInitialBusinessCombination" id="fact-identifier-537" contextref="c20210101to20211231_RangeAxis_MinimumMember_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_CommonClassAMember" format="ixt-sec:durday" inside-table="false" data-original-id="Fact_c47d620593b14d68b0bfd54465f2a062" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">120</ix:nonnumeric></span> days after a Business Combination, or (y) the date on which the Company completes a liquidation,
            merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a3218" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a3219" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;"> <br>
          </div>
</ix:continuation></span>
        </div>

        <div>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a3219" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32110" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">On November 13, 2020, the Sponsor transferred <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-540" contextref="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_PamelaKleinMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_f7e556794fec42bca0b10925e0e392e0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-541" contextref="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_RichardVanDorenMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_ee49400c4acf4e45957045d384c73266" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-542" contextref="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_SrinivasAkkarajuMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_daac47fbc476436cbd5a3a49ff13e4de" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-543" contextref="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_PerryKarsenMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_d9990ea0e60144b687a8f408391b572f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-544" contextref="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_CoryFreedlandMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_bdaed5f8195e43db86ca7615e8a11e20" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-545" contextref="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_DanielSpiegelmanMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_70406571c8a748eba63d28a37b7712af" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-546" contextref="c20201113to20201113_RelatedPartyTransactionsByRelatedPartyAxis_SteveKelseyMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_0d0c859062474c5aba4da6983a35b652" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">30,000</ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span>
            shares of Class B common stock to each of Srinivas Akkaraju, M.D., Ph.D., Richard Van Doren, Cory Freedland, Ph.D., Daniel Spiegelman, Perry Karsen, Pamela Klein <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">and Steve Kelsey. These shares of Class B common stock will not be subject to forfeiture in the event the
              underwriters’ over-allotment option is not exercised.</span></div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32110" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32111" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br>
            </span></div>
</ix:continuation></span>
          <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">
            <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32111" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32112" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On September 23, 2021, Perry Karsen resigned from the Board effective immediately, and such, forfeited their Class B shares back to the sponsor. On September 24, 2021, the Company announced that Dr. Lori Friedman was appointed to serve
              as a Class I director of the Company and was granted <span><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="fact-identifier-549" contextref="c20210924to20210924_RelatedPartyTransactionsByRelatedPartyAxis_DrLoriFriedmanMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_f9951d38146d48979bfbb7dc5fb32a1f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">30,000</ix:nonfraction></span> Class B shares of the Company, which were granted from the sponsor. No
              new Class B shares were issued as part of Dr. Friedman’s appointment or Perry Karsen’s resignation.</div>
</ix:continuation></span>
          </div>

          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32112" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32113" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32113" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32114" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company entered into an agreement with Ms. Hemrajani, the Company’s Chief Executive Officer, pursuant to which Ms. Hemrajani has agreed to
            provide up to <span><ix:nonfraction name="jyac:MaximumPercentageOfWorkingTime" id="fact-identifier-552" contextref="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_da342726cffd4f16a3bfbef4eac45588" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">60</ix:nonfraction></span>% of her normal working time to the Company in her capacity as Chief Executive Officer. In connection with her
            services, Ms. Hemrajani will receive an annual base salary of $<span><ix:nonfraction name="us-gaap:OfficersCompensation" id="fact-identifier-553" contextref="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_d0cfcee4362f4cdcb0a315106a3c42d6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">270,000</ix:nonfraction></span> and will be eligible to participate in the Company’s benefit
            programs in effect from time to time. In addition, on November 16, 2020, the Sponsor transferred to Ms. Hemrajani <span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="fact-identifier-554" contextref="c20201116to20201116_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionAxis_FounderSharesMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_87df7db90e6a4d028b84ba2c5908cd8b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">200,000</ix:nonfraction></span> Founder
            Shares, which will vest <span><ix:nonfraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="fact-identifier-555" contextref="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionAxis_FounderSharesMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_89301b2042d042a2b6d6815e0c7255b9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">25</ix:nonfraction></span>% on the first anniversary of the grant date, with the remaining <span><ix:nonfraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="fact-identifier-556" contextref="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionAxis_FounderSharesMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_dca79382128548c39e2c51fdf3955542" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">75</ix:nonfraction></span>% vesting in equal monthly installments over <span><ix:nonnumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="fact-identifier-557" contextref="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionAxis_FounderSharesMember" format="ixt-sec:durmonth" inside-table="false" data-original-id="Fact_fa7da765eb46439e9f8bc5790a83c889" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">36</ix:nonnumeric></span> months, in
            each case, subject to Ms. Hemrajani’s continued employment with the Company. The shares are generally be subject to the same terms and conditions as the Founder Shares held by the Sponsor, except that they were not subject to forfeiture in the
            event the underwriters’ over-allotment option was not exercised. Ms. Hemrajani’s agreement also provides that, in the event Ms. Hemrajani’s employment is terminated by the Company without “cause” or Ms. Hemrajani resigns for “good reason” (such
            terms are defined in the agreement), then Ms. Hemrajani will be entitled to receive (i) base salary continuation and payment of monthly COBRA premiums, in each case for <span><ix:nonnumeric name="jyac:PeriodEntitledToReceiveCompensationAfterTermination" id="fact-identifier-558" contextref="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember" format="ixt-sec:durwordsen" inside-table="false" data-original-id="Fact_821dbc9f7bd140f79ecc5799ffd57811" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">three months</ix:nonnumeric></span> following the date of her termination and (ii) an additional <span><ix:nonnumeric name="jyac:AdditionalPeriodForVesting" id="fact-identifier-559" contextref="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember" format="ixt-sec:durwordsen" inside-table="false" data-original-id="Fact_40573592fa7941f4816c4e086c2b8788" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">three months</ix:nonnumeric></span> of vesting for purposes of her Class B shares (or, if such termination of employment occurs prior to August 24, 2021, acceleration of <span><ix:nonfraction name="jyac:AccelerationPercentage" id="fact-identifier-560" contextref="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_13d3ea8670c444c4ae304a6f2b3dcee3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">25</ix:nonfraction></span>% of her Class B shares). Payment of the severance benefits is contingent on Ms. Hemrajani’s execution and non-revocation of a release of claims, as a well as her continued compliance with customary
            confidentiality and non-solicitation restrictions set forth in her agreement. In addition, in the event Ms. Hemrajani is not offered a position as an executive officer of the target business following the initial Business Combination, then <span><ix:nonfraction name="jyac:PercentageOfSharesFullyVestedOnCondition" id="fact-identifier-561" contextref="c20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_6ad2f21b99ff44519946bdfc74c178cc" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">100</ix:nonfraction></span>% of Ms. Hemrajani’s Class B shares will become fully vested.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32114" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32115" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32115" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32116" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company has also entered into an agreement on November 4, 2020 with Mayank Gandhi, the Company’s Vice President, Corporate Development,
            pursuant to which Mr. Gandhi will receive an annual base salary of $<span><ix:nonfraction name="us-gaap:OfficersCompensation" id="fact-identifier-564" contextref="c20201104to20201104_GranteeStatusAxis_VicePresidentMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_2713cca58d92439b90192dc489f17e28" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">225,000</ix:nonfraction></span> and will be eligible to participate in the Company’s
            benefit programs in effect from time to time. In addition, on November 16, 2020, the Sponsor transferred to Mr. Gandhi <span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="fact-identifier-565" contextref="c20201104to20201104_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_8c4659fe88d240fbbb4ab2fa41ddc836" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">40,000</ix:nonfraction></span>
            Founder Shares, which will vest <span><ix:nonfraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="fact-identifier-566" contextref="c20210101to20211231_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_a219cfccd2af4ea5bf4ee0db972cdc41" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">25</ix:nonfraction></span>% on the first anniversary of the transfer date, with the remaining <span><ix:nonfraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="fact-identifier-567" contextref="c20210101to20211231_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_456e622cc9ac420a9f11b50ef870f868" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">75</ix:nonfraction></span>% vesting in equal monthly installments over <span><ix:nonnumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="fact-identifier-568" contextref="c20210101to20211231_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember" format="ixt-sec:durmonth" inside-table="false" data-original-id="Fact_a0b7e713908e4754bf802ae3ae0c06a7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">36</ix:nonnumeric></span>
            months, in each case subject to Mr. Gandhi’s continued employment with the Company. The Sponsor also transferred <span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="fact-identifier-569" contextref="c20201116to20201116_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionAxis_FounderSharesMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_9bd514db12184ed8866f64fa28b19171" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">8,000</ix:nonfraction></span> Founder
            Shares to Mr. Gandhi on November 16, 2020 that will vest on the second anniversary of the consummation of the initial Business Combination, subject to Mr. Gandhi’s continued employment through such date. In the event Mr. Gandhi is not offered
            an ongoing role with the target business following the initial Business Combination, then <span><ix:nonfraction name="jyac:PercentageOfSharesFullyVestedOnCondition" id="fact-identifier-570" contextref="c20211231_GranteeStatusAxis_VicePresidentMember_StatementClassOfStockAxis_CommonClassBMember" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_602ee096fba940539a994c7027bcd6f4" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">100</ix:nonfraction></span>% of Mr. Gandhi’s Class B shares will
            become fully vested. For the year ended December 31, 2021, the Company incurred a total of approximately $<span><ix:nonfraction name="us-gaap:DueToOfficersOrStockholdersCurrentAndNoncurrent" id="fact-identifier-571" contextref="c20211231_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_034ceee86d244b0c8d056dca66d77b97" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">548,000</ix:nonfraction></span> for executive
            payroll related expense. As of December 31, 2020, the Company incurred a total of approximately $<span><ix:nonfraction name="us-gaap:DueToOfficersOrStockholdersCurrentAndNoncurrent" id="fact-identifier-572" contextref="c20201231_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_4331ef33208343d8a5baabcf3d44d522" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">155,000</ix:nonfraction></span> for executive payroll
            related expenses, which was comprised of approximately $<span><ix:nonfraction name="us-gaap:DueToOfficersOrStockholdersCurrentAndNoncurrent" id="fact-identifier-573" contextref="c20201231_GranteeStatusAxis_ChiefExecutiveOfficerMember_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_45335a7118c74a4183ae1ad204bf586e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">95,800</ix:nonfraction></span> related to the annual salary of Ms. Hemirajani and $<span><ix:nonfraction name="us-gaap:DueToOfficersOrStockholdersCurrentAndNoncurrent" id="fact-identifier-574" contextref="c20201231_GranteeStatusAxis_VicePresidentMember_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_916dd17bdc5a4e288b0aa961cc73c77d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">59,200</ix:nonfraction></span> related to the annual salary of Mr. Gandhi. At December 31, 2021 and 2020, $<span><ix:nonfraction name="us-gaap:DueToOfficersOrStockholdersCurrent" id="fact-identifier-575" contextref="c20211231_BalanceSheetLocationAxis_AccountsPayableAndAccruedLiabilitiesMember_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_ae93b7b7916c46d68841f2964092e562" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0</ix:nonfraction></span> and $<span><ix:nonfraction name="us-gaap:DueToOfficersOrStockholdersCurrent" id="fact-identifier-576" contextref="c20201231_BalanceSheetLocationAxis_AccountsPayableAndAccruedLiabilitiesMember_RelatedPartyTransactionsByRelatedPartyAxis_ManagementMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_32ab8e116a8a4a96b51133097b2dab2b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">20,093</ix:nonfraction></span> of payroll expenses was unpaid and recorded in accrued
            expense<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">s, respectively.<br>
            </span></div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32116" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32117" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br>
            </span></div>
</ix:continuation></span>
          <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">
            <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32117" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32118" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The transfer of
              the Founders Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”).&nbsp; Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The
              Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence
              under the applicable accounting literature in this circumstance. As of December 31,&nbsp;2021, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized.
              Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per
              share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares.</div>
</ix:continuation></span>
            <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32118" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32119" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br>
            </div>
</ix:continuation></span>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFPageNumberArea"><span style="font-size: 8pt; font-weight: normal; font-style: normal; font-family: 'Times New Roman';" class="DSPFPageNumber">F-13</span></div>

              <div style="page-break-after: always;" class="DSPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

              <div style="width: 100%;" class="DSPFPageHeader">
                <div>
                  <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                  </div>

                  <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                      </a></span></div>

                  <div>
                    <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                      <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                      <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                      <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                    </div>

                    <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

                </div>

              </div>

            </div>

          </div>

          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32119" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32120" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32120" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32121" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Administrative Services Agreement</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32121" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32122" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32122" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32123" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company entered into an agreement, commencing on November 18, 2020 through the earlier of the Company’s consummation of a Business
            Combination and its liquidation, to pay the Sponsor a total of $<span><ix:nonfraction name="jyac:MonthlyAdministrativeServiceFee" id="fact-identifier-584" contextref="c20201118to20201118_RelatedPartyTransactionAxis_AdministrativeSupportAgreementMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_f23d5a0e3ff74e06b26d4251c1896c77" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">10,000</ix:nonfraction></span> per month for office space, secretarial and administrative
            support. For the year ended December 31, 2021 and for the period from August 27, 2020 (inception) through December 31, 2020, the Company incurred and paid $<span><ix:nonfraction name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" id="fact-identifier-585" contextref="c20210101to20211231_RelatedPartyTransactionAxis_AdministrativeSupportAgreementMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_f213d1e7d4a245b6b364438413a93bfc" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">120,000</ix:nonfraction></span> and $<span><ix:nonfraction name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" id="fact-identifier-586" contextref="c20200827to20201231_RelatedPartyTransactionAxis_AdministrativeSupportAgreementMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_c9047072293045d48bc5a3f200c31c2b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">20,000</ix:nonfraction></span>, respectively, in fees for these services.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32123" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32124" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.6pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32124" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32125" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Promissory Note <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">—</span> Related Party</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32125" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32126" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32126" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32127" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">On September 9, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company
            could borrow up to an aggregate principal amount of $<span><ix:nonfraction name="us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent" id="fact-identifier-591" contextref="c20200909_RangeAxis_MaximumMember_RelatedPartyTransactionAxis_PromissoryNoteMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_ec20a13a1e0e4211987a262adc5b7d1a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">200,000</ix:nonfraction></span>. The Promissory Note was non-interest bearing and payable on the earlier
            of (i) April 30, 2021 or (ii) the consummation of the Initial Public Offering. As of December 31, 2021 and 2020, there was $<span><ix:nonfraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" id="fact-identifier-592" contextref="c20211231_RelatedPartyTransactionAxis_PromissoryNoteMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_df358c6bc3c048b5909f28875de49368" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0</ix:nonfraction></span> and $<span><ix:nonfraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" id="fact-identifier-593" contextref="c20201231_RelatedPartyTransactionAxis_PromissoryNoteMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_a9202c5eb7e24058b3b0a817967c3690" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">348</ix:nonfraction></span>, respectively, outstanding under the Promissory Note.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32127" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32128" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;"> <br>
          </div>
</ix:continuation></span>
        </div>

        <div>
          <div style="text-align: justify; font-family: 'Times New Roman';">
            <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32128" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32129" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="margin-right: 0.5pt; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Related Party Loans</div>
</ix:continuation></span>
            <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32129" continuedat="Text_bf88fa13d7344ead9dbbd8244bd1a32130" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
            </div>
</ix:continuation></span>
            <span><ix:continuation id="Text_bf88fa13d7344ead9dbbd8244bd1a32130" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor or
              certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds on a non-interest basis as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would
              repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination
              does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing,
              the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would be repaid upon consummation of a Business Combination, without interest, or,
              at the lender’s discretion, up to $<span><ix:nonfraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" id="fact-identifier-598" contextref="c20210101to20211231_RelatedPartyTransactionAxis_WorkingCapitalLoansMember_RelatedPartyTransactionsByRelatedPartyAxis_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_2dbeaa60112944e0af77e223cb10a927" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,500,000</ix:nonfraction></span> of such Working Capital Loans may be convertible into shares at a price of $<span><ix:nonfraction name="us-gaap:SharesIssuedPricePerShare" id="fact-identifier-599" contextref="c20211231_RelatedPartyTransactionAxis_WorkingCapitalLoansMember_RelatedPartyTransactionsByRelatedPartyAxis_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_01d908769e5e459aaf8a6f76fbd4d363" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span> per share. As of December 31, 2021 and 2020, the Company did <span><ix:nonfraction name="us-gaap:ProceedsFromRelatedPartyDebt" id="fact-identifier-600" contextref="c20210101to20211231_RelatedPartyTransactionAxis_WorkingCapitalLoansMember_RelatedPartyTransactionsByRelatedPartyAxis_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember" unitref="U001" decimals="0" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_63bb315c024a4f4c8377ff7fe76e1adc" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:ProceedsFromRelatedPartyDebt" id="fact-identifier-601" contextref="c20200827to20201231_RelatedPartyTransactionAxis_WorkingCapitalLoansMember_RelatedPartyTransactionsByRelatedPartyAxis_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember" unitref="U001" decimals="0" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_0a2c33a1dc6d4294b697737cd868fa0a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">no</ix:nonfraction></span></ix:nonfraction></span>t draw down on the Working Capital Loans.</div>
</ix:continuation></span>
             </div>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="fact-identifier-602" contextref="c20210101to20211231" escape="true" continuedat="Text_cf96798c7b9747a89556eda8d04db0821" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_23913d4007af4770882a8b66d6893fd7" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">NOTE

















            6 <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">—</span> COMMITMENTS</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db0821" continuedat="Text_cf96798c7b9747a89556eda8d04db0822" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db0822" continuedat="Text_cf96798c7b9747a89556eda8d04db0823" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Registration Rights</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db0823" continuedat="Text_cf96798c7b9747a89556eda8d04db0824" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db0824" continuedat="Text_cf96798c7b9747a89556eda8d04db0825" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">Pursuant

















            to a registration rights agreement entered into on November 18, 2020, the holders of the Founder Shares, Private Placement Shares and shares that may be issued upon conversion of Working Capital Loans will have registration rights to require
            the Company to register a sale of any of its securities held by them. The holders of these securities are entitled to make up to <span><ix:nonfraction name="jyac:NumberOfDemandsEligibleSecurityHolderCanMake" id="fact-identifier-607" contextref="c20211231_RangeAxis_MaximumMember" unitref="U005" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_55be155aee3d49e29a63b678bf1515e6" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">three</ix:nonfraction></span>
            demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business
            Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering our securities. The Company will bear the expenses incurred in connection with the
            filing of any such registration statements.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db0825" continuedat="Text_cf96798c7b9747a89556eda8d04db0826" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db0826" continuedat="Text_cf96798c7b9747a89556eda8d04db0827" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Pursuant to the forward purchase agreement, the Company will agree that it will use its commercially reasonable efforts to file within 30 days
            after the closing of a Business Combination a registration statement with the SEC for a secondary offering of the forward purchase shares and to cause such registration statement to be declared effective as soon as practicable after it is
            filed.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db0827" continuedat="Text_cf96798c7b9747a89556eda8d04db0828" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db0828" continuedat="Text_cf96798c7b9747a89556eda8d04db0829" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Underwriting Agreement</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db0829" continuedat="Text_cf96798c7b9747a89556eda8d04db08210" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db08210" continuedat="Text_cf96798c7b9747a89556eda8d04db08211" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The underwriters are entitled to a deferred fee of $<span><ix:nonfraction name="jyac:UnderwritingDiscountFeeDeferred" id="fact-identifier-614" contextref="c20210101to20211231" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_831eb10064a74ffc85b537fd603e48ee" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">0.35</ix:nonfraction></span>
            per Share, or $<span><ix:nonfraction name="jyac:UnderwritingFeesDeferred" id="fact-identifier-615" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_df7042eec59a4d8bac5f815e60eebf01" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">3,623,214</ix:nonfraction></span> in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the
            Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db08211" continuedat="Text_cf96798c7b9747a89556eda8d04db08212" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db08212" continuedat="Text_cf96798c7b9747a89556eda8d04db08213" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Forward Purchase Agreement</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db08213" continuedat="Text_cf96798c7b9747a89556eda8d04db08214" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_cf96798c7b9747a89556eda8d04db08214" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company entered into a forward purchase agreement pursuant to which Samsara BioCapital has agreed to purchase an aggregate of up to <span><ix:nonfraction name="jyac:ForwardPurchaseSharesAuthorized" id="fact-identifier-620" contextref="c20211231_SubsidiarySaleOfStockAxis_ForwardPurchaseArrangementMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_81a3bfc9ffc142a8a3022aedeb6b54cf" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">2,500,000</ix:nonfraction></span> shares (the “forward purchase shares”), for a purchase price of $<span><ix:nonfraction name="us-gaap:SharesIssuedPricePerShare" id="fact-identifier-621" contextref="c20211231_SubsidiarySaleOfStockAxis_ForwardPurchaseArrangementMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_dacf260d315d4c4383b82022e85a2db0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10.00</ix:nonfraction></span> per share, or an aggregate of $<span><ix:nonfraction name="jyac:SharePurchaseAgreementValue" id="fact-identifier-622" contextref="c20211231_SubsidiarySaleOfStockAxis_ForwardPurchaseArrangementMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_a273cb6514614fa3b7f7b8d0f92537d2" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">25,000,000</ix:nonfraction></span>, in a private
            placement to close concurrently with the closing of a Business Combination. The obligations under the forward purchase agreement will not depend on whether any shares of Class A common stock are redeemed by the public stockholders. The
            Sponsor’s obligation to purchase forward purchase shares will, among other things, be conditioned on the Business Combination (including the target assets or business, and the terms of the Business Combination) being reasonably acceptable to
            the Sponsor and on a requirement that such initial Business Combination is approved by a unanimous vote of the Company’s Board of Directors. Samsara BioCapital does not have the ability to override the Board of Directors vote. The forward
            purchase shares will be identical to the shares of Class A common stock included in the Public Shares being sold in the Initial Public Offering, except that they will be subject to certain registration rights.</div>
</ix:continuation></span>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">F-14</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                    </a></span></div>

                <div>
                  <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                    <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                  </div>

                  <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

              </div>

            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="fact-identifier-623" contextref="c20210101to20211231" escape="true" continuedat="Text_1ca871a79297424a8654e7e4c0ae59511" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_263915364746446aa40f980acf7c6472" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTE 7 <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">—</span><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></span>STOCKHOLDERS’ EQUITY<br>
          </div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae59511" continuedat="Text_1ca871a79297424a8654e7e4c0ae59512" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae59512" continuedat="Text_1ca871a79297424a8654e7e4c0ae59513" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;"><span style="font-weight: bold; font-style: italic;">Preferred Stock</span> — The Company is authorized to issue <span><ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" id="fact-identifier-626" contextref="c20211231" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_aa2bbb2787d64e3684517390b0a4895c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,000,000</ix:nonfraction></span> shares of preferred stock with a par value of $<span><ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="fact-identifier-627" contextref="c20211231" unitref="U003" decimals="4" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_c9b4c35a53994a50b24ed96f759a88ae" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0001</ix:nonfraction></span> per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. At December 31, 2021 and 2020, there were <span><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" id="fact-identifier-628" contextref="c20201231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_f41623467e79443fb5adf50cf955dc1a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" id="fact-identifier-629" contextref="c20211231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_c3089ab05d7e463da376e6cea7e940e5" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" id="fact-identifier-630" contextref="c20211231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_b675846be2fb43ab83976c36ee7e8907" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" id="fact-identifier-631" contextref="c20201231" unitref="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_92047051c8514ad2b80ba90b5094ac7e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">no</ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span> shares of preferred stock issued or outstanding.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae59513" continuedat="Text_1ca871a79297424a8654e7e4c0ae59514" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae59514" continuedat="Text_1ca871a79297424a8654e7e4c0ae59515" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;"><span style="font-weight: bold; font-style: italic;">Class A Common Stock</span> — The Company is authorized to issue <span><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" id="fact-identifier-634" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_e7c9830fa2ad4799a1ae36003520f723" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">100,000,000</ix:nonfraction></span> shares of Class A common stock with a par value of $<span><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="fact-identifier-635" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U003" decimals="4" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_3b694d306caa497f984c7f006133b9c9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0001</ix:nonfraction></span> per share. Holders of Class A common stock are entitled to <span><ix:nonfraction name="jyac:CommonStockVotesPerShare" id="fact-identifier-636" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_04b7cc6d18f04ba0bcf1f79564cbee16" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">one</ix:nonfraction></span> vote for each share. At
            December 31, 2021 and 2020, there were <span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-637" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_ddc76a85d13f4b068a0164829b542b2a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-638" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_746b7663f3804479895b1be326457978" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-639" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_722ee581c7924c729f8132a2948846d9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-640" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_1eac7a862b91499d82eca5a52ba580e0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">507,041</ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span> shares of Class A common stock issued and outstanding, excluding <span><ix:nonfraction name="us-gaap:TemporaryEquitySharesOutstanding" id="fact-identifier-641" contextref="c20201231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_73bb05e5f6704d0799dadcd4c20c2338" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:TemporaryEquitySharesOutstanding" id="fact-identifier-642" contextref="c20211231_StatementClassOfStockAxis_CommonClassAMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_40ac797234fa44d5a2d5b53fd4eef455" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,352,040</ix:nonfraction></span></ix:nonfraction></span> shares of Class A common stock subject to possible redemption.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae59515" continuedat="Text_1ca871a79297424a8654e7e4c0ae59516" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae59516" continuedat="Text_1ca871a79297424a8654e7e4c0ae59517" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;"><span style="font-weight: bold; font-style: italic;">Class B Common Stock</span> — The Company is authorized to issue <span><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" id="fact-identifier-645" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_b0ee67bdcd1741d7ac9e50e8bde3e57a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">10,000,000</ix:nonfraction></span> shares of Class B common stock with a par value of $<span><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="fact-identifier-646" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U003" decimals="4" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_23928f4ea1a94db6af82625493c778ed" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0001</ix:nonfraction></span> per share. Holders of Class B common stock are entitled to <span><ix:nonfraction name="jyac:CommonStockVotesPerShare" id="fact-identifier-647" contextref="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_93664c45c246415f92294c55c75c4814" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">one</ix:nonfraction></span> vote for each share. At
            December 31, 2021 and 2020, there were <span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-648" contextref="c20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_b5b541b70de0440ca64d131e901f457f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" id="fact-identifier-649" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_8588feb235094837bb5d0a25387a08f1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-650" contextref="c20211231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_78c560e326d3400c9159a63fb860a1ef" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:nonfraction name="us-gaap:CommonStockSharesIssued" id="fact-identifier-651" contextref="c20201231_StatementClassOfStockAxis_CommonClassBMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_21f4f1c5db8a4cb8acdf32ce4bf50c74" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2,588,010</ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span></ix:nonfraction></span> shares of Class B common stock issued and outstanding. </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae59517" continuedat="Text_1ca871a79297424a8654e7e4c0ae59518" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae59518" continuedat="Text_1ca871a79297424a8654e7e4c0ae59519" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of
            stockholders, except as required by law.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae59519" continuedat="Text_1ca871a79297424a8654e7e4c0ae595110" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_1ca871a79297424a8654e7e4c0ae595110" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The shares of Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the
            consummation of a Business Combination on a <span><ix:nonfraction name="jyac:StockConversionRatio" id="fact-identifier-656" contextref="c20210101to20211231" unitref="U004" decimals="INF" scale="0" format="ixt-sec:numwordsen" inside-table="false" data-original-id="Fact_631fa672b55446969c96a9f7a895a9e7" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">one</ix:nonfraction></span>-for-one basis, subject to adjustment. In the case that additional shares of Class A
            common stock or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
            as-converted basis, <span><ix:nonfraction name="jyac:StockConversionPercentageThreshold" id="fact-identifier-657" contextref="c20211231" unitref="U004" decimals="2" scale="-2" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_adb9f553b14e4ddf9c22548bf24858d5" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">20</ix:nonfraction></span>% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect
            to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or
            rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible
            into shares of Class A common stock issued, or to be issued, or forward purchase shares, to any seller in a Business Combination.</div>
</ix:continuation></span>

          <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="fact-identifier-658" contextref="c20210101to20211231" escape="true" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c1" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_d2f404c929584184ac4bc5a3d1fba38a" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">NOTE 8 <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">—</span>
            STOCK-BASED COMPENSATION</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c1" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c2" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c3" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">On November 16, 2020, the Sponsor transferred <span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="fact-identifier-661" contextref="c20201116to20201116_GranteeStatusAxis_ChiefExecutiveOfficerMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_587549b4af6b4f60918a71dae4f208e3" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">200,000</ix:nonfraction></span>
            Founder Shares to the Chief Executive Officer. The fair value of the Founder Shares on the grant date was $<span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="fact-identifier-662" contextref="c20201116_GranteeStatusAxis_ChiefExecutiveOfficerMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_80fa91c9b7ea43b487de097e8ed31827" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3.00</ix:nonfraction></span> per share, based upon
            a valuation performed by the Company. The valuation performed by the Company determined the fair value of the shares on the date of grant by applying a discount based upon a) the probability of a successful business combination, b) expected
            dilution concession as a result of a closed business combination and c) the lack of marketability of the Founder Shares. The aggregate grant date fair value of the award amounted to $<span><ix:nonfraction name="jyac:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantDateFairValue" id="fact-identifier-663" contextref="c20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_6a02f13e840d4486b9f62a7016ce4f67" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">600,000</ix:nonfraction></span>, of which $<span><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="fact-identifier-664" contextref="c20210101to20211231_GranteeStatusAxis_ChiefExecutiveOfficerMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_7024d79894ad4b42a37a14738535d77b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">150,000</ix:nonfraction></span> and $<span><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="fact-identifier-665" contextref="c20200827to20201231_GranteeStatusAxis_ChiefExecutiveOfficerMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_1f742a0a205545489c1597c42e158067" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">18,750</ix:nonfraction></span> was recorded as compensation expense during the year ended December 31, 2021 and for the period from August 27, 2020 (inception) through December 31, 2020,
            respectively.<br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c3" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c4" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c4" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c5" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">On November 16, 2020, the Sponsor transferred <span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="fact-identifier-668" contextref="c20201116to20201116_GranteeStatusAxis_VicePresidentMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_b4b648645c4b47958352e89b73547a6f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">48,000</ix:nonfraction></span>
            Founder Shares to the Vice President, Corporate Development. The fair value of the Founder Shares on the grant date was $<span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="fact-identifier-669" contextref="c20201116_GranteeStatusAxis_VicePresidentMember" unitref="U003" decimals="2" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_eb2c86605a184ebe8d5a8f4a47ea1a4a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3.00</ix:nonfraction></span> per
            share, based upon a valuation performed by the Company. The valuation performed by the Company determined the fair value of the shares on the date of grant by applying a discount based upon a) the probability of a successful business
            combination, b) expected dilution concession as a result of a closed business combination and c) the lack of marketability of the Founder Shares. The aggregate grant date fair value of the award amounted to $<span><ix:nonfraction name="jyac:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantDateFairValue" id="fact-identifier-670" contextref="c20211231_GranteeStatusAxis_VicePresidentMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_d028513916304bd19ef5c7295c88da15" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">144,000</ix:nonfraction></span>, of which $<span><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="fact-identifier-671" contextref="c20210101to20211231_GranteeStatusAxis_VicePresidentMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_575cdcb4e1fe46a7ae2c70b4d5cbe815" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">30,000</ix:nonfraction></span> and $<span><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="fact-identifier-672" contextref="c20200827to20201231_GranteeStatusAxis_VicePresidentMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_1a8a2b7cb7684cadafcaf59a51024c73" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">3,750</ix:nonfraction></span> was recorded as compensation expense during the year ended December 31, 2021 and for the period from August 27, 2020 (inception) through
            December 31, 2020, respectively.</div>
</ix:continuation></span><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="fact-identifier-673" contextref="c20210101to20211231" escape="true" continuedat="Text_6560ee6850854b99a668ae203887998a1" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_68b7c6b985464a8494359dc4b42ccf6e" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false"><span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c5" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c6" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div><br>

          </div>
</ix:continuation></span></ix:nonnumeric></span>
          <span><ix:continuation id="Text_6560ee6850854b99a668ae203887998a1" continuedat="Text_6560ee6850854b99a668ae203887998a2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c6" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c7" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">A summary of the restricted stock award and restricted unit activity for the year ended December 31, 2021 is as follows:</div>
</ix:continuation></span></ix:continuation></span>
          <a id="BKMK_87"></a><span><ix:continuation id="Text_6560ee6850854b99a668ae203887998a2" continuedat="Text_6560ee6850854b99a668ae203887998a3" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c7" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c8" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"></span><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_6560ee6850854b99a668ae203887998a3" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c8" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c9" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Number of</div>
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Shares</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Unvested Outstanding at August 27, 2020 (inception)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="fact-identifier-681" contextref="c20200826_AwardTypeAxis_RestrictedStockMember" unitref="U002" decimals="INF" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_a2fa7781b4464c94b640e8678c3bc05c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Granted</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="fact-identifier-682" contextref="c20200827to20211231_AwardTypeAxis_RestrictedStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_0ae4176e97474984b651b8597630b790" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">248,000</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Forfeited</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="fact-identifier-683" contextref="c20200827to20211231_AwardTypeAxis_RestrictedStockMember" unitref="U002" decimals="INF" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_26f73962aaf14b15b300fecbb3c87398" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Vested</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="fact-identifier-684" contextref="c20200827to20211231_AwardTypeAxis_RestrictedStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_7f615a1d7a284731b751c0d0deab5b78" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">65,000</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman'; font-weight: bold;">Unvested Outstanding at December 31, 2021</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;"><span><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="fact-identifier-685" contextref="c20211231_AwardTypeAxis_RestrictedStockMember" unitref="U002" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_ba1499d66108445997fd6a6c091e9805" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">183,000</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>


</tbody></table>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c9" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c10" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">F-15</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                    </a></span></div>

                <div>
                  <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                    <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                  </div>

                  <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

              </div>

            </div>

          </div>

          <span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c10" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c11" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company recorded non-cash compensation expense of $<span><ix:nonfraction name="us-gaap:ShareBasedCompensation" id="fact-identifier-688" contextref="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_6e9a3d0bc8aa485f95b5d18fcef86c2f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">180,000</ix:nonfraction></span> and $<span><ix:nonfraction name="us-gaap:ShareBasedCompensation" id="fact-identifier-689" contextref="c20200827to20201231_AwardTypeAxis_RestrictedStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_caa397bdebc14592889a55f666110d46" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">22,500</ix:nonfraction></span> for the year ended December 31, 2021 and December 31,
            2020, respectively.<br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c11" continuedat="Text_57bfa148223a491f8ad447ff0e1abf2c12" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_57bfa148223a491f8ad447ff0e1abf2c12" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">Total unrecognized compensation expense related to unvested Founder Shares at December 31, 2021 amounted to $<span><ix:nonfraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" id="fact-identifier-692" contextref="c20211231_AwardTypeAxis_RestrictedStockMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_99cc62e40e994b7288aeaedd611c7909" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">541,500</ix:nonfraction></span> and is expected to be recognized over a weighted average period of <span><ix:nonnumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="fact-identifier-693" contextref="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" format="ixt-sec:duryear" inside-table="false" data-original-id="Fact_1e7e5a612fe44a059ae1b1fc992bbe60" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">2.8</ix:nonnumeric></span> years.</div>
</ix:continuation></span>

          <div style="text-align: justify; text-indent: 303.75pt; margin-right: 0.6pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:IncomeTaxDisclosureTextBlock" id="fact-identifier-694" contextref="c20210101to20211231" escape="true" continuedat="Text_688979efcdac4294a69c3da8eaaa04391" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_a5a69c56696242d5bfc79e95d1133286" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTE 9 <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">—</span> INCOME TAX</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa04391" continuedat="Text_688979efcdac4294a69c3da8eaaa04392" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa04392" continuedat="Text_688979efcdac4294a69c3da8eaaa04393" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="fact-identifier-697" contextref="c20210101to20211231" escape="true" continuedat="Text_ac85fe71a4664003a2c40296f3aa39031" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_efc98d7b6d744ba3afc1e3a634e98713" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company’s net deferred tax assets is as follows:</div>
</ix:nonnumeric></span></ix:continuation></span>
          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa04393" continuedat="Text_688979efcdac4294a69c3da8eaaa04394" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_ac85fe71a4664003a2c40296f3aa39031" continuedat="Text_ac85fe71a4664003a2c40296f3aa39032" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa04394" continuedat="Text_688979efcdac4294a69c3da8eaaa04395" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_ac85fe71a4664003a2c40296f3aa39032" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">
                    <div style="font-weight: bold;">December 31,</div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: top; white-space: nowrap;" colspan="2">
                  <div style="font-weight: bold;">December 31, <br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" rowspan="1">&nbsp;</td>

    <td style="vertical-align: top; font-weight: bold; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2" rowspan="1">&nbsp;2021</td>

    <td style="text-align: center; vertical-align: top; font-weight: bold; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="1">&nbsp;</td>

    <td style="text-align: center; vertical-align: top; font-weight: bold; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="1">&nbsp;</td>

    <td style="text-align: center; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2" rowspan="1">2020</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Deferred tax assets<br>
                  </div>
                </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Net operating loss carryforward</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" id="fact-identifier-702" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_1ea829b3b0ba461dab7e370f04ef6f77" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">416,904</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" id="fact-identifier-703" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_3a7428b140294c38a7768f797fef6eff" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">51,301</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Stock compensation</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" id="fact-identifier-704" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_c3cc911e82ca4e479146046e1ab24842" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">42,525</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" id="fact-identifier-705" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_a6d89d077c6c4f7f8fa74c22baa365d9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">4,725</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Unrealized gain on marketable securities</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="jyac:DeferredTaxAssetsUnrealizedGainOnMarketableSecurities" id="fact-identifier-706" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_fc5c95c8fa374bc99b48c6dcc5b27b6c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';"></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="jyac:DeferredTaxAssetsUnrealizedGainOnMarketableSecurities" id="fact-identifier-707" contextref="c20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_93819eebcd684616bd12841527f53552" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="false" iscustomonly="true">435</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Total deferred tax assets (liabilities)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:DeferredTaxAssetsGross" id="fact-identifier-708" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_1af2f37d0de34704b946ff78fa189915" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">459,429</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:DeferredTaxAssetsGross" id="fact-identifier-709" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_bc1cba53c14b4aabb2598f517a5f5481" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">55,591</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Valuation Allowance</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:DeferredTaxAssetsValuationAllowance" id="fact-identifier-710" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_30e1d0c4d4b4459da26b841f2520c611" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">459,429</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:DeferredTaxAssetsValuationAllowance" id="fact-identifier-711" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_101aa8e1aad742c4b21253bb674c0de0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">55,591</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Deferred tax assets, net of allowance</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:DeferredTaxAssetsNet" id="fact-identifier-712" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_ee2dc2ff302d4ce5bede2f723f32d601" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:DeferredTaxAssetsNet" id="fact-identifier-713" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_f3aa32da29b04387b1c63b8ed45a5574" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>


</tbody></table>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa04395" continuedat="Text_688979efcdac4294a69c3da8eaaa04396" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa04396" continuedat="Text_688979efcdac4294a69c3da8eaaa04397" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="fact-identifier-716" contextref="c20210101to20211231" escape="true" continuedat="Text_4d0af30cc16d4d8084bf8f4c3725c9d41" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_096fba4b23b94fcab2bd69818e00b0a5" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The income tax provision consists of the following:</div>
</ix:nonnumeric></span></ix:continuation></span>
          <a id="BKMK_89"></a><span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa04397" continuedat="Text_688979efcdac4294a69c3da8eaaa04398" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_4d0af30cc16d4d8084bf8f4c3725c9d41" continuedat="Text_4d0af30cc16d4d8084bf8f4c3725c9d42" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"></span><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa04398" continuedat="Text_688979efcdac4294a69c3da8eaaa04399" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_4d0af30cc16d4d8084bf8f4c3725c9d42" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">
                    <div style="font-weight: bold;">As of </div>
                    <div style="font-weight: bold;">December 31,</div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: top; white-space: nowrap;" colspan="2">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">
                    <div style="font-weight: bold;">As of<br>
                      December 31,</div>
                    <span style="font-weight: bold;"> </span></div>
                  <span style="font-weight: bold;"> </span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="1">&nbsp;</td>

    <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; text-align: center; white-space: nowrap;" colspan="2" rowspan="1">2021<br>
                </td>

    <td style="text-align: center; vertical-align: top; padding-bottom: 2px; font-weight: bold; white-space: nowrap;" colspan="1" rowspan="1">&nbsp;</td>

    <td style="text-align: center; vertical-align: top; padding-bottom: 2px; font-weight: bold; white-space: nowrap;" colspan="1" rowspan="1">&nbsp;</td>

    <td style="text-align: center; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" colspan="2" rowspan="1">2020</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Federal</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Current</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="fact-identifier-721" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_f7750154519d405db90571e4ebd13b12" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="fact-identifier-722" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_409156f200384615a773b28fc3c3920d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Deferred</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="fact-identifier-723" contextref="c20210101to20211231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_5d4cfe531a264aa381fba40d5850a7e1" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">403,838</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="fact-identifier-724" contextref="c20200827to20201231" unitref="U001" decimals="0" sign="-" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_011d78fc2b5540dfa27de008eabc017e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">55,591</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">State and Local</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Current</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="fact-identifier-725" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_9b443ccfbe1a419884d9ba467a12e44c" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="fact-identifier-726" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_caf7096d4ae34fde9fed391db66cd244" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Deferred</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="fact-identifier-727" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_ae604161def64c3aa408bc58ab10f65e" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="fact-identifier-728" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_77a2ff99ee8649dcbac28db2061d89ee" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Change in valuation allowance</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1"><span><ix:nonfraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="fact-identifier-729" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_2e70c3de5f8f4e039b9a32d4c660d650" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">403,838</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="fact-identifier-730" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_0ee61840249a49ad820c07f77432a067" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">55,591</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Income tax provision</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" id="fact-identifier-731" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_b1d0a87bd44346a582dc9da1aef975a9" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" id="fact-identifier-732" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:zerodash" inside-table="true" data-original-id="Fact_1e9797779e7c434786d424a8f11d5797" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">—</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>


</tbody></table>
</ix:continuation></span></ix:continuation></span><span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa04399" continuedat="Text_688979efcdac4294a69c3da8eaaa043910" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div>
           <br></div>
</ix:continuation></span>
          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa043910" continuedat="Text_688979efcdac4294a69c3da8eaaa043911" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">As of December 31, 2021 and 2020, the Company had $<span><ix:nonfraction name="us-gaap:OperatingLossCarryforwards" id="fact-identifier-735" contextref="c20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_6b0fb7f8a1884769ab0bf4294ca64c3b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">1,740,969</ix:nonfraction></span>
            and $<span><ix:nonfraction name="us-gaap:OperatingLossCarryforwards" id="fact-identifier-736" contextref="c20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_86f56e4ed50b4a08badb6be7798b5bce" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">244,288</ix:nonfraction></span> of U.S. federal and state net operating loss carryovers available to offset future taxable income, respectively.<br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa043911" continuedat="Text_688979efcdac4294a69c3da8eaaa043912" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa043912" continuedat="Text_688979efcdac4294a69c3da8eaaa043913" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the
            deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts
            become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. <span style="color: rgb(35, 31, 32);">After consideration of all
              of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2021
              and for the period from</span> August 27, 2020 (inception) through December 31, 2020<span style="color: rgb(35, 31, 32);">, the change in the valuation allowance was $<span><ix:nonfraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="fact-identifier-739" contextref="c20210101to20211231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_75f7836f6ceb442b990dcfd0fc29db4d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">403,838</ix:nonfraction></span> and $<span><ix:nonfraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="fact-identifier-740" contextref="c20200827to20201231" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="false" data-original-id="Fact_95ef754d507c429ca5fe7abfc02b547f" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">55,591</ix:nonfraction></span>, respectively.<br>
            </span></div>
</ix:continuation></span>
          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa043913" continuedat="Text_688979efcdac4294a69c3da8eaaa043914" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa043914" continuedat="Text_688979efcdac4294a69c3da8eaaa043915" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="fact-identifier-743" contextref="c20210101to20211231" escape="true" continuedat="Text_6e95eb0d946f44e2a0166f52b164d7d01" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_24e739c07e564254a460bac481cd204f" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows:</div>
</ix:nonnumeric></span></ix:continuation></span>
          <a id="BKMK_90"></a><span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa043915" continuedat="Text_688979efcdac4294a69c3da8eaaa043916" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_6e95eb0d946f44e2a0166f52b164d7d01" continuedat="Text_6e95eb0d946f44e2a0166f52b164d7d02" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"></span><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa043916" continuedat="Text_688979efcdac4294a69c3da8eaaa043917" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_6e95eb0d946f44e2a0166f52b164d7d02" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">December 31,</div>
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> 2021</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                  <div style="font-weight: bold;">December 31, </div>
                  <div style="font-weight: bold;">2020<br>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: center; vertical-align: top; white-space: nowrap;" rowspan="1" colspan="2">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Statutory federal income tax rate</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="fact-identifier-748" contextref="c20210101to20211231" unitref="U004" decimals="3" scale="-2" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d4235e9e5ce449b7aa8df2e1306ed9ed" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">21.0</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">%</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="fact-identifier-749" contextref="c20200827to20201231" unitref="U004" decimals="3" scale="-2" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_2f69c629fd3746d68bbf5082ec86dd7b" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">21.0</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">State taxes, net of federal tax benefit</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="fact-identifier-750" contextref="c20210101to20211231" unitref="U004" decimals="3" scale="-2" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_90417de1a717431385229135d648a6ff" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">%</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="fact-identifier-751" contextref="c20200827to20201231" unitref="U004" decimals="3" scale="-2" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_f4f80542c19e421abbc82829e63c725a" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Valuation allowance</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="font-family: 'Times New Roman';">(<span><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="fact-identifier-752" contextref="c20210101to20211231" unitref="U004" decimals="3" sign="-" scale="-2" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e9e40417d0224435bf747bfa454af69d" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">21.0</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">)%</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">(<span><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="fact-identifier-753" contextref="c20200827to20201231" unitref="U004" decimals="3" sign="-" scale="-2" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_c68b1478bfb94967be35ff8589ff58a0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="true" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">21.0</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                  <div style="margin-right: 0.8pt; font-family: 'Times New Roman';">Income tax provision</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="fact-identifier-754" contextref="c20210101to20211231" unitref="U004" decimals="3" scale="-2" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_e8e2eb8cf2854d62852342ea2a65cb50" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">%</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1"><span><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="fact-identifier-755" contextref="c20200827to20201231" unitref="U004" decimals="3" scale="-2" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_0ec97e734d2c46a198c559e12090d351" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="true" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">0.0</ix:nonfraction></span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">%</td>

  </tr>


</tbody></table>
</ix:continuation></span></ix:continuation></span>

          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa043917" continuedat="Text_688979efcdac4294a69c3da8eaaa043918" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">F-16</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div>
                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18">Table of Contents</a></span><br>
                </div>

                <div><span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> <br>
                    </a></span></div>

                <div>
                  <div style="text-align: justify; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">
                    <div style="text-align: center; margin-right: 11.25pt; margin-left: 11.25pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">JIYA ACQUISITION CORP.</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTES TO FINANCIAL STATEMENTS</div>

                    <div style="text-align: center; margin-right: 0.5pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">DECEMBER 31, 2021</div>

                  </div>

                  <span style="font-style: italic; font-size: 8pt;"><a href="#TABLEOF" tabindex="18"> </a></span></div>

              </div>

            </div>

          </div>

          <span><ix:continuation id="Text_688979efcdac4294a69c3da8eaaa043918" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The
            Company's tax returns since inception remain open to examination by the taxing authorities. The Company considers California to be a significant state tax jurisdiction.</div>
</ix:continuation></span>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:FairValueDisclosuresTextBlock" id="fact-identifier-758" contextref="c20210101to20211231" escape="true" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b1" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_6461145f2df347a7832a4669f0259aed" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.6pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTE 10 <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">—</span> FAIR VALUE MEASUREMENTS</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b1" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b2" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="text-align: justify; margin-right: 0.6pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b2" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b3" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are re-measured and reported at fair value at
            each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b3" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b4" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.6pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b4" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b5" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received
            in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and
            liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and
            liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</div>
</ix:continuation></span>
          <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b5" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b6" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.6pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
          </div>
</ix:continuation></span>
          <div style="text-align: justify; font-family: 'Times New Roman';">
            <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b6" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b7" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tbody><tr>

    <td style="width: 18pt;"><br>
                  </td>

    <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman';">Level&nbsp;1:</td>

    <td style="width: auto; vertical-align: top;">
                    <div style="font-family: 'Times New Roman'; text-align: justify;">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or
                      liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</div>
                  </td>

  </tr>


</tbody></table>
</ix:continuation></span>
            <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b7" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b8" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
            </div>
</ix:continuation></span>
            <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b8" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b9" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tbody><tr>

    <td style="width: 18pt;"><br>
                  </td>

    <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman';">Level&nbsp;2:</td>

    <td style="width: auto; vertical-align: top;">
                    <div style="font-family: 'Times New Roman'; text-align: justify;">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for
                      identical assets or liabilities in markets that are not active.</div>
                  </td>

  </tr>


</tbody></table>
</ix:continuation></span>
            <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b9" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b10" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
            </div>
</ix:continuation></span>
            <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b10" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b11" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tbody><tr>

    <td style="width: 18pt;"><br>
                  </td>

    <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman';">Level&nbsp;3:</td>

    <td style="width: auto; vertical-align: top;">
                    <div style="font-family: 'Times New Roman'; text-align: justify;">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</div>
                  </td>

  </tr>


</tbody></table>
</ix:continuation></span>
          </div>

          <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b11" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b12" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.6pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
          </div>
</ix:continuation></span>

          <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b12" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b13" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="fact-identifier-771" contextref="c20210101to20211231" escape="true" continuedat="Text_5e869c40d322458684c954c0dbc984411" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_70adc2a38b6b4722ac3153649ed5a33a" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2021
            and 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</div>
</ix:nonnumeric></span></ix:continuation></span>
          <a id="BKMK_91"></a><span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b13" continuedat="Text_ac9efab99f4c4979b1b32c5954370a2b14" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_5e869c40d322458684c954c0dbc984411" continuedat="Text_5e869c40d322458684c954c0dbc984412" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="margin-right: 0.6pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"></span><br>
          </div>
</ix:continuation></span></ix:continuation></span>
          <span><ix:continuation id="Text_ac9efab99f4c4979b1b32c5954370a2b14" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false"><span><ix:continuation id="Text_5e869c40d322458684c954c0dbc984412" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tbody><tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: justify; margin-right: 0.8pt; font-family: 'Times New Roman'; font-weight: bold;">Description</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Level</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">December 31,</div>
                  <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">2021<br>
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; text-align: center; border-bottom: #000000 solid 2px; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; font-weight: bold;">December 31, <br>
                  </div>
                  <span style="font-weight: bold;">2020</span><br>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
                  <div style="text-align: justify; margin-right: 0.8pt; font-family: 'Times New Roman';">Assets:</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&nbsp;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
                  <div style="text-align: justify; margin-right: 0.8pt; font-family: 'Times New Roman';">Marketable securities held in Trust Account</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; text-align: center;">1</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman';"><span><ix:nonfraction name="us-gaap:InvestmentsFairValueDisclosure" id="fact-identifier-776" contextref="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_75ebb1484d0d432a935e777525926a46" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,542,974</ix:nonfraction></span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><span><ix:nonfraction name="us-gaap:InvestmentsFairValueDisclosure" id="fact-identifier-777" contextref="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitref="U001" decimals="0" scale="0" format="ixt:numdotdecimal" inside-table="true" data-original-id="Fact_d76f7444b8a44774b9454c8fa77d3861" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="true" istextonly="false" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">103,522,529</ix:nonfraction></span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&nbsp;</td>

  </tr>


</tbody></table>
</ix:continuation></span></ix:continuation></span>

          <div style="text-align: justify; text-indent: 16.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><a id="BKMK_92"></a><span style="font-family: 'Times New Roman';"></span><br>
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol."></span><span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol."></span><span><ix:nonnumeric name="us-gaap:SubsequentEventsTextBlock" id="fact-identifier-778" contextref="c20210101to20211231" escape="true" continuedat="Text_8a04c5b41d894159a4d7cddfd1a5a7b61" inside-table="false" continued-main-taxonomy="true" data-original-id="Text_c5463b7932494a408a6fdc28f8d32471" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isamountsonly="false" istextonly="true" iscalculationsonly="false" isnegativesonly="false" isadditionalitemsonly="false" isstandardonly="true" iscustomonly="false">
<div style="text-align: justify; margin-right: 0.6pt; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">NOTE 11 <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">—</span> SUBSEQUENT EVENTS</div>
</ix:nonnumeric></span>
          <span><ix:continuation id="Text_8a04c5b41d894159a4d7cddfd1a5a7b61" continuedat="Text_8a04c5b41d894159a4d7cddfd1a5a7b62" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>
</ix:continuation></span>
          <span><ix:continuation id="Text_8a04c5b41d894159a4d7cddfd1a5a7b62" inside-table="false" continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" selected-taxonomy="false" hover-taxonomy="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" tabindex="18" isadditionalitemsonly="false">
<div style="display:none;"><br></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 18pt;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
            were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</div>
</ix:continuation></span>

          <div style="text-align: justify; text-indent: 16.2pt; margin-right: 0.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
          </div>

        </div>

      </div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFPageNumberArea"><span style="font-size: 8pt; font-weight: normal; font-style: normal; font-family: 'Times New Roman';" class="DSPFPageNumber">F-17</span></div>

    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"></div>

  </div>





</body>
</html>